{
  "data": [
    {
      "PCERDocID": "PCER000013815",
      "_id": "AlleleRecords/1692876078",
      "_key": "1692876078",
      "_rev": "_md_ZeJO---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA224451",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97105",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.106C>T",
        "NC_000023.11:g.38367319C>T",
        "CM000685.2:g.38367319C>T",
        "NC_000023.10:g.38226572C>T",
        "CM000685.1:g.38226572C>T",
        "NC_000023.9:g.38111516C>T",
        "NG_008471.1:g.19837C>T",
        "ENST00000039007.5:c.106C>T",
        "ENST00000643344.1:c.106C>T",
        "ENST00000039007.4:c.106C>T",
        "ENST00000465127.1:c.172-298802C>T",
        "ENST00000488812.1:n.198C>T",
        "NM_000531.5:c.106C>T",
        "XM_017029556.1:c.106C>T",
        "NM_000531.6(OTC):c.106C>T (p.Gln36Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.106c>t nc_000023.11:g.38367319c>t cm000685.2:g.38367319c>t nc_000023.10:g.38226572c>t cm000685.1:g.38226572c>t nc_000023.9:g.38111516c>t ng_008471.1:g.19837c>t enst00000039007.5:c.106c>t enst00000643344.1:c.106c>t enst00000039007.4:c.106c>t enst00000465127.1:c.172-298802c>t enst00000488812.1:n.198c>t nm_000531.5:c.106c>t xm_017029556.1:c.106c>t nm_000531.6(otc):c.106c>t (p.gln36ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.106C>T (p.Gln36Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.106C>T variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "84152d17-f73e-4799-a328-db7c53e6acfb",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013816",
      "_id": "AlleleRecords/1692877803",
      "_key": "1692877803",
      "_rev": "_md_h6Ka---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233316",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.630del",
        "NC_000023.11:g.38403707del",
        "CM000685.2:g.38403707del",
        "NC_000023.10:g.38262960del",
        "CM000685.1:g.38262960del",
        "NC_000023.9:g.38147904del",
        "NG_008471.1:g.56225del",
        "ENST00000039007.5:c.630del",
        "ENST00000643344.1:c.*380del",
        "ENST00000039007.4:c.630del",
        "ENST00000465127.1:c.172-262414del",
        "NM_000531.5:c.630del",
        "XM_017029556.1:c.630del"
      ],
      "hgvsSearch": "nm_000531.6:c.630del nc_000023.11:g.38403707del cm000685.2:g.38403707del nc_000023.10:g.38262960del cm000685.1:g.38262960del nc_000023.9:g.38147904del ng_008471.1:g.56225del enst00000039007.5:c.630del enst00000643344.1:c.*380del enst00000039007.4:c.630del enst00000465127.1:c.172-262414del nm_000531.5:c.630del xm_017029556.1:c.630del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.630del",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.630del (p.Lys210AsnfsTer20) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 6/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1), total +9.",
      "uuid": "126fbce8-5d3a-489f-8193-80f840d4ec06",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013817",
      "_id": "AlleleRecords/1692879745",
      "_key": "1692879745",
      "_rev": "_md_qWLu---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233327",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.799dup",
        "NC_000023.11:g.38408957dup",
        "CM000685.2:g.38408957dup",
        "NC_000023.10:g.38268210dup",
        "CM000685.1:g.38268210dup",
        "NC_000023.9:g.38153154dup",
        "NG_008471.1:g.61475dup",
        "ENST00000039007.5:c.799dup",
        "ENST00000643344.1:c.*549dup",
        "ENST00000039007.4:c.799dup",
        "ENST00000465127.1:c.172-257164dup",
        "NM_000531.5:c.799dup",
        "XM_017029556.1:c.799dup"
      ],
      "hgvsSearch": "nm_000531.6:c.799dup nc_000023.11:g.38408957dup cm000685.2:g.38408957dup nc_000023.10:g.38268210dup cm000685.1:g.38268210dup nc_000023.9:g.38153154dup ng_008471.1:g.61475dup enst00000039007.5:c.799dup enst00000643344.1:c.*549dup enst00000039007.4:c.799dup enst00000465127.1:c.172-257164dup nm_000531.5:c.799dup xm_017029556.1:c.799dup",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.799dup",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.799dup (p.Ser267LysfsTer26) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 8/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "588a994e-78a0-4345-a2a8-8f88ecd9732f",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013818",
      "_id": "AlleleRecords/1692881123",
      "_key": "1692881123",
      "_rev": "_md_yye----",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233305",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.461_471del",
        "NC_000023.11:g.38401349_38401359del",
        "CM000685.2:g.38401349_38401359del",
        "NC_000023.10:g.38260602_38260612del",
        "CM000685.1:g.38260602_38260612del",
        "NC_000023.9:g.38145546_38145556del",
        "NG_008471.1:g.53867_53877del",
        "ENST00000039007.5:c.461_471del",
        "ENST00000643344.1:c.*211_*221del",
        "ENST00000039007.4:c.461_471del",
        "ENST00000465127.1:c.172-264772_172-264762del",
        "ENST00000488812.1:n.498_508del",
        "NM_000531.5:c.461_471del",
        "XM_017029556.1:c.461_471del"
      ],
      "hgvsSearch": "nm_000531.6:c.461_471del nc_000023.11:g.38401349_38401359del cm000685.2:g.38401349_38401359del nc_000023.10:g.38260602_38260612del cm000685.1:g.38260602_38260612del nc_000023.9:g.38145546_38145556del ng_008471.1:g.53867_53877del enst00000039007.5:c.461_471del enst00000643344.1:c.*211_*221del enst00000039007.4:c.461_471del enst00000465127.1:c.172-264772_172-264762del enst00000488812.1:n.498_508del nm_000531.5:c.461_471del xm_017029556.1:c.461_471del",
      "metCodes": [
        "PVS1",
        "PM6_Supporting",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm6_supporting pm2_supporting pp4",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.461_471del",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.461_471del (p.Glu154AlafsTer18) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed neonatal onset, oroticaciduria, hyperammonemia which is highly specific for OTC deficiency (1.25pt; PP4_Supporting, PMID: 23278509). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 23278509). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt), PM6 (+2 pts), PP4_Supporting (+1 pt).",
      "uuid": "4be28294-4f7a-41e1-98b9-2ca38dd02333",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013819",
      "_id": "AlleleRecords/1692883587",
      "_key": "1692883587",
      "_rev": "_md_7Ovy---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA412723777",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "2573437",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.853C>T",
        "NC_000023.11:g.38409011C>T",
        "CM000685.2:g.38409011C>T",
        "NC_000023.10:g.38268264C>T",
        "CM000685.1:g.38268264C>T",
        "NC_000023.9:g.38153208C>T",
        "NG_008471.1:g.61529C>T",
        "ENST00000039007.5:c.853C>T",
        "ENST00000643344.1:c.*603C>T",
        "ENST00000039007.4:c.853C>T",
        "ENST00000465127.1:c.172-257110C>T",
        "NM_000531.5:c.853C>T",
        "XM_017029556.1:c.853C>T",
        "NM_000531.6(OTC):c.853C>T (p.Gln285Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.853c>t nc_000023.11:g.38409011c>t cm000685.2:g.38409011c>t nc_000023.10:g.38268264c>t cm000685.1:g.38268264c>t nc_000023.9:g.38153208c>t ng_008471.1:g.61529c>t enst00000039007.5:c.853c>t enst00000643344.1:c.*603c>t enst00000039007.4:c.853c>t enst00000465127.1:c.172-257110c>t nm_000531.5:c.853c>t xm_017029556.1:c.853c>t nm_000531.6(otc):c.853c>t (p.gln285ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm2_supporting pp4",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.853C>T (p.Gln285Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.853C>T(p.Gln285Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 8 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). One patient with this variant displayed Hyperammonemia, oroticaciduria, Childhood onset which is highly specific for OTC deficiency (1.25pts; PP4_Supporting, PMID: 23278509). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt), PP4_Supporting (+1 pt).",
      "unMetCodes": [
        "PM6",
        "PS2"
      ],
      "unMetCodesSearch": "pm6 ps2",
      "uuid": "ea467d08-57b7-4634-aff0-724585f2e198",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013820",
      "_id": "AlleleRecords/1692885043",
      "_key": "1692885043",
      "_rev": "_mdADrHG---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA913190354",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "597358",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.391_397dup",
        "NC_000023.11:g.38401279_38401285dup",
        "CM000685.2:g.38401279_38401285dup",
        "NC_000023.10:g.38260532_38260538dup",
        "CM000685.1:g.38260532_38260538dup",
        "NC_000023.9:g.38145476_38145482dup",
        "NG_008471.1:g.53797_53803dup",
        "ENST00000039007.5:c.391_397dup",
        "ENST00000643344.1:c.*141_*147dup",
        "ENST00000039007.4:c.391_397dup",
        "ENST00000465127.1:c.172-264842_172-264836dup",
        "ENST00000488812.1:n.428_434dup",
        "NM_000531.5:c.391_397dup",
        "XM_017029556.1:c.391_397dup"
      ],
      "hgvsSearch": "nm_000531.6:c.391_397dup nc_000023.11:g.38401279_38401285dup cm000685.2:g.38401279_38401285dup nc_000023.10:g.38260532_38260538dup cm000685.1:g.38260532_38260538dup nc_000023.9:g.38145476_38145482dup ng_008471.1:g.53797_53803dup enst00000039007.5:c.391_397dup enst00000643344.1:c.*141_*147dup enst00000039007.4:c.391_397dup enst00000465127.1:c.172-264842_172-264836dup enst00000488812.1:n.428_434dup nm_000531.5:c.391_397dup xm_017029556.1:c.391_397dup",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.391_397dup",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.391_397dup (p.Ser133IlefsTer3) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). One patient with this variant displayed orotic aciduria, hyperglutaminemia, hyperammonemia, childhood onset of the disease, low plasma citrulline, which is highly specific for OTC deficiency (1.75pt; PP4_Moderate, PMID: 17334707). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+ 1 pt), PP4_Moderate (+2 pts).",
      "uuid": "8cdf5f38-3715-4f91-a350-af59f91ec0ff",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013821",
      "_id": "AlleleRecords/1692886689",
      "_key": "1692886689",
      "_rev": "_mdAMIW6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA224771",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97311",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.759del",
        "NC_000023.11:g.38408917del",
        "CM000685.2:g.38408917del",
        "NC_000023.10:g.38268170del",
        "CM000685.1:g.38268170del",
        "NC_000023.9:g.38153114del",
        "NG_008471.1:g.61435del",
        "ENST00000039007.5:c.759del",
        "ENST00000643344.1:c.*509del",
        "ENST00000039007.4:c.759del",
        "ENST00000465127.1:c.172-257204del",
        "NM_000531.5:c.759del",
        "XM_017029556.1:c.759del",
        "NM_000531.6(OTC):c.759del (p.Ala254fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.759del nc_000023.11:g.38408917del cm000685.2:g.38408917del nc_000023.10:g.38268170del cm000685.1:g.38268170del nc_000023.9:g.38153114del ng_008471.1:g.61435del enst00000039007.5:c.759del enst00000643344.1:c.*509del enst00000039007.4:c.759del enst00000465127.1:c.172-257204del nm_000531.5:c.759del xm_017029556.1:c.759del nm_000531.6(otc):c.759del (p.ala254fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.759del (p.Ala254fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.759del (p.Ala254ArgfsTer7) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 8/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "a754c0e2-28ed-4b71-9b5f-6b28a2600911",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013822",
      "_id": "AlleleRecords/1692888166",
      "_key": "1692888166",
      "_rev": "_mdAUlCC---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3203994",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "853579",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.4360C>T",
        "NC_000005.10:g.13864633G>A",
        "CM000667.2:g.13864633G>A",
        "NC_000005.9:g.13864742G>A",
        "CM000667.1:g.13864742G>A",
        "NC_000005.8:g.13917742G>A",
        "NG_013081.1:g.84848C>T",
        "NG_013081.2:g.84848C>T",
        "ENST00000265104.5:c.4360C>T",
        "ENST00000681290.1:c.4315C>T",
        "ENST00000265104.4:c.4360C>T",
        "NM_001369.2:c.4360C>T",
        "XM_005248262.2:c.4315C>T",
        "XM_011513990.1:c.4360C>T",
        "XR_925598.1:n.4567C>T",
        "XM_005248262.3:c.4468C>T",
        "XM_017009177.1:c.4468C>T",
        "XM_017009178.1:c.3373C>T",
        "XM_017009179.2:c.3373C>T",
        "XM_017009180.1:c.4468C>T",
        "XM_017009181.1:c.4468C>T",
        "XM_017009182.1:c.4468C>T",
        "XM_017009183.1:c.4468C>T",
        "XM_017009184.1:c.4468C>T",
        "XM_017009187.1:c.4468C>T",
        "XM_024454388.1:c.3373C>T",
        "XM_024454389.1:c.2962C>T",
        "XR_001742034.1:n.4485C>T",
        "XR_001742035.1:n.4485C>T",
        "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.4360c>t nc_000005.10:g.13864633g>a cm000667.2:g.13864633g>a nc_000005.9:g.13864742g>a cm000667.1:g.13864742g>a nc_000005.8:g.13917742g>a ng_013081.1:g.84848c>t ng_013081.2:g.84848c>t enst00000265104.5:c.4360c>t enst00000681290.1:c.4315c>t enst00000265104.4:c.4360c>t nm_001369.2:c.4360c>t xm_005248262.2:c.4315c>t xm_011513990.1:c.4360c>t xr_925598.1:n.4567c>t xm_005248262.3:c.4468c>t xm_017009177.1:c.4468c>t xm_017009178.1:c.3373c>t xm_017009179.2:c.3373c>t xm_017009180.1:c.4468c>t xm_017009181.1:c.4468c>t xm_017009182.1:c.4468c>t xm_017009183.1:c.4468c>t xm_017009184.1:c.4468c>t xm_017009187.1:c.4468c>t xm_024454388.1:c.3373c>t xm_024454389.1:c.2962c>t xr_001742034.1:n.4485c>t xr_001742035.1:n.4485c>t nm_001369.3(dnah5):c.4360c>t (p.arg1454ter)",
      "metCodes": [
        "PVS1",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pvs1 pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter) is a nonsense variant that introduces a premature stop codon into exon 28 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v4.1.1 at a Grpmax allele frequency of 0.00001062, with 3 alleles / 75,022 total alleles in the African / African American population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00008426 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant has been found in the homozygous state in one occurrence in gnomAD v4.1.0, in the Finnish population, however, at least three occurrences in gnomAD are required to meet BS2. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9346C>T (p.Arg3116Ter) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 total point, PMID: 38206729, PM3). The proband harboring this variant exhibits a phenotype including onset at age 3 years, family history consistent with autosomal recessive inheritance, recurrent wet cough (1 pt), absence of outer dynein arms in ciliary axonemes (4 pts), recurrent respiratory infections including sinusitis (1 pt) with purulent rhinorrhea, bilateral pneumonia, bronchiectasis (1 pt), and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 38206729, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS2"
      ],
      "unMetCodesSearch": "pm2 bs2",
      "uuid": "d8fbd409-0580-4cf4-83a1-ec53714c30a8",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013823",
      "_id": "AlleleRecords/1692892443",
      "_key": "1692892443",
      "_rev": "_mdAtdly---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA339772",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "65636",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.10815delT",
        "NM_001369.3:c.10815del",
        "NC_000005.10:g.13753290del",
        "CM000667.2:g.13753290del",
        "NC_000005.9:g.13753399del",
        "CM000667.1:g.13753399del",
        "NC_000005.8:g.13806399del",
        "NG_013081.1:g.196191del",
        "NG_013081.2:g.196191del",
        "ENST00000265104.5:c.10815del",
        "ENST00000681290.1:c.10770del",
        "ENST00000265104.4:c.10815del",
        "NM_001369.2:c.10815del",
        "XM_005248262.2:c.10770del",
        "XM_005248262.3:c.10923del",
        "XM_017009177.1:c.10923del",
        "XM_017009178.1:c.9828del",
        "XM_017009179.2:c.9828del",
        "XM_017009180.1:c.10923del",
        "XM_017009181.1:c.10923del",
        "XM_017009182.1:c.10923del",
        "XM_017009185.1:c.6012del",
        "XM_017009186.1:c.5565del",
        "XM_017009188.1:c.4902del",
        "XM_024454388.1:c.9828del",
        "XM_024454389.1:c.9417del",
        "NM_001369.3(DNAH5):c.10815del (p.Pro3606fs)"
      ],
      "hgvsSearch": "nm_001369.3:c.10815delt nm_001369.3:c.10815del nc_000005.10:g.13753290del cm000667.2:g.13753290del nc_000005.9:g.13753399del cm000667.1:g.13753399del nc_000005.8:g.13806399del ng_013081.1:g.196191del ng_013081.2:g.196191del enst00000265104.5:c.10815del enst00000681290.1:c.10770del enst00000265104.4:c.10815del nm_001369.2:c.10815del xm_005248262.2:c.10770del xm_005248262.3:c.10923del xm_017009177.1:c.10923del xm_017009178.1:c.9828del xm_017009179.2:c.9828del xm_017009180.1:c.10923del xm_017009181.1:c.10923del xm_017009182.1:c.10923del xm_017009185.1:c.6012del xm_017009186.1:c.5565del xm_017009188.1:c.4902del xm_024454388.1:c.9828del xm_024454389.1:c.9417del nm_001369.3(dnah5):c.10815del (p.pro3606fs)",
      "metCodes": [
        "PVS1",
        "PM3_Supporting",
        "PP1",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm3_supporting pp1 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.10815del (p.Pro3606fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.10815del (p.Pro3606HisfsTer23) is a frameshift variant that introduces a premature stop codon into exon 63 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1, PMIDs: 16627867, 34556108). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.00051, with 638 alleles / 1,179,900 total alleles in the European (non-Finnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.000411 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was homozygous for the variant (0.5 points, PMID: 16627867, PMID: 20301301, PM3_Supporting). This variant has also been reported in at least 4 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.232C>T (p.Arg78Ter) variant confirmed in trans (PMID: 16627867, PMID: 31879361), the NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) confirmed in trans (PMID: 16627867, 39115449), or the NM_001369.3:c.13486C>T (p.Arg4496Ter) (PMID: 16627867) confirmed in trans, all of which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP, which were not counted for PM3 in order to avoid circularity. At least one proband harboring this variant exhibits a phenotype including: absent outer dynein arms (4 pt), productive cough (1 pt), decreased nasal nitric oxide (1 pt), neonatal respiratory distress (1 pt), sinusitis, rhinitis, chronic otitis media (1 pt) and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 9 points, PMID:23477994, PP4). The variant has been reported to co-segregate with primary ciliary dyskinesia through at least one segregation within the family of the proband, with the variant present in the compound heterozygous state (PMID: 23477994, PP1). In summary, this variant meets the criteria to be classified as Pathogenic for primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3_Supporting, PP4, and PP1. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "8f286f60-da57-4194-9500-39f3188038b2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013824",
      "_id": "AlleleRecords/1692893601",
      "_key": "1692893601",
      "_rev": "_mdA15wW---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA113954672",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "1458963",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5147G>T",
        "NC_000005.10:g.13844961C>A",
        "CM000667.2:g.13844961C>A",
        "NC_000005.9:g.13845070C>A",
        "CM000667.1:g.13845070C>A",
        "NC_000005.8:g.13898070C>A",
        "NG_013081.1:g.104520G>T",
        "NG_013081.2:g.104520G>T",
        "ENST00000265104.5:c.5147G>T",
        "ENST00000681290.1:c.5102G>T",
        "ENST00000265104.4:c.5147G>T",
        "NM_001369.2:c.5147G>T",
        "XM_005248262.2:c.5102G>T",
        "XM_011513990.1:c.5147G>T",
        "XR_925598.1:n.5354G>T",
        "XM_005248262.3:c.5255G>T",
        "XM_017009177.1:c.5255G>T",
        "XM_017009178.1:c.4160G>T",
        "XM_017009179.2:c.4160G>T",
        "XM_017009180.1:c.5255G>T",
        "XM_017009181.1:c.5255G>T",
        "XM_017009182.1:c.5255G>T",
        "XM_017009183.1:c.5255G>T",
        "XM_017009184.1:c.5255G>T",
        "XM_017009185.1:c.344G>T",
        "XM_017009186.1:c.22-3057G>T",
        "XM_017009187.1:c.5255G>T",
        "XM_024454388.1:c.4160G>T",
        "XM_024454389.1:c.3749G>T",
        "XR_001742034.1:n.5272G>T",
        "XR_001742035.1:n.5272G>T",
        "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu)"
      ],
      "hgvsSearch": "nm_001369.3:c.5147g>t nc_000005.10:g.13844961c>a cm000667.2:g.13844961c>a nc_000005.9:g.13845070c>a cm000667.1:g.13845070c>a nc_000005.8:g.13898070c>a ng_013081.1:g.104520g>t ng_013081.2:g.104520g>t enst00000265104.5:c.5147g>t enst00000681290.1:c.5102g>t enst00000265104.4:c.5147g>t nm_001369.2:c.5147g>t xm_005248262.2:c.5102g>t xm_011513990.1:c.5147g>t xr_925598.1:n.5354g>t xm_005248262.3:c.5255g>t xm_017009177.1:c.5255g>t xm_017009178.1:c.4160g>t xm_017009179.2:c.4160g>t xm_017009180.1:c.5255g>t xm_017009181.1:c.5255g>t xm_017009182.1:c.5255g>t xm_017009183.1:c.5255g>t xm_017009184.1:c.5255g>t xm_017009185.1:c.344g>t xm_017009186.1:c.22-3057g>t xm_017009187.1:c.5255g>t xm_024454388.1:c.4160g>t xm_024454389.1:c.3749g>t xr_001742034.1:n.5272g>t xr_001742035.1:n.5272g>t nm_001369.3(dnah5):c.5147g>t (p.arg1716leu)",
      "metCodes": [
        "PP3_Strong",
        "PM2_Supporting",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pp3_strong pm2_supporting pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu) is a missense variant encoding substitution of arginine by leucine at amino acid 1716. This variant is present in gnomAD v4.1.1 at a total allele frequency of 0.0000006196, with 1 allele / 1,614,004 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 points, PMID:16627867, PM3). The proband harboring this variant exhibits a phenotype including absence of outer dynein arms by immunofluorescence (4 pts), situs inversus (1 pt), recurrent pneumonia (0.5 pt), onset of bronchiectasis in childhood before 18 years of age (1 pt) and respiratory cilia with severely altered or no motility (1 pt), which together are specific for primary ciliary dyskinesia (7.5 total points, PMID: 16627867, PP4). The computational predictor REVEL gives a score of 0.954, which is above the ClinGen Motile Ciliopathy VCEP threshold of ≥0.932 and predicts a damaging effect on DNAH5 function (PP3_Strong). The splicing impact predictor SpliceAI gives delta scores of 0.35 for acceptor gain and 0.29 for acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predicts a damaging impact on DNAH5 splicing. Another missense variant in the same codon, NM_001369.3(DNAH5):c.5146C>T (p.Arg1716Trp), has been classified as likely pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 36864285, PMID: 32502479). Splicing prediction using SpliceAI predicted an effect on splicing for this variant that was not predicted for the previous variant, so PM5_Supporting has not been counted. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PM2_Supporting, PM3, PP4, and PP3_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM5"
      ],
      "unMetCodesSearch": "pm5",
      "uuid": "da4b884e-85d2-44dd-b8f9-6858be7ce871",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013825",
      "_id": "AlleleRecords/1692895055",
      "_key": "1692895055",
      "_rev": "_mdB-W8i---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA359214371",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "934373",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5147G>C",
        "NC_000005.10:g.13844961C>G",
        "CM000667.2:g.13844961C>G",
        "NC_000005.9:g.13845070C>G",
        "CM000667.1:g.13845070C>G",
        "NC_000005.8:g.13898070C>G",
        "NG_013081.1:g.104520G>C",
        "NG_013081.2:g.104520G>C",
        "ENST00000265104.5:c.5147G>C",
        "ENST00000681290.1:c.5102G>C",
        "ENST00000265104.4:c.5147G>C",
        "NM_001369.2:c.5147G>C",
        "XM_005248262.2:c.5102G>C",
        "XM_011513990.1:c.5147G>C",
        "XR_925598.1:n.5354G>C",
        "XM_005248262.3:c.5255G>C",
        "XM_017009177.1:c.5255G>C",
        "XM_017009178.1:c.4160G>C",
        "XM_017009179.2:c.4160G>C",
        "XM_017009180.1:c.5255G>C",
        "XM_017009181.1:c.5255G>C",
        "XM_017009182.1:c.5255G>C",
        "XM_017009183.1:c.5255G>C",
        "XM_017009184.1:c.5255G>C",
        "XM_017009185.1:c.344G>C",
        "XM_017009186.1:c.22-3057G>C",
        "XM_017009187.1:c.5255G>C",
        "XM_024454388.1:c.4160G>C",
        "XM_024454389.1:c.3749G>C",
        "XR_001742034.1:n.5272G>C",
        "XR_001742035.1:n.5272G>C",
        "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro)"
      ],
      "hgvsSearch": "nm_001369.3:c.5147g>c nc_000005.10:g.13844961c>g cm000667.2:g.13844961c>g nc_000005.9:g.13845070c>g cm000667.1:g.13845070c>g nc_000005.8:g.13898070c>g ng_013081.1:g.104520g>c ng_013081.2:g.104520g>c enst00000265104.5:c.5147g>c enst00000681290.1:c.5102g>c enst00000265104.4:c.5147g>c nm_001369.2:c.5147g>c xm_005248262.2:c.5102g>c xm_011513990.1:c.5147g>c xr_925598.1:n.5354g>c xm_005248262.3:c.5255g>c xm_017009177.1:c.5255g>c xm_017009178.1:c.4160g>c xm_017009179.2:c.4160g>c xm_017009180.1:c.5255g>c xm_017009181.1:c.5255g>c xm_017009182.1:c.5255g>c xm_017009183.1:c.5255g>c xm_017009184.1:c.5255g>c xm_017009185.1:c.344g>c xm_017009186.1:c.22-3057g>c xm_017009187.1:c.5255g>c xm_024454388.1:c.4160g>c xm_024454389.1:c.3749g>c xr_001742034.1:n.5272g>c xr_001742035.1:n.5272g>c nm_001369.3(dnah5):c.5147g>c (p.arg1716pro)",
      "metCodes": [
        "PP3_Strong",
        "PM3_Supporting",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pp3_strong pm3_supporting pm2_supporting pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro) is a missense variant encoding substitution of arginine by proline at amino acid 1716. This variant is absent from gnomAD v4.1.1 (PM2_Supporting). This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9799C>T (p.Gln3267Ter) variant suspected but not confirmed in trans, which was previously classified pathogenic by the Motile Ciliopathy VCEP (0.5 points, PMID: 30067075, PM3_Supporting). The proband harboring this variant exhibits a phenotype including an outer dynein defect (4 pts) and other clinical details confirmed through confidential correspondence, which together are specific for primary ciliary dyskinesia 3 (total 6 points, PMID: 30067075, PP4). The computational predictor REVEL gives a score of 0.973, which is above the ClinGen Motile Ciliopathy VCEP threshold of ≥0.932 and predicts a damaging effect on DNAH5 function (PP3_Strong). The splicing impact predictor SpliceAI gives a delta score of 0.13 for acceptor gain, which is below the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and does not strongly predict a damaging impact on DNAH5 splicing. Another missense variant in the same codon, NM_001369.3(DNAH5):c.5146C>T (p.Arg1716Trp), has been classified as likely pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 36864285, PMID: 32502479). Splicing prediction using SpliceAI did not strongly predict an effect on splicing due to either of these variants. However, PM5_Supporting was not counted as this code is mutually exclusive with PP3_Strong. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PM2_Supporting, PP4, PM3_Supporting, and PP3_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM5"
      ],
      "unMetCodesSearch": "pm5",
      "uuid": "e9e4da4d-6caf-440f-8c5a-90ba9607370d",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013826",
      "_id": "AlleleRecords/1692896931",
      "_key": "1692896931",
      "_rev": "_mdBGzW2---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3201398",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "572293",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.13338+5G>A",
        "NC_000005.10:g.13708118C>T",
        "CM000667.2:g.13708118C>T",
        "NC_000005.9:g.13708227C>T",
        "CM000667.1:g.13708227C>T",
        "NC_000005.8:g.13761227C>T",
        "NG_013081.1:g.241363G>A",
        "NG_013081.2:g.241363G>A",
        "ENST00000683611.1:n.671+5G>A",
        "ENST00000265104.5:c.13338+5G>A",
        "ENST00000681290.1:c.13293+5G>A",
        "ENST00000265104.4:c.13338+5G>A",
        "NM_001369.2:c.13338+5G>A",
        "XM_005248262.2:c.13293+5G>A",
        "XM_005248262.3:c.13446+5G>A",
        "XM_017009177.1:c.13026+5G>A",
        "XM_017009178.1:c.12351+5G>A",
        "XM_017009179.2:c.12351+5G>A",
        "XM_017009185.1:c.8535+5G>A",
        "XM_017009186.1:c.8088+5G>A",
        "XM_017009188.1:c.7425+5G>A",
        "XM_024454388.1:c.12351+5G>A",
        "XM_024454389.1:c.11940+5G>A",
        "NM_001369.3(DNAH5):c.13338+5G>A"
      ],
      "hgvsSearch": "nm_001369.3:c.13338+5g>a nc_000005.10:g.13708118c>t cm000667.2:g.13708118c>t nc_000005.9:g.13708227c>t cm000667.1:g.13708227c>t nc_000005.8:g.13761227c>t ng_013081.1:g.241363g>a ng_013081.2:g.241363g>a enst00000683611.1:n.671+5g>a enst00000265104.5:c.13338+5g>a enst00000681290.1:c.13293+5g>a enst00000265104.4:c.13338+5g>a nm_001369.2:c.13338+5g>a xm_005248262.2:c.13293+5g>a xm_005248262.3:c.13446+5g>a xm_017009177.1:c.13026+5g>a xm_017009178.1:c.12351+5g>a xm_017009179.2:c.12351+5g>a xm_017009185.1:c.8535+5g>a xm_017009186.1:c.8088+5g>a xm_017009188.1:c.7425+5g>a xm_024454388.1:c.12351+5g>a xm_024454389.1:c.11940+5g>a nm_001369.3(dnah5):c.13338+5g>a",
      "metCodes": [
        "PM2_Supporting",
        "PS1",
        "PM3_Strong",
        "PP3",
        "PP4"
      ],
      "metCodesSearch": "pm2_supporting ps1 pm3_strong pp3 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.13338+5G>A",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.13338+5G>A is an intronic variant located outside of the canonical splice site at the +5 nucleotide position of the donor splice region downstream of exon 76. The splicing impact predictor SpliceAI gives delta scores of 0.92 for splice donor loss and 0.84 for splice acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predict a damaging impact on DNAH5 splicing (PP3). Another intronic variant in the same nucleotide position, NM_001369.3(DNAH5):c.13338+5G>C, has been classified pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 39014333, PS1). This variant is present in gnomAD v4.1.1 at a total allele frequency of 0.00001177, with 19 alleles / 1,613,716 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 3 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.5563dup (p.Ile1855AsnfsTer6) variant confirmed in trans (PMID:16627867, personal communication), or the NM_001369.3(DNAH5):c.10384C>T (p.Gln3462Ter) variant suspected but not confirmed in trans (found in two unrelated probands, PMID: 24498942, PMID:  29363216), both of which were previously classified as pathogenic by the ClinGen Motile Ciliopathy VCEP (total 2 pts, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including absent outer dynein arms by transmission electron microscopy (4 pt), neonatal respiratory distress (1 pt), recurrent pneumonia (0.5 pt), bronchiectasis with undetermined age of onset (0.5 pt), sinusitis and chronic otitis media (1 pt), and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 16627867, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PP3, PS1, PM2_Supporting, PM3_Strong, and PP4. (VCEP specifications version 1.0.0).",
      "uuid": "be90e8d5-d17c-4395-b095-bfb549518b05",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013827",
      "_id": "AlleleRecords/1692898211",
      "_key": "1692898211",
      "_rev": "_mdBPQBa---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3203638",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "407241",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5563dup",
        "NC_000005.10:g.13841058dup",
        "CM000667.2:g.13841058dup",
        "NC_000005.9:g.13841167dup",
        "CM000667.1:g.13841167dup",
        "NC_000005.8:g.13894167dup",
        "NG_013081.1:g.108429dup",
        "NG_013081.2:g.108429dup",
        "ENST00000265104.5:c.5563dup",
        "ENST00000681290.1:c.5518dup",
        "ENST00000265104.4:c.5563dup",
        "NM_001369.2:c.5563dup",
        "XM_005248262.2:c.5518dup",
        "XM_011513990.1:c.5563dup",
        "XR_925598.1:n.5770dup",
        "XM_005248262.3:c.5671dup",
        "XM_017009177.1:c.5671dup",
        "XM_017009178.1:c.4576dup",
        "XM_017009179.2:c.4576dup",
        "XM_017009180.1:c.5671dup",
        "XM_017009181.1:c.5671dup",
        "XM_017009182.1:c.5671dup",
        "XM_017009183.1:c.5671dup",
        "XM_017009184.1:c.5671dup",
        "XM_017009185.1:c.760dup",
        "XM_017009186.1:c.313dup",
        "XM_017009187.1:c.5671dup",
        "XM_024454388.1:c.4576dup",
        "XM_024454389.1:c.4165dup",
        "XR_001742034.1:n.5688dup",
        "XR_001742035.1:n.5688dup",
        "NM_001369.3(DNAH5):c.5563dup (p.Ile1855fs)"
      ],
      "hgvsSearch": "nm_001369.3:c.5563dup nc_000005.10:g.13841058dup cm000667.2:g.13841058dup nc_000005.9:g.13841167dup cm000667.1:g.13841167dup nc_000005.8:g.13894167dup ng_013081.1:g.108429dup ng_013081.2:g.108429dup enst00000265104.5:c.5563dup enst00000681290.1:c.5518dup enst00000265104.4:c.5563dup nm_001369.2:c.5563dup xm_005248262.2:c.5518dup xm_011513990.1:c.5563dup xr_925598.1:n.5770dup xm_005248262.3:c.5671dup xm_017009177.1:c.5671dup xm_017009178.1:c.4576dup xm_017009179.2:c.4576dup xm_017009180.1:c.5671dup xm_017009181.1:c.5671dup xm_017009182.1:c.5671dup xm_017009183.1:c.5671dup xm_017009184.1:c.5671dup xm_017009185.1:c.760dup xm_017009186.1:c.313dup xm_017009187.1:c.5671dup xm_024454388.1:c.4576dup xm_024454389.1:c.4165dup xr_001742034.1:n.5688dup xr_001742035.1:n.5688dup nm_001369.3(dnah5):c.5563dup (p.ile1855fs)",
      "metCodes": [
        "PVS1",
        "PP1_Strong",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pp1_strong pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5563dup (p.Ile1855fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5563dup (p.Ile1855AsnfsTer6) is a frameshift variant that introduces a premature stop codon into exon 34 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.0003497, with 23 alleles / 44,884 total alleles in the East Asian population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00006010 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. At least one proband harboring this variant exhibits a phenotype including chronic sinusitis and otitis media (1 pt, PMID: 11062149), absence of the outer dynein arms (4 pt, required), early onset bronchiectasis (1 pt), immotile cilia (1 pt), and situs inversus (1 pt), which together are specific for primary ciliary dyskinesia 3 (8 points, PMID: 11788826, PP4).The variant has been reported to co-segregate with primary ciliary dyskinesia through at least three segregations within the family of the proband, with the variant present in the homozygous state (PP1_Strong; PMID: 11788826). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PP4, and PP1_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2"
      ],
      "unMetCodesSearch": "pm2",
      "uuid": "8cf7e7ce-129c-433d-87dc-7a4d02f8d3c3",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013828",
      "_id": "AlleleRecords/1692899335",
      "_key": "1692899335",
      "_rev": "_mdBXsem---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3201359",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "350995",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.13458dup",
        "NC_000005.10:g.13701323dup",
        "CM000667.2:g.13701323dup",
        "NC_000005.9:g.13701432dup",
        "CM000667.1:g.13701432dup",
        "NC_000005.8:g.13754432dup",
        "NG_013081.1:g.248164dup",
        "NG_013081.2:g.248164dup",
        "ENST00000683611.1:n.791dup",
        "ENST00000265104.5:c.13458dup",
        "ENST00000681290.1:c.13413dup",
        "ENST00000265104.4:c.13458dup",
        "NM_001369.2:c.13458dup",
        "XM_005248262.2:c.13413dup",
        "XM_005248262.3:c.13566dup",
        "XM_017009177.1:c.13146dup",
        "XM_017009178.1:c.12471dup",
        "XM_017009179.2:c.12471dup",
        "XM_017009185.1:c.8655dup",
        "XM_017009186.1:c.8208dup",
        "XM_017009188.1:c.7545dup",
        "XM_024454388.1:c.12471dup",
        "XM_024454389.1:c.12060dup",
        "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.13458dup nc_000005.10:g.13701323dup cm000667.2:g.13701323dup nc_000005.9:g.13701432dup cm000667.1:g.13701432dup nc_000005.8:g.13754432dup ng_013081.1:g.248164dup ng_013081.2:g.248164dup enst00000683611.1:n.791dup enst00000265104.5:c.13458dup enst00000681290.1:c.13413dup enst00000265104.4:c.13458dup nm_001369.2:c.13458dup xm_005248262.2:c.13413dup xm_005248262.3:c.13566dup xm_017009177.1:c.13146dup xm_017009178.1:c.12471dup xm_017009179.2:c.12471dup xm_017009185.1:c.8655dup xm_017009186.1:c.8208dup xm_017009188.1:c.7545dup xm_024454388.1:c.12471dup xm_024454389.1:c.12060dup nm_001369.3(dnah5):c.13458dup (p.asn4487ter)",
      "metCodes": [
        "PVS1",
        "PM3_Very Strong",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm3_very strong pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) is a frameshift variant that introduces a premature stop codon into exon 77 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.0001850, with 244 alleles / 1,179,964 total alleles in the European (non-Finnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.0001605 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was homozygous for the variant (0.5 points, PMID: 16627867). This variant has also been reported in at least 4 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.10815del (p.Pro3606fs) variant (PMID: 33479112), the NM_001369.3(DNAH5):c.3905del (p.Leu1302ArgfsTer19) variant (PMID: 16627867), the NM_001369.3(DNAH5):c.349dup (p.Glu117GlyfsTer18) variant (PMID: 38154480), or the NM_001369.3(DNAH5):c.13486C>T (p.Arg4496Ter) variant (PMID: 33479112, thesis of Mahmoud Fassad entitled \"Novel Gene Discovery in Primary Ciliary Dyskinesia\") confirmed in trans, which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (4 total points, PM3_Very Strong). At least one proband harboring this variant exhibits a phenotype including neonatal respiratory distress (1 pt), situs inversus (1 pt), sinusitis and otitis media (1 pt), and bronchiectasis (1 pt), as well as low nasal nitric oxide (1 pt), and an outer dynein arm defect detected by electron microscopy (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 6 points, PMID: 21270641, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3_Very Strong, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "8d94dfc2-769e-4e2b-b2c9-e709ff616d2b",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013829",
      "_id": "AlleleRecords/1692900667",
      "_key": "1692900667",
      "_rev": "_mdBgI0u---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA501221",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "228251",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.6249G>A",
        "NC_000005.10:g.13830026C>T",
        "CM000667.2:g.13830026C>T",
        "NC_000005.9:g.13830135C>T",
        "CM000667.1:g.13830135C>T",
        "NC_000005.8:g.13883135C>T",
        "NG_013081.1:g.119455G>A",
        "NG_013081.2:g.119455G>A",
        "ENST00000683090.1:n.1180G>A",
        "ENST00000265104.5:c.6249G>A",
        "ENST00000681290.1:c.6204G>A",
        "ENST00000265104.4:c.6249G>A",
        "NM_001369.2:c.6249G>A",
        "XM_005248262.2:c.6204G>A",
        "XM_011513990.1:c.6249G>A",
        "XR_925598.1:n.6456G>A",
        "XM_005248262.3:c.6357G>A",
        "XM_017009177.1:c.6357G>A",
        "XM_017009178.1:c.5262G>A",
        "XM_017009179.2:c.5262G>A",
        "XM_017009180.1:c.6357G>A",
        "XM_017009181.1:c.6357G>A",
        "XM_017009182.1:c.6357G>A",
        "XM_017009183.1:c.6357G>A",
        "XM_017009184.1:c.6357G>A",
        "XM_017009185.1:c.1446G>A",
        "XM_017009186.1:c.999G>A",
        "XM_017009187.1:c.6357G>A",
        "XM_017009188.1:c.336G>A",
        "XM_024454388.1:c.5262G>A",
        "XM_024454389.1:c.4851G>A",
        "XR_001742034.1:n.6374G>A",
        "XR_001742035.1:n.6374G>A",
        "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile)"
      ],
      "hgvsSearch": "nm_001369.3:c.6249g>a nc_000005.10:g.13830026c>t cm000667.2:g.13830026c>t nc_000005.9:g.13830135c>t cm000667.1:g.13830135c>t nc_000005.8:g.13883135c>t ng_013081.1:g.119455g>a ng_013081.2:g.119455g>a enst00000683090.1:n.1180g>a enst00000265104.5:c.6249g>a enst00000681290.1:c.6204g>a enst00000265104.4:c.6249g>a nm_001369.2:c.6249g>a xm_005248262.2:c.6204g>a xm_011513990.1:c.6249g>a xr_925598.1:n.6456g>a xm_005248262.3:c.6357g>a xm_017009177.1:c.6357g>a xm_017009178.1:c.5262g>a xm_017009179.2:c.5262g>a xm_017009180.1:c.6357g>a xm_017009181.1:c.6357g>a xm_017009182.1:c.6357g>a xm_017009183.1:c.6357g>a xm_017009184.1:c.6357g>a xm_017009185.1:c.1446g>a xm_017009186.1:c.999g>a xm_017009187.1:c.6357g>a xm_017009188.1:c.336g>a xm_024454388.1:c.5262g>a xm_024454389.1:c.4851g>a xr_001742034.1:n.6374g>a xr_001742035.1:n.6374g>a nm_001369.3(dnah5):c.6249g>a (p.met2083ile)",
      "metCodes": [
        "PS3_Supporting",
        "PM3_Strong",
        "PP1",
        "PP3",
        "PP4"
      ],
      "metCodesSearch": "ps3_supporting pm3_strong pp1 pp3 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile) is a potential missense variant that is predicted to replace methionine with isoleucine at amino acid 2083, but is also located in the final nucleotide of exon 37. The computational predictor REVEL gives a score of 0.640, which is below the ClinGen Motile Ciliopathy VCEP threshold of ≥0.690 and does not predict a damaging effect on DNAH5 function. The splicing impact predictor SpliceAI gives delta scores of 0.84 for donor loss and 0.81 for acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predict a damaging impact on DNAH5 splicing (PP3). RT-PCR analysis of patient mRNA showed that this variant causes a splicing defect that results in out-of-frame skipping of either exon 37 alone or exons 36 and 37 together, both of which are predicted to introduce a premature termination codon. The patient is compound heterozygous and harbors the variant in only half of the transcripts, so normally spliced mRNA is also present in the sample and may complicate attempts to accurately assess whether any normally spliced mRNA is produced from the variant allele (PMID: 23261302, PS3_Supporting). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.00006643, with 94 alleles / 1,179,576 total alleles in the European (non-FInnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00006199 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 5 probands with primary ciliary dyskinesia, one of whom was compound heterozygous with the NM_001369.3(DNAH5):c.2261dup (p.Met754fs) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 point, PMID: 23261302). Two other probands with primary ciliary dyskinesia were compound heterozygous with either the NM_001369.3(DNAH5):c.3905del (p.Leu1302fs) variant or the NM_001369.3(DNAH5):c.8404C>T (p.Gln2802Ter) variant suspected but not reported as confirmed in trans (1 total point, PMID: 30067075, PMID: 33479112), both of which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (2 total points, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including diagnosis of primary ciliary dyskinesia with situs inversus (1 pt) and outer dynein arm defects (4 pts), family history consistent with autosomal recessive inheritance, low nasal nitric oxide (1 pt), recurrent otitis media and sinusitis (1 pt), and bronchiectasis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 23261302, PP4). Genotyping by whole exome sequencing identified no alternative basis for disease but did not include all genes now known to be associated with primary ciliary dyskinesia with outer dynein arm defects. The variant has been reported to co-segregate with primary ciliary dyskinesia through at least one segregation within the family of the proband, with the variant present in the compound heterozygous state (PMID: 23261302, PP1). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PP3, PS3_Supporting, PM3_Strong, PP1, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "84d4f2eb-b77d-4678-9cd9-a3700328075a",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013830",
      "_id": "AlleleRecords/1692901844",
      "_key": "1692901844",
      "_rev": "_mdBolZu---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA359196177",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "454760",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.2710G>T",
        "NC_000005.10:g.13885997C>A",
        "CM000667.2:g.13885997C>A",
        "NC_000005.9:g.13886106C>A",
        "CM000667.1:g.13886106C>A",
        "NC_000005.8:g.13939106C>A",
        "NG_013081.1:g.63484G>T",
        "NG_013081.2:g.63484G>T",
        "ENST00000265104.5:c.2710G>T",
        "ENST00000681290.1:c.2665G>T",
        "ENST00000265104.4:c.2710G>T",
        "NM_001369.2:c.2710G>T",
        "XM_005248262.2:c.2665G>T",
        "XM_011513990.1:c.2710G>T",
        "XR_925598.1:n.2917G>T",
        "XM_005248262.3:c.2818G>T",
        "XM_017009177.1:c.2818G>T",
        "XM_017009178.1:c.1723G>T",
        "XM_017009179.2:c.1723G>T",
        "XM_017009180.1:c.2818G>T",
        "XM_017009181.1:c.2818G>T",
        "XM_017009182.1:c.2818G>T",
        "XM_017009183.1:c.2818G>T",
        "XM_017009184.1:c.2818G>T",
        "XM_017009187.1:c.2818G>T",
        "XM_024454388.1:c.1723G>T",
        "XM_024454389.1:c.1312G>T",
        "XR_001742034.1:n.2835G>T",
        "XR_001742035.1:n.2835G>T",
        "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.2710g>t nc_000005.10:g.13885997c>a cm000667.2:g.13885997c>a nc_000005.9:g.13886106c>a cm000667.1:g.13886106c>a nc_000005.8:g.13939106c>a ng_013081.1:g.63484g>t ng_013081.2:g.63484g>t enst00000265104.5:c.2710g>t enst00000681290.1:c.2665g>t enst00000265104.4:c.2710g>t nm_001369.2:c.2710g>t xm_005248262.2:c.2665g>t xm_011513990.1:c.2710g>t xr_925598.1:n.2917g>t xm_005248262.3:c.2818g>t xm_017009177.1:c.2818g>t xm_017009178.1:c.1723g>t xm_017009179.2:c.1723g>t xm_017009180.1:c.2818g>t xm_017009181.1:c.2818g>t xm_017009182.1:c.2818g>t xm_017009183.1:c.2818g>t xm_017009184.1:c.2818g>t xm_017009187.1:c.2818g>t xm_024454388.1:c.1723g>t xm_024454389.1:c.1312g>t xr_001742034.1:n.2835g>t xr_001742035.1:n.2835g>t nm_001369.3(dnah5):c.2710g>t (p.glu904ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pvs1 pm2_supporting pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter) is a nonsense variant that introduces a premature stop codon into exon 18 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PMIDs: 16627867, 11788826; PVS1). This variant is present in gnomAD v.4.1.1 at a total allele frequency of 0.0000006199, with 1 allele / 1,613,220 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 2 probands with primary ciliary dyskinesia who were homozygous for the variant (1 total point, PMID: 31765523, PMID: 31638833, PM3). This variant has also been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9106-1G>A variant suspected but not confirmed in trans (PMID: 31772028), which has not been considered for PM3 in order to avoid circularity. At least one proband harboring this variant exhibits a phenotype including absence of outer dynein arms by immunofluorescence study (4 pts), neonatal respiratory distress (1 pt), sinusitis and chronic otitis media (1 pt), recurrent pneumonia (0.5 pts), and bronchiectasis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 7.5 points, PMID: 40558543). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM2_Supporting, PM3, and PP4. (VCEP specifications version 1.0.0).",
      "uuid": "d8b8221c-68cc-48ca-bb64-1223c74d0579",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013278",
      "_id": "AlleleRecords/1542073448",
      "_key": "1542073448",
      "_rev": "_mcrvTfO---",
      "affiliationId": "50100",
      "approvedDate": "2026-09-04",
      "caId": "CA412716882",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.245T>A",
        "NC_000023.11:g.38369824T>A",
        "CM000685.2:g.38369824T>A",
        "NC_000023.10:g.38229077T>A",
        "CM000685.1:g.38229077T>A",
        "NC_000023.9:g.38114021T>A",
        "NG_008471.1:g.22342T>A",
        "ENST00000039007.5:c.245T>A",
        "ENST00000643344.1:c.245T>A",
        "ENST00000039007.4:c.245T>A",
        "ENST00000465127.1:c.172-296297T>A",
        "ENST00000488812.1:n.337T>A",
        "NM_000531.5:c.245T>A",
        "XM_017029556.1:c.245T>A"
      ],
      "hgvsSearch": "nm_000531.6:c.245t>a nc_000023.11:g.38369824t>a cm000685.2:g.38369824t>a nc_000023.10:g.38229077t>a cm000685.1:g.38229077t>a nc_000023.9:g.38114021t>a ng_008471.1:g.22342t>a enst00000039007.5:c.245t>a enst00000643344.1:c.245t>a enst00000039007.4:c.245t>a enst00000465127.1:c.172-296297t>a enst00000488812.1:n.337t>a nm_000531.5:c.245t>a xm_017029556.1:c.245t>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.245T>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.245T>A (p.Leu82Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "630bf32a-5038-4493-8fa8-a7906b77d6a3",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013279",
      "_id": "AlleleRecords/1542073827",
      "_key": "1542073827",
      "_rev": "_mcsdEa6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224503",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97135",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.216+1G>T",
        "NC_000023.11:g.38367430G>T",
        "CM000685.2:g.38367430G>T",
        "NC_000023.10:g.38226683G>T",
        "CM000685.1:g.38226683G>T",
        "NC_000023.9:g.38111627G>T",
        "NG_008471.1:g.19948G>T",
        "ENST00000039007.5:c.216+1G>T",
        "ENST00000643344.1:c.216+1G>T",
        "ENST00000039007.4:c.216+1G>T",
        "ENST00000465127.1:c.172-298691G>T",
        "ENST00000488812.1:n.308+1G>T",
        "NM_000531.5:c.216+1G>T",
        "XM_017029556.1:c.216+1G>T",
        "NM_000531.6(OTC):c.216+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.216+1g>t nc_000023.11:g.38367430g>t cm000685.2:g.38367430g>t nc_000023.10:g.38226683g>t cm000685.1:g.38226683g>t nc_000023.9:g.38111627g>t ng_008471.1:g.19948g>t enst00000039007.5:c.216+1g>t enst00000643344.1:c.216+1g>t enst00000039007.4:c.216+1g>t enst00000465127.1:c.172-298691g>t enst00000488812.1:n.308+1g>t nm_000531.5:c.216+1g>t xm_017029556.1:c.216+1g>t nm_000531.6(otc):c.216+1g>t",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.216+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.216+1G>T variant in the OTC gene affects the canonical donor splice site of intron 2 and is predicted to lead to an out of frame consequence and loss of function via nonsense mediated decay (PVS1). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). One patient with this variant displayed features including Orotic aciduria (+1), Hyperammonemia, Hyperglutaminemia ( +0.5), 10% Liver enzyme activity (+2), which is highly specific for OTC deficiency (PP4_Moderate, 3.5 points, PMID: 12175783). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PP4_Moderate).",
      "uuid": "9b07d8cd-b8fc-45fc-9f11-ff392d1fbf01",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000001190",
      "_id": "AlleleRecords/1573013067",
      "_key": "1573013067",
      "_rev": "_mcqrI_C---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA8815251",
      "classification": "Uncertain Significance",
      "condition": "glycogen storage disease II",
      "cvId": "501777",
      "docVersion": "1.7.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.4:c.1288G>A",
        "NC_000017.11:g.80108790G>A",
        "CM000679.2:g.80108790G>A",
        "NC_000017.10:g.78082589G>A",
        "CM000679.1:g.78082589G>A",
        "NC_000017.9:g.75697184G>A",
        "NG_009822.1:g.12235G>A",
        "LRG_673:g.12235G>A",
        "ENST00000570803.6:c.1288G>A",
        "ENST00000572080.2:c.1288G>A",
        "ENST00000577106.6:c.1288G>A",
        "ENST00000302262.8:c.1288G>A",
        "ENST00000302262.7:c.1288G>A",
        "ENST00000390015.7:c.1288G>A",
        "NM_000152.3:c.1288G>A",
        "LRG_673t1:c.1288G>A",
        "NM_001079803.1:c.1288G>A",
        "NM_001079804.1:c.1288G>A",
        "XM_005257193.1:c.1288G>A",
        "XM_005257194.3:c.1288G>A",
        "NM_001079803.2:c.1288G>A",
        "NM_001079804.2:c.1288G>A",
        "XM_005257193.2:c.1288G>A",
        "XM_005257194.4:c.1288G>A",
        "NM_000152.5:c.1288G>A",
        "NM_001079803.3:c.1288G>A",
        "NM_001079804.3:c.1288G>A",
        "NM_000152.4(GAA):c.1288G>A (p.Glu430Lys)"
      ],
      "hgvsSearch": "nm_000152.4:c.1288g>a nc_000017.11:g.80108790g>a cm000679.2:g.80108790g>a nc_000017.10:g.78082589g>a cm000679.1:g.78082589g>a nc_000017.9:g.75697184g>a ng_009822.1:g.12235g>a lrg_673:g.12235g>a enst00000570803.6:c.1288g>a enst00000572080.2:c.1288g>a enst00000577106.6:c.1288g>a enst00000302262.8:c.1288g>a enst00000302262.7:c.1288g>a enst00000390015.7:c.1288g>a nm_000152.3:c.1288g>a lrg_673t1:c.1288g>a nm_001079803.1:c.1288g>a nm_001079804.1:c.1288g>a xm_005257193.1:c.1288g>a xm_005257194.3:c.1288g>a nm_001079803.2:c.1288g>a nm_001079804.2:c.1288g>a xm_005257193.2:c.1288g>a xm_005257194.4:c.1288g>a nm_000152.5:c.1288g>a nm_001079803.3:c.1288g>a nm_001079804.3:c.1288g>a nm_000152.4(gaa):c.1288g>a (p.glu430lys)",
      "metCodes": [
        "PP4_Moderate",
        "PM2_Supporting",
        "PM3"
      ],
      "metCodesSearch": "pp4_moderate pm2_supporting pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.4(GAA):c.1288G>A (p.Glu430Lys)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1288G>A variant in GAA results in the missense substitution of glutamate by lysine at amino acid 430 (p.Glu430Lys). This variant has been identified in a patient with infantile onset Pompe disease based on his clinical symptoms of hypotonia, hypertrophic cardiomyopathy, and elevated CK and transaminases. He had no detectable GAA activity in fibroblasts, was CRIM-negative, and started enzyme replacement therapy at 3 months of age (PMID: 39161458) (PP4_Moderate). This individual is compound heterozygous for c.368G>A (p.Gly123Glu) and c.1288G>A (p.Glu430Lys) on one allele, confirmed in trans with c.693-2A>C (PMID: 39161458). The variant in cis, c.368G>A (p.Gly123Glu), has been classified as likely benign by the ClinGen LD VCEP, while c.693-2A>C has been classified as pathogenic (1 pt) (PM3). The highest population minor allele frequency in gnomAD v4.1.2. is 0.0002936 (22/74922 alleles) in the African/African American population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting).  The computational predictor REVEL gives a score of 0.577 which is neither above nor below the thresholds predicting a damaging (>0.7) or benign (<0.5) impact on GAA function. SpliceAI predicts no impact on splicing. There is a ClinVar entry for this variant (Variation ID: 501777). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PM3, PP4_Moderate, PM2_Supporting.",
      "unMetCodes": [
        "PP3",
        "BP4"
      ],
      "unMetCodesSearch": "pp3 bp4",
      "uuid": "68d0c25e-977d-4211-b166-3f52d076d6b1",
      "versionsList": [
        "1.7.0",
        "1.6.0",
        "1.5.0",
        "1.4.0",
        "1.3.0",
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000001748",
      "_id": "AlleleRecords/1573015418",
      "_key": "1573015418",
      "_rev": "_mcsT8iS---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA8815179",
      "classification": "Likely Pathogenic",
      "condition": "glycogen storage disease II",
      "cvId": "497032",
      "docVersion": "1.2.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.1130del",
        "NC_000017.11:g.80108543del",
        "CM000679.2:g.80108543del",
        "NC_000017.10:g.78082342del",
        "CM000679.1:g.78082342del",
        "NC_000017.9:g.75696937del",
        "NG_009822.1:g.11988del",
        "LRG_673:g.11988del",
        "ENST00000570803.6:c.1130del",
        "ENST00000572080.2:c.1130del",
        "ENST00000577106.6:c.1130del",
        "ENST00000302262.8:c.1130del",
        "ENST00000302262.7:c.1130del",
        "ENST00000390015.7:c.1130del",
        "NM_000152.3:c.1130del",
        "LRG_673t1:c.1130del",
        "NM_001079803.1:c.1130del",
        "NM_001079804.1:c.1130del",
        "XM_005257193.1:c.1130del",
        "XM_005257194.3:c.1130del",
        "NM_000152.4:c.1130del",
        "NM_001079803.2:c.1130del",
        "NM_001079804.2:c.1130del",
        "XM_005257193.2:c.1130del",
        "XM_005257194.4:c.1130del",
        "NM_001079803.3:c.1130del",
        "NM_001079804.3:c.1130del",
        "NM_000152.5(GAA):c.1130del (p.Gly377fs)"
      ],
      "hgvsSearch": "nm_000152.5:c.1130del nc_000017.11:g.80108543del cm000679.2:g.80108543del nc_000017.10:g.78082342del cm000679.1:g.78082342del nc_000017.9:g.75696937del ng_009822.1:g.11988del lrg_673:g.11988del enst00000570803.6:c.1130del enst00000572080.2:c.1130del enst00000577106.6:c.1130del enst00000302262.8:c.1130del enst00000302262.7:c.1130del enst00000390015.7:c.1130del nm_000152.3:c.1130del lrg_673t1:c.1130del nm_001079803.1:c.1130del nm_001079804.1:c.1130del xm_005257193.1:c.1130del xm_005257194.3:c.1130del nm_000152.4:c.1130del nm_001079803.2:c.1130del nm_001079804.2:c.1130del xm_005257193.2:c.1130del xm_005257194.4:c.1130del nm_001079803.3:c.1130del nm_001079804.3:c.1130del nm_000152.5(gaa):c.1130del (p.gly377fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.1130del (p.Gly377fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1130del (p.Gly377AlafsTer15) variant in GAA is a frameshift variant that is predicted to cause a premature stop codon in exon 7 out of a total of 20 exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v4.1.0. is 0.00001356 (16/1179904 alleles) in the European non-Finnish population, which is lower than the ClinGen LD VCEP threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). This variant has been reported in one patient with a reported diagnosis of Pompe disease, however, no further clinical or laboratory data is provided (insufficient data to apply PP4 or PM3). This individual is compound heterozygous for the variant and c.1548G>A (p.Trp516Ter), phase unconfirmed (PMID: 36007526). There is a ClinVar entry for this variant (Variation ID: 497032). In summary, this variant meets the criteria to be classified as likely pathogenic for Pompe disease. The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ).GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LD VCEP (Specifications Version 2.0): PVS1, PM2_Supporting.",
      "unMetCodes": [
        "PP4",
        "PM3"
      ],
      "unMetCodesSearch": "pp4 pm3",
      "uuid": "47478b30-7442-41c3-a8b7-9bccaf02ed15",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004135",
      "_id": "AlleleRecords/1573025053",
      "_key": "1573025053",
      "_rev": "_mcpE6Fu---",
      "affiliationId": "50009",
      "approvedDate": "2026-11-17",
      "caId": "CA16607903",
      "classification": "Uncertain Significance",
      "condition": "glycogen storage disease II",
      "cvId": "392862",
      "docVersion": "1.1.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.2316G>T",
        "NC_000017.11:g.80117094G>T",
        "CM000679.2:g.80117094G>T",
        "NC_000017.10:g.78090893G>T",
        "CM000679.1:g.78090893G>T",
        "NC_000017.9:g.75705488G>T",
        "NG_009822.1:g.20539G>T",
        "LRG_673:g.20539G>T",
        "ENST00000570803.6:c.2316G>T",
        "ENST00000572080.2:c.*454G>T",
        "ENST00000577106.6:c.2316G>T",
        "ENST00000302262.8:c.2316G>T",
        "ENST00000302262.7:c.2316G>T",
        "ENST00000390015.7:c.2316G>T",
        "ENST00000573556.1:n.269G>T",
        "NM_000152.3:c.2316G>T",
        "LRG_673t1:c.2316G>T",
        "NM_001079803.1:c.2316G>T",
        "NM_001079804.1:c.2316G>T",
        "XM_005257193.1:c.2316G>T",
        "XM_005257194.3:c.2316G>T",
        "NM_000152.4:c.2316G>T",
        "NM_001079803.2:c.2316G>T",
        "NM_001079804.2:c.2316G>T",
        "XM_005257193.2:c.2316G>T",
        "XM_005257194.4:c.2316G>T",
        "NM_001079803.3:c.2316G>T",
        "NM_001079804.3:c.2316G>T",
        "NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)"
      ],
      "hgvsSearch": "nm_000152.5:c.2316g>t nc_000017.11:g.80117094g>t cm000679.2:g.80117094g>t nc_000017.10:g.78090893g>t cm000679.1:g.78090893g>t nc_000017.9:g.75705488g>t ng_009822.1:g.20539g>t lrg_673:g.20539g>t enst00000570803.6:c.2316g>t enst00000572080.2:c.*454g>t enst00000577106.6:c.2316g>t enst00000302262.8:c.2316g>t enst00000302262.7:c.2316g>t enst00000390015.7:c.2316g>t enst00000573556.1:n.269g>t nm_000152.3:c.2316g>t lrg_673t1:c.2316g>t nm_001079803.1:c.2316g>t nm_001079804.1:c.2316g>t xm_005257193.1:c.2316g>t xm_005257194.3:c.2316g>t nm_000152.4:c.2316g>t nm_001079803.2:c.2316g>t nm_001079804.2:c.2316g>t xm_005257193.2:c.2316g>t xm_005257194.4:c.2316g>t nm_001079803.3:c.2316g>t nm_001079804.3:c.2316g>t nm_000152.5(gaa):c.2316g>t (p.trp772cys)",
      "metCodes": [
        "PM2_Supporting",
        "PM5_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pm5_supporting pp3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.2316G>T variant in GAA is a missense variant predicted to cause substitution of Tryptophan by Cysteine at amino acid 772 (p.Trp772Cys). The highest population minor allele frequency in gnomAD v4.1.2. is 0.000001695 (2/1180018 alleles) in the European non-Finnish population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant and it has not been reported in the literature in any individuals with Pompe disease. The computational predictor REVEL gives a score of 0.942 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). Another missense variant c.2314T>C (p.Trp772Arg) (PMID: 31619483, 18757064, ClinVar ID: 552527) in the same codon has been classified as likely pathogenic for Pompe disease by the ClinGen LD VCEP (PM5_Supporting). There is a ClinVar entry for this variant (Variation ID: 392862). In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for Pompe disease based on the GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 2.0): PP3, PM2_Supporting, PM5_Supporting.",
      "unMetCodes": [
        "PS3",
        "PM3"
      ],
      "unMetCodesSearch": "ps3 pm3",
      "uuid": "118c8346-2b31-42f6-8ca9-24f4c03b5bc1",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013319",
      "_id": "AlleleRecords/1599510307",
      "_key": "1599510307",
      "_rev": "_mcsuMeG---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224567",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97180",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.386+2T>C",
        "NC_000023.11:g.38381431T>C",
        "CM000685.2:g.38381431T>C",
        "NC_000023.10:g.38240684T>C",
        "CM000685.1:g.38240684T>C",
        "NC_000023.9:g.38125628T>C",
        "NG_008471.1:g.33949T>C",
        "ENST00000039007.5:c.386+2T>C",
        "ENST00000643344.1:c.*136+2T>C",
        "ENST00000039007.4:c.386+2T>C",
        "ENST00000465127.1:c.172-284690T>C",
        "ENST00000488812.1:n.423+2T>C",
        "NM_000531.5:c.386+2T>C",
        "XM_017029556.1:c.386+2T>C",
        "NM_000531.6(OTC):c.386+2T>C"
      ],
      "hgvsSearch": "nm_000531.6:c.386+2t>c nc_000023.11:g.38381431t>c cm000685.2:g.38381431t>c nc_000023.10:g.38240684t>c cm000685.1:g.38240684t>c nc_000023.9:g.38125628t>c ng_008471.1:g.33949t>c enst00000039007.5:c.386+2t>c enst00000643344.1:c.*136+2t>c enst00000039007.4:c.386+2t>c enst00000465127.1:c.172-284690t>c enst00000488812.1:n.423+2t>c nm_000531.5:c.386+2t>c xm_017029556.1:c.386+2t>c nm_000531.6(otc):c.386+2t>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.386+2T>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.386+2T>C variant in the OTC gene affects the canonical donor/acceptor splice site in the 4th intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.24, -89bp; donor loss, score 0.94, -2bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) (Total points of +9.)",
      "uuid": "1bd7fb98-eb4b-4e9b-8a93-db94c74d3105",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013320",
      "_id": "AlleleRecords/1599510568",
      "_key": "1599510568",
      "_rev": "_mcs2oz6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224544",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97160",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.298+1G>T",
        "NC_000023.11:g.38369878G>T",
        "CM000685.2:g.38369878G>T",
        "NC_000023.10:g.38229131G>T",
        "CM000685.1:g.38229131G>T",
        "NC_000023.9:g.38114075G>T",
        "NG_008471.1:g.22396G>T",
        "ENST00000039007.5:c.298+1G>T",
        "ENST00000643344.1:c.298+1G>T",
        "ENST00000039007.4:c.298+1G>T",
        "ENST00000465127.1:c.172-296243G>T",
        "ENST00000488812.1:n.353+38G>T",
        "NM_000531.5:c.298+1G>T",
        "XM_017029556.1:c.298+1G>T",
        "NM_000531.6(OTC):c.298+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.298+1g>t nc_000023.11:g.38369878g>t cm000685.2:g.38369878g>t nc_000023.10:g.38229131g>t cm000685.1:g.38229131g>t nc_000023.9:g.38114075g>t ng_008471.1:g.22396g>t enst00000039007.5:c.298+1g>t enst00000643344.1:c.298+1g>t enst00000039007.4:c.298+1g>t enst00000465127.1:c.172-296243g>t enst00000488812.1:n.353+38g>t nm_000531.5:c.298+1g>t xm_017029556.1:c.298+1g>t nm_000531.6(otc):c.298+1g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.298+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.298+1G>T variant in the OTC gene affects the canonical donor/acceptor splice site in the 2nd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.65, -82bp; donor loss, score 0.92, -1bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1), Total points +9.",
      "uuid": "de3fd1f2-b5b7-4d60-9d99-33c6bcd9161c",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013321",
      "_id": "AlleleRecords/1599510806",
      "_key": "1599510806",
      "_rev": "_mctIAf2---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412718254",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.313G>T",
        "NC_000023.11:g.38381356G>T",
        "CM000685.2:g.38381356G>T",
        "NC_000023.10:g.38240609G>T",
        "CM000685.1:g.38240609G>T",
        "NC_000023.9:g.38125553G>T",
        "NG_008471.1:g.33874G>T",
        "ENST00000039007.5:c.313G>T",
        "ENST00000643344.1:c.*63G>T",
        "ENST00000039007.4:c.313G>T",
        "ENST00000465127.1:c.172-284765G>T",
        "ENST00000488812.1:n.354-4G>T",
        "NM_000531.5:c.313G>T",
        "XM_017029556.1:c.313G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.313g>t nc_000023.11:g.38381356g>t cm000685.2:g.38381356g>t nc_000023.10:g.38240609g>t cm000685.1:g.38240609g>t nc_000023.9:g.38125553g>t ng_008471.1:g.33874g>t enst00000039007.5:c.313g>t enst00000643344.1:c.*63g>t enst00000039007.4:c.313g>t enst00000465127.1:c.172-284765g>t enst00000488812.1:n.354-4g>t nm_000531.5:c.313g>t xm_017029556.1:c.313g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.313G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.313G>T (p.Gly105Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 4/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) Total points +9.",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "ef323b86-4f21-4a7a-88a7-b5c7dfcf389e",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013762",
      "_id": "AlleleRecords/1692510770",
      "_key": "1692510770",
      "_rev": "_mchyX_m---",
      "affiliationId": "50052",
      "approvedDate": "2026-11-17",
      "caId": "CA16602267",
      "classification": "Likely Pathogenic",
      "condition": "HBA2-related alpha thalassemia spectrum",
      "cvId": "375744",
      "docVersion": "1.0.0",
      "ep": "Hemoglobinopathy VCEP",
      "gene": "HBA2",
      "geneNcbiId": "3040",
      "hgvs": [
        "NM_000517.6:c.94_95del",
        "NC_000016.10:g.173006_173007del",
        "CM000678.2:g.173006_173007del",
        "NC_000016.9:g.223005_223006del",
        "CM000678.1:g.223005_223006del",
        "NC_000016.8:g.163005_163006del",
        "NG_000006.1:g.33869_33870del",
        "NG_059186.1:g.1356_1357del",
        "NG_059271.1:g.5160_5161del",
        "ENST00000251595.11:c.94_95del",
        "ENST00000251595.10:c.94_95del",
        "ENST00000397806.1:c.-2+48_-2+49del",
        "ENST00000482565.1:n.113_114del",
        "ENST00000484216.1:n.63_64del",
        "NM_000517.4:c.94_95del",
        "NM_000517.6(HBA2):c.94_95del (p.Arg32fs)"
      ],
      "hgvsSearch": "nm_000517.6:c.94_95del nc_000016.10:g.173006_173007del cm000678.2:g.173006_173007del nc_000016.9:g.223005_223006del cm000678.1:g.223005_223006del nc_000016.8:g.163005_163006del ng_000006.1:g.33869_33870del ng_059186.1:g.1356_1357del ng_059271.1:g.5160_5161del enst00000251595.11:c.94_95del enst00000251595.10:c.94_95del enst00000397806.1:c.-2+48_-2+49del enst00000482565.1:n.113_114del enst00000484216.1:n.63_64del nm_000517.4:c.94_95del nm_000517.6(hba2):c.94_95del (p.arg32fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0100562",
      "preferredVarTitle": "NM_000517.6(HBA2):c.94_95del (p.Arg32fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000517.6(HBA2).94_95del, p.(Arg32AspfsTer25) variant is a 2-bp deletion in the HBA2 gene, predicted to cause a frameshift and premature termination of the α-globin protein [PVS1]. To date, this variant has been reported in the literature in the context of the HBA2–HBA1 fusion gene resulting from the −α³·⁷ deletion (IthaGenes ID: 365; PMIDs: 2831226, 22187958).\nThe variant has been reported in individuals with HbH disease, including an individual with Hb G-Philadelphia–HbH disease and two unrelated individuals carrying the −α³·⁷ deletion on the homologous chromosome [PMIDs: 2831226, 22187958]. Hemoglobin biosynthesis analysis revealed altered α/β-globin synthesis ratios in individuals with related α-globin genotypes [PMID: 6935689]. However, these findings do not establish the independent functional impact of c.94_95del, and PS3_P was therefore not applied. The variant is absent from gnomAD v4.1.2 [PM2_Supporting].\nIn summary, this variant is classified as Likely Pathogenic for HBA2-related alpha thalassemia spectrum diseases (MONDO:0100562) in an autosomal recessive manner, based on the ACMG/AMP criteria as specified by the ClinGen Hemoglobinopathy VCEP (specification version 1.0.0): PVS1, PM2_Supporting. This classification follows the ClinGen SVI Recommendation for Absence/Rarity (PM2), Version 1.0 (September 4, 2020), which supports a Likely Pathogenic classification based on the combination of one Very Strong and one Supporting pathogenic criterion.",
      "unMetCodes": [
        "PS3",
        "PS4",
        "PM3"
      ],
      "unMetCodesSearch": "ps3 ps4 pm3",
      "uuid": "3867ca28-1827-49b5-941f-4c9e630db3d2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013763",
      "_id": "AlleleRecords/1692512176",
      "_key": "1692512176",
      "_rev": "_mch7r9G---",
      "affiliationId": "50052",
      "approvedDate": "2026-11-17",
      "caId": "CA379274972",
      "classification": "Pathogenic",
      "condition": "beta-thalassemia HBB/LCRB",
      "cvId": "869271",
      "docVersion": "1.0.0",
      "ep": "Hemoglobinopathy VCEP",
      "gene": "HBB",
      "geneNcbiId": "3043",
      "hgvs": [
        "NM_000518.5:c.22G>T",
        "NC_000011.10:g.5227000C>A",
        "CM000673.2:g.5227000C>A",
        "NC_000011.9:g.5248230C>A",
        "CM000673.1:g.5248230C>A",
        "NC_000011.8:g.5204806C>A",
        "NG_000007.3:g.70616G>T",
        "NG_059281.1:g.5072G>T",
        "ENST00000647020.1:c.22G>T",
        "ENST00000335295.4:c.22G>T",
        "ENST00000380315.2:c.22G>T",
        "ENST00000485743.1:n.73G>T",
        "ENST00000633227.1:c.22G>T",
        "NM_000518.4:c.22G>T",
        "NM_000518.5(HBB):c.22G>T (p.Glu8Ter)"
      ],
      "hgvsSearch": "nm_000518.5:c.22g>t nc_000011.10:g.5227000c>a cm000673.2:g.5227000c>a nc_000011.9:g.5248230c>a cm000673.1:g.5248230c>a nc_000011.8:g.5204806c>a ng_000007.3:g.70616g>t ng_059281.1:g.5072g>t enst00000647020.1:c.22g>t enst00000335295.4:c.22g>t enst00000380315.2:c.22g>t enst00000485743.1:n.73g>t enst00000633227.1:c.22g>t nm_000518.4:c.22g>t nm_000518.5(hbb):c.22g>t (p.glu8ter)",
      "metCodes": [
        "PVS1_Strong",
        "PM2_Supporting",
        "PS4",
        "PM3"
      ],
      "metCodesSearch": "pvs1_strong pm2_supporting ps4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0013517",
      "preferredVarTitle": "NM_000518.5(HBB):c.22G>T (p.Glu8Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000518.4(HBB):c.22G>T (p.Glu8Ter) nonsense variant introduces a premature stop codon at amino acid position 8, which is not predicted to trigger NMD, resulting in a truncated protein lacking 95.2% of its amino acids and predicted loss of function [PVS1_Strong]. This variant is absent from gnomAD v4.1.2 [PM2_P]. It has been reported in three unrelated individuals displaying a hematological phenotype consistent with beta thalassemia trait [reduced MCV (avg 63.7 fL), MCH (avg 20.6 pg) and elevated HbA2 (avg 5.4%) with normal or increased RBC count], giving a total phenotype score of 4.5 [PS4; PMID: 36000573; Molecular Pathology Laboratory, Reference Haematology, King's College Hospital]. Additionally, the variant was identified in an individual with β-thalassemia intermedia in compound heterozygosity with an HBB variant classified as pathogenic/likely pathogenic by VCEP consensus [c.315+1G>A; ClinVar ID: 15438; ithaID: 200], and confirmed to be in trans by an unspecified method. The total PM3 score is 1, meeting the threshold for moderate evidence [PM3; PMID: 32406020]. In summary, this variant meets the criteria to be classified as Pathogenic for beta thalassemia (MONDO:0013517) in an autosomal recessive manner based on the ACMG/AMP criteria applied, as specified by the ClinGen Hemoglobinopathy VCEP (specification version 1.0.0): PVS1_S, PS4, PM3, PM2_P.",
      "uuid": "54663e19-11de-4bd2-95f3-e8c6a95a8ae7",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013764",
      "_id": "AlleleRecords/1692513270",
      "_key": "1692513270",
      "_rev": "_mciEJrO---",
      "affiliationId": "50052",
      "approvedDate": "2026-11-17",
      "caId": "CA16609384",
      "classification": "Pathogenic",
      "condition": "beta-thalassemia HBB/LCRB",
      "cvId": "393704",
      "docVersion": "1.0.0",
      "ep": "Hemoglobinopathy VCEP",
      "gene": "HBB",
      "geneNcbiId": "3043",
      "hgvs": [
        "NM_000518.5:c.-18C>G",
        "NC_000011.10:g.5227039G>C",
        "CM000673.2:g.5227039G>C",
        "NC_000011.9:g.5248269G>C",
        "CM000673.1:g.5248269G>C",
        "NC_000011.8:g.5204845G>C",
        "NG_000007.3:g.70577C>G",
        "NG_059281.1:g.5033C>G",
        "ENST00000647020.1:c.-18C>G",
        "ENST00000335295.4:c.-18C>G",
        "ENST00000380315.2:c.-18C>G",
        "ENST00000485743.1:n.34C>G",
        "ENST00000633227.1:c.-18C>G",
        "NM_000518.4:c.-18C>G",
        "NM_000518.5(HBB):c.-18C>G"
      ],
      "hgvsSearch": "nm_000518.5:c.-18c>g nc_000011.10:g.5227039g>c cm000673.2:g.5227039g>c nc_000011.9:g.5248269g>c cm000673.1:g.5248269g>c nc_000011.8:g.5204845g>c ng_000007.3:g.70577c>g ng_059281.1:g.5033c>g enst00000647020.1:c.-18c>g enst00000335295.4:c.-18c>g enst00000380315.2:c.-18c>g enst00000485743.1:n.34c>g enst00000633227.1:c.-18c>g nm_000518.4:c.-18c>g nm_000518.5(hbb):c.-18c>g",
      "metCodes": [
        "PM2_Supporting",
        "PM3_Very Strong",
        "PP1_Moderate",
        "PS3_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pm3_very strong pp1_moderate ps3_supporting pp3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0013517",
      "preferredVarTitle": "NM_000518.5(HBB):c.-18C>G",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000518.5(HBB):c.-18C>G variant is located in the 5′UTR of HBB, within the downstream core promoter element (DCE), where it disrupts transcription factor IID (TFIID) binding and RNA polymerase II recruitment. However, this region is not covered by the VCEP specifications for PM1 application [PMID: 10840054].\nThe variant has been reported in six probands with β-thalassemia intermedia or variable transfusion requirements, in compound heterozygosity with pathogenic HBB variants: c.118C>T (codon 39; ClinVar ID: 15402), c.92+1G>A (IVS-I-1; ClinVar ID: 15436), and c.93-21G>A (IVS-I-110; ClinVar ID: 15454). The variants were confirmed to be in trans through molecular and family studies and are exempt from PM2_Supporting requirements under the VCEP specifications. The total PM3 score exceeds 4, meeting the threshold for Very Strong evidence [PMIDs: 8562944, 38397898]. Segregation with β-thalassemia intermedia in three affected family members across three independent families, with no unaffected segregations, yielded a combined LOD score of 1.81 [PP1_Moderate; PMIDs: 8562944, 38397898].\nFunctional studies in two heterozygous carriers demonstrated elevated α/β-globin synthesis ratios of 1.5 and 1.8 (β/α: 0.67 and 0.56), alongside reduced mutant β-globin transcript abundance (33% and 30% of wild-type), supporting impaired β-globin expression [PS3_Supporting; PMID: 8562944]. The computational predictor CADD (PHRED score 17.86; VCEP threshold >12 ) further suggests a potential impact of this variant on HBB function [PP3]. The variant is absent from gnomAD v4.1.2 [PM2_P].\nIn summary, this variant meets the criteria for classification as Pathogenic for autosomal recessive β-thalassemia (MONDO:0013517) according to the ACMG/AMP criteria as specified by the ClinGen Hemoglobinopathy VCEP (specification version 1.0.0): PM3_Very Strong, PP1_Moderate, PS3_Supporting, PP3, and PM2_Supporting.",
      "unMetCodes": [
        "PS4",
        "PM1"
      ],
      "unMetCodesSearch": "ps4 pm1",
      "uuid": "b6eec46a-c092-4f79-af3c-087ee835ee02",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013765",
      "_id": "AlleleRecords/1692514536",
      "_key": "1692514536",
      "_rev": "_mciMm-W---",
      "affiliationId": "50052",
      "approvedDate": "2026-11-17",
      "caId": "CA16602272",
      "classification": "Pathogenic",
      "condition": "HBA2-related alpha thalassemia spectrum",
      "cvId": "375749",
      "docVersion": "1.0.0",
      "ep": "Hemoglobinopathy VCEP",
      "gene": "HBA2",
      "geneNcbiId": "3040",
      "hgvs": [
        "NM_000517.6:c.*94A>G",
        "NC_000016.10:g.173694A>G",
        "CM000678.2:g.173694A>G",
        "NC_000016.9:g.223693A>G",
        "CM000678.1:g.223693A>G",
        "NC_000016.8:g.163693A>G",
        "NG_000006.1:g.34557A>G",
        "NG_059186.1:g.2044A>G",
        "NG_059271.1:g.5848A>G",
        "ENST00000251595.11:c.*94A>G",
        "ENST00000251595.10:c.*94A>G",
        "ENST00000397806.1:c.*94A>G",
        "NM_000517.4:c.*94A>G",
        "NM_000517.6(HBA2):c.*94A>G"
      ],
      "hgvsSearch": "nm_000517.6:c.*94a>g nc_000016.10:g.173694a>g cm000678.2:g.173694a>g nc_000016.9:g.223693a>g cm000678.1:g.223693a>g nc_000016.8:g.163693a>g ng_000006.1:g.34557a>g ng_059186.1:g.2044a>g ng_059271.1:g.5848a>g enst00000251595.11:c.*94a>g enst00000251595.10:c.*94a>g enst00000397806.1:c.*94a>g nm_000517.4:c.*94a>g nm_000517.6(hba2):c.*94a>g",
      "metCodes": [
        "PP1_Strong",
        "PM2_Supporting",
        "PS3_Supporting",
        "PS4",
        "PM3_Strong",
        "PM1",
        "PP3"
      ],
      "metCodesSearch": "pp1_strong pm2_supporting ps3_supporting ps4 pm3_strong pm1 pp3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0100562",
      "preferredVarTitle": "NM_000517.6(HBA2):c.*94A>G",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The c.*94A>G variant is located in the HBA2 gene. This variant has been reported in 25 unrelated individuals displaying an hematological phenotype consistent with alpha thalassemia trait (low MCV and MCH) giving a total score 4.4 [PS4; PMID:128162; Blood Disorder Genetics & Thalassemia Department, CING; Thalassemia and rare inherited anemias Unit, AOU San Luigi Gonzaga University Hospital; Department of Medical Genetics, National and Kapodistrian University of Athens; Molecular Pathology Laboratory, Reference Haematology, King’s College Hospital]. The variant has been reported to segregate with HbH disease in 8 affected family members from 5 families. It has also been reported to segregate with a rare form of HbH hydrops fetalis syndrome. The total number of unaffected segregations is 0, resulting in a LOD score of 5.42 [PP1_Strong; PMID:7701914,1281602, 12028055]. \nThe c.*94A>G variant was identified in two compound heterozygous individuals, both confirmed in trans by parental testing: one with HbH hydrops fetalis syndrome carrying the --MED (α⁰-thalassemia) deletion [PMIDs: 12028055] and another carrying the established pathogenic α(-5nt) variant [ClinVar ID: 375746;  PMID: 7701914]. An additional compound heterozygous case involving the --MED deletion was reported in a six-year-old child with severe HbH disease, for whom parental confirmation of phase was not documented [PMID: 12358934]. Additionally, 7 individuals with HbH disease were reported to be homozygous for the variant, contributing the maximum permitted cumulative score of 1 point [PMID: 1281602]. The total PM3 score is 3.5 [PM3_Strong]. The variant is located within the polyadenylation signal (AATAAA) of HBA2, a region defined as a mutational hotspot and critical functional domain by the ClinGen Hemoglobinopathy VCEP [PM1]. In vivo cell-based assays showed a 15% reduction in mRNA levels associated with the c.*94A>G variant, while in vitro studies demonstrated that transcription failed to terminate in the absence of active 3′-end processing, supporting an impact on transcriptional termination [PS3_P; PMID:3024968 and 6646217]. The computational predictor CADD (PHRED score 12.77; VCEP threshold >12) suggests that this variant impacts HBA2 function [PP3]. The minor allele frequency in gnomAD v4.1.2 is 0.000009787 (15/1532660) which is lower that the ClinGen Hemoglobinopathy VCEP threshold (<0.0001) for PM2_Supporting, and therefore meets this criterion [PM2_P]. In summary, this variant meets the criteria to be classified as pathogenic for HBA2-related alpha thalassemia spectrum (MONDO:0100562) in an autosomal recessive manner based on the ACMG/AMP criteria applied, as specified by the ClinGen Hemoglobinopathy VCEP (specification version 1.0.0): PP1_S, PS4, PM3_S, PM1, PM2_P, PP3, PS3_P.",
      "uuid": "5e4e4c17-b303-41d3-abc1-5f33b6d7c972",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013766",
      "_id": "AlleleRecords/1692599646",
      "_key": "1692599646",
      "_rev": "_mcpOO-q---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412715679",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "2582607",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.78-2A>G",
        "NC_000023.11:g.38367289A>G",
        "CM000685.2:g.38367289A>G",
        "NC_000023.10:g.38226542A>G",
        "CM000685.1:g.38226542A>G",
        "NC_000023.9:g.38111486A>G",
        "NG_008471.1:g.19807A>G",
        "ENST00000039007.5:c.78-2A>G",
        "ENST00000643344.1:c.78-2A>G",
        "ENST00000039007.4:c.78-2A>G",
        "ENST00000465127.1:c.172-298832A>G",
        "ENST00000488812.1:n.170-2A>G",
        "NM_000531.5:c.78-2A>G",
        "XM_017029556.1:c.78-2A>G"
      ],
      "hgvsSearch": "nm_000531.6:c.78-2a>g nc_000023.11:g.38367289a>g cm000685.2:g.38367289a>g nc_000023.10:g.38226542a>g cm000685.1:g.38226542a>g nc_000023.9:g.38111486a>g ng_008471.1:g.19807a>g enst00000039007.5:c.78-2a>g enst00000643344.1:c.78-2a>g enst00000039007.4:c.78-2a>g enst00000465127.1:c.172-298832a>g enst00000488812.1:n.170-2a>g nm_000531.5:c.78-2a>g xm_017029556.1:c.78-2a>g",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.78-2A>G",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.78-2A>G variant in the OTC gene affects the canonical donor/acceptor splice site in the 1st intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.98, 2bp and donor loss, score 0.37, 140bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (8 points), PM2_Supporting (1 point).",
      "uuid": "fef3cec9-0d90-4b8e-929b-f3bb174e9f5e",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013767",
      "_id": "AlleleRecords/1692601219",
      "_key": "1692601219",
      "_rev": "_mcpWqL2--_",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA3246642481",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.103_104insA",
        "NC_000023.11:g.38367316_38367317insA",
        "CM000685.2:g.38367316_38367317insA",
        "NC_000023.10:g.38226569_38226570insA",
        "CM000685.1:g.38226569_38226570insA",
        "NC_000023.9:g.38111513_38111514insA",
        "NG_008471.1:g.19834_19835insA",
        "ENST00000039007.5:c.103_104insA",
        "ENST00000643344.1:c.103_104insA",
        "ENST00000039007.4:c.103_104insA",
        "ENST00000465127.1:c.172-298805_172-298804insA",
        "ENST00000488812.1:n.195_196insA",
        "NM_000531.5:c.103_104insA",
        "XM_017029556.1:c.103_104insA"
      ],
      "hgvsSearch": "nm_000531.6:c.103_104insa nc_000023.11:g.38367316_38367317insa cm000685.2:g.38367316_38367317insa nc_000023.10:g.38226569_38226570insa cm000685.1:g.38226569_38226570insa nc_000023.9:g.38111513_38111514insa ng_008471.1:g.19834_19835insa enst00000039007.5:c.103_104insa enst00000643344.1:c.103_104insa enst00000039007.4:c.103_104insa enst00000465127.1:c.172-298805_172-298804insa enst00000488812.1:n.195_196insa nm_000531.5:c.103_104insa xm_017029556.1:c.103_104insa",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.103_104insA",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.103_104insA (p.Val35AspfsTer7) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 2/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (8 points), PM2_Supporting (1 point).",
      "uuid": "d9b60c43-ef60-48a5-acee-fb4035903a42",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013768",
      "_id": "AlleleRecords/1692602892",
      "_key": "1692602892",
      "_rev": "_mcpfGrK---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224462",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97111",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.140del",
        "NC_000023.11:g.38367353del",
        "CM000685.2:g.38367353del",
        "NC_000023.10:g.38226606del",
        "CM000685.1:g.38226606del",
        "NC_000023.9:g.38111550del",
        "NG_008471.1:g.19871del",
        "ENST00000039007.5:c.140del",
        "ENST00000643344.1:c.140del",
        "ENST00000039007.4:c.140del",
        "ENST00000465127.1:c.172-298768del",
        "ENST00000488812.1:n.232del",
        "NM_000531.5:c.140del",
        "XM_017029556.1:c.140del",
        "NM_000531.6(OTC):c.140del (p.Asn47fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.140del nc_000023.11:g.38367353del cm000685.2:g.38367353del nc_000023.10:g.38226606del cm000685.1:g.38226606del nc_000023.9:g.38111550del ng_008471.1:g.19871del enst00000039007.5:c.140del enst00000643344.1:c.140del enst00000039007.4:c.140del enst00000465127.1:c.172-298768del enst00000488812.1:n.232del nm_000531.5:c.140del xm_017029556.1:c.140del nm_000531.6(otc):c.140del (p.asn47fs)",
      "metCodes": [
        "PM6",
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting",
        "PS4_Supporting"
      ],
      "metCodesSearch": "pm6 pvs1 pp4_moderate pm2_supporting ps4_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.140del (p.Asn47fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.140del (p.Asn47ThrfsTer17) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 2/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed 0% OTC activity, which is highly specific for OTC deficiency (PP4_Moderate, PMID: 9452049). This variant has been reported in 1 additional proband with biochemical or clinical evidence of OTC deficiency (PS4_Supporting; PMID: 9452049). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 39256843). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PM6, PP4_Moderate, PS4_Supporting.",
      "uuid": "e18de546-9ac5-4c25-a0bc-80cfc5ce47eb",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013769",
      "_id": "AlleleRecords/1692604459",
      "_key": "1692604459",
      "_rev": "_mcpnjim--D",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224472",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "11002",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.148G>T",
        "NC_000023.11:g.38367361G>T",
        "CM000685.2:g.38367361G>T",
        "NC_000023.10:g.38226614G>T",
        "CM000685.1:g.38226614G>T",
        "NC_000023.9:g.38111558G>T",
        "NG_008471.1:g.19879G>T",
        "ENST00000039007.5:c.148G>T",
        "ENST00000643344.1:c.148G>T",
        "ENST00000039007.4:c.148G>T",
        "ENST00000465127.1:c.172-298760G>T",
        "ENST00000488812.1:n.240G>T",
        "NM_000531.5:c.148G>T",
        "XM_017029556.1:c.148G>T",
        "NM_000531.6(OTC):c.148G>T (p.Gly50Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.148g>t nc_000023.11:g.38367361g>t cm000685.2:g.38367361g>t nc_000023.10:g.38226614g>t cm000685.1:g.38226614g>t nc_000023.9:g.38111558g>t ng_008471.1:g.19879g>t enst00000039007.5:c.148g>t enst00000643344.1:c.148g>t enst00000039007.4:c.148g>t enst00000465127.1:c.172-298760g>t enst00000488812.1:n.240g>t nm_000531.5:c.148g>t xm_017029556.1:c.148g>t nm_000531.6(otc):c.148g>t (p.gly50ter)",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM6_Supporting",
        "PM2_Supporting",
        "PS4_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm6_supporting pm2_supporting ps4_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.148G>T (p.Gly50Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.148G>T(p.Gly50Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been reported in 1 additional proband with hyperammonemia (PS4_Supporting; PMID:1353535). One patient with this variant displayed neonatal onset, hyperammonemia, lethargy, low plasma citrulline, hyperglutaminemia, oriticaciduria, which is highly specific for OTC deficiency (1.75pt; PP4_Moderate, PMID:30175132). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual female with Oroticaciduria, Hyperammonemia (PM6_Supporting, PMID: 1353535). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PS4_Very Strong, PP4_Moderate, PM6_Supporting.",
      "uuid": "b3542d66-df1d-4dcc-968c-510b261477b9",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013770",
      "_id": "AlleleRecords/1692606090",
      "_key": "1692606090",
      "_rev": "_mcpw_q2---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224527",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97149",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.271del",
        "NC_000023.11:g.38369850del",
        "CM000685.2:g.38369850del",
        "NC_000023.10:g.38229103del",
        "CM000685.1:g.38229103del",
        "NC_000023.9:g.38114047del",
        "NG_008471.1:g.22368del",
        "ENST00000039007.5:c.271del",
        "ENST00000643344.1:c.271del",
        "ENST00000039007.4:c.271del",
        "ENST00000465127.1:c.172-296271del",
        "ENST00000488812.1:n.353+10del",
        "NM_000531.5:c.271del",
        "XM_017029556.1:c.271del",
        "NM_000531.6(OTC):c.271del (p.Thr91fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.271del nc_000023.11:g.38369850del cm000685.2:g.38369850del nc_000023.10:g.38229103del cm000685.1:g.38229103del nc_000023.9:g.38114047del ng_008471.1:g.22368del enst00000039007.5:c.271del enst00000643344.1:c.271del enst00000039007.4:c.271del enst00000465127.1:c.172-296271del enst00000488812.1:n.353+10del nm_000531.5:c.271del xm_017029556.1:c.271del nm_000531.6(otc):c.271del (p.thr91fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.271del (p.Thr91fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC): c.271del (p. Thr91LeufsTer30) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 3/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "048045a3-baa2-42a7-96e2-9ef71b91c31a",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013771",
      "_id": "AlleleRecords/1692607840",
      "_key": "1692607840",
      "_rev": "_mcp4cVK---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2695233290",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.140dup",
        "NC_000023.11:g.38367353dup",
        "CM000685.2:g.38367353dup",
        "NC_000023.10:g.38226606dup",
        "CM000685.1:g.38226606dup",
        "NC_000023.9:g.38111550dup",
        "NG_008471.1:g.19871dup",
        "ENST00000039007.5:c.140dup",
        "ENST00000643344.1:c.140dup",
        "ENST00000039007.4:c.140dup",
        "ENST00000465127.1:c.172-298768dup",
        "ENST00000488812.1:n.232dup",
        "NM_000531.5:c.140dup",
        "XM_017029556.1:c.140dup"
      ],
      "hgvsSearch": "nm_000531.6:c.140dup nc_000023.11:g.38367353dup cm000685.2:g.38367353dup nc_000023.10:g.38226606dup cm000685.1:g.38226606dup nc_000023.9:g.38111550dup ng_008471.1:g.19871dup enst00000039007.5:c.140dup enst00000643344.1:c.140dup enst00000039007.4:c.140dup enst00000465127.1:c.172-298768dup enst00000488812.1:n.232dup nm_000531.5:c.140dup xm_017029556.1:c.140dup",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.140dup",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.140dup (p.Asn47LysfsTer8) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 2/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "b11a630e-8d50-4ff6-a105-ee7f14c421bb",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013772",
      "_id": "AlleleRecords/1692609567",
      "_key": "1692609567",
      "_rev": "_mcqA5FO---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224476",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97119",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.154G>T",
        "NC_000023.11:g.38367367G>T",
        "CM000685.2:g.38367367G>T",
        "NC_000023.10:g.38226620G>T",
        "CM000685.1:g.38226620G>T",
        "NC_000023.9:g.38111564G>T",
        "NG_008471.1:g.19885G>T",
        "ENST00000039007.5:c.154G>T",
        "ENST00000643344.1:c.154G>T",
        "ENST00000039007.4:c.154G>T",
        "ENST00000465127.1:c.172-298754G>T",
        "ENST00000488812.1:n.246G>T",
        "NM_000531.5:c.154G>T",
        "XM_017029556.1:c.154G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.154g>t nc_000023.11:g.38367367g>t cm000685.2:g.38367367g>t nc_000023.10:g.38226620g>t cm000685.1:g.38226620g>t nc_000023.9:g.38111564g>t ng_008471.1:g.19885g>t enst00000039007.5:c.154g>t enst00000643344.1:c.154g>t enst00000039007.4:c.154g>t enst00000465127.1:c.172-298754g>t enst00000488812.1:n.246g>t nm_000531.5:c.154g>t xm_017029556.1:c.154g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.154G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.154G>T (p.Glu52Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "a0e61ad5-f568-4441-a937-0cfb78dc95e2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013773",
      "_id": "AlleleRecords/1692611721",
      "_key": "1692611721",
      "_rev": "_mcqJVa----",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224490",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97127",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.174G>A",
        "NC_000023.11:g.38367387G>A",
        "CM000685.2:g.38367387G>A",
        "NC_000023.10:g.38226640G>A",
        "CM000685.1:g.38226640G>A",
        "NC_000023.9:g.38111584G>A",
        "NG_008471.1:g.19905G>A",
        "ENST00000039007.5:c.174G>A",
        "ENST00000643344.1:c.174G>A",
        "ENST00000039007.4:c.174G>A",
        "ENST00000465127.1:c.172-298734G>A",
        "ENST00000488812.1:n.266G>A",
        "NM_000531.5:c.174G>A",
        "XM_017029556.1:c.174G>A",
        "NM_000531.6(OTC):c.174G>A (p.Trp58Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.174g>a nc_000023.11:g.38367387g>a cm000685.2:g.38367387g>a nc_000023.10:g.38226640g>a cm000685.1:g.38226640g>a nc_000023.9:g.38111584g>a ng_008471.1:g.19905g>a enst00000039007.5:c.174g>a enst00000643344.1:c.174g>a enst00000039007.4:c.174g>a enst00000465127.1:c.172-298734g>a enst00000488812.1:n.266g>a nm_000531.5:c.174g>a xm_017029556.1:c.174g>a nm_000531.6(otc):c.174g>a (p.trp58ter)",
      "metCodes": [
        "PVS1",
        "PM6_Supporting",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm6_supporting pm2_supporting pp4",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.174G>A (p.Trp58Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.174G>A (p.Trp58Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed childhood onset, oroticaciduria, elevated circulating uracil concentration, which is highly specific for OTC deficiency (1pt; PP4_Supporting, PMID: 33272297). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 33272297). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PM6, PP4_Moderate.",
      "uuid": "ada38030-644e-405d-aac5-d3536bdfe65d",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013774",
      "_id": "AlleleRecords/1692616004",
      "_key": "1692616004",
      "_rev": "_mcqaO3m---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224500",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97133",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.205C>T",
        "NC_000023.11:g.38367418C>T",
        "CM000685.2:g.38367418C>T",
        "NC_000023.10:g.38226671C>T",
        "CM000685.1:g.38226671C>T",
        "NC_000023.9:g.38111615C>T",
        "NG_008471.1:g.19936C>T",
        "ENST00000039007.5:c.205C>T",
        "ENST00000643344.1:c.205C>T",
        "ENST00000039007.4:c.205C>T",
        "ENST00000465127.1:c.172-298703C>T",
        "ENST00000488812.1:n.297C>T",
        "NM_000531.5:c.205C>T",
        "XM_017029556.1:c.205C>T"
      ],
      "hgvsSearch": "nm_000531.6:c.205c>t nc_000023.11:g.38367418c>t cm000685.2:g.38367418c>t nc_000023.10:g.38226671c>t cm000685.1:g.38226671c>t nc_000023.9:g.38111615c>t ng_008471.1:g.19936c>t enst00000039007.5:c.205c>t enst00000643344.1:c.205c>t enst00000039007.4:c.205c>t enst00000465127.1:c.172-298703c>t enst00000488812.1:n.297c>t nm_000531.5:c.205c>t xm_017029556.1:c.205c>t",
      "metCodes": [
        "PM6",
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting",
        "PS4_Supporting"
      ],
      "metCodesSearch": "pm6 pvs1 pp4_moderate pm2_supporting ps4_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.205C>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.205C>T (p.Gln69Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed childhood onset, seizures, Hyperammonemia, Hyperglutaminemia, Low plasma citrulline, Oroticaciduria , Childhood onset which is highly specific for OTC deficiency (1.75pt; PP4_Moderate, PMID: 34987927). This variant has been reported in 1 additional proband with biochemical or clinical evidence of OTC deficiency (PS4_Supporting; PMID: PMID:10502831). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 10502831). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PM6, PP4_Moderate, PS4_Supporting.",
      "uuid": "05079039-3fb3-4fb1-abf5-b60d78785c7b",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013775",
      "_id": "AlleleRecords/1692618008",
      "_key": "1692618008",
      "_rev": "_mcqirPq---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2838139630",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.207_226del",
        "NC_000023.11:g.38367420_38369805del",
        "CM000685.2:g.38367420_38369805del",
        "NC_000023.10:g.38226673_38229058del",
        "CM000685.1:g.38226673_38229058del",
        "NC_000023.9:g.38111617_38114002del",
        "NG_008471.1:g.19938_22323del",
        "ENST00000039007.5:c.207_226del",
        "ENST00000643344.1:c.207_226del",
        "ENST00000039007.4:c.207_226del",
        "ENST00000465127.1:c.172-298701_172-296316del",
        "ENST00000488812.1:n.299_318del",
        "NM_000531.5:c.207_226del",
        "XM_017029556.1:c.207_226del"
      ],
      "hgvsSearch": "nm_000531.6:c.207_226del nc_000023.11:g.38367420_38369805del cm000685.2:g.38367420_38369805del nc_000023.10:g.38226673_38229058del cm000685.1:g.38226673_38229058del nc_000023.9:g.38111617_38114002del ng_008471.1:g.19938_22323del enst00000039007.5:c.207_226del enst00000643344.1:c.207_226del enst00000039007.4:c.207_226del enst00000465127.1:c.172-298701_172-296316del enst00000488812.1:n.299_318del nm_000531.5:c.207_226del xm_017029556.1:c.207_226del",
      "metCodes": [
        "PM6",
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pm6 pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.207_226del",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.207_226del (p.Gln69Hisfs*12) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 2/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed Hyperammonemia, hyperglutaminemia, orotic aciduria, Elevated circulating ALT concentration, Elevated circulating uracil concentration, Childhood onset which is highly specific for OTC deficiency (1.75pts; PP4_Moderate, PMID: 33272297). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 33272297). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PM6, PP4_Moderate.",
      "uuid": "d3f2cc98-0720-4ee9-88d6-b00e89b84c03",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013776",
      "_id": "AlleleRecords/1692622731",
      "_key": "1692622731",
      "_rev": "_mcqzvSa---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412716486",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.211G>T",
        "NC_000023.11:g.38367424G>T",
        "CM000685.2:g.38367424G>T",
        "NC_000023.10:g.38226677G>T",
        "CM000685.1:g.38226677G>T",
        "NC_000023.9:g.38111621G>T",
        "NG_008471.1:g.19942G>T",
        "ENST00000039007.5:c.211G>T",
        "ENST00000643344.1:c.211G>T",
        "ENST00000039007.4:c.211G>T",
        "ENST00000465127.1:c.172-298697G>T",
        "ENST00000488812.1:n.303G>T",
        "NM_000531.5:c.211G>T",
        "XM_017029556.1:c.211G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.211g>t nc_000023.11:g.38367424g>t cm000685.2:g.38367424g>t nc_000023.10:g.38226677g>t cm000685.1:g.38226677g>t nc_000023.9:g.38111621g>t ng_008471.1:g.19942g>t enst00000039007.5:c.211g>t enst00000643344.1:c.211g>t enst00000039007.4:c.211g>t enst00000465127.1:c.172-298697g>t enst00000488812.1:n.303g>t nm_000531.5:c.211g>t xm_017029556.1:c.211g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.211G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.211G>T (p.Gly71Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "8ea0428d-41b6-4d5d-a2ec-f05980be8a5e",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013777",
      "_id": "AlleleRecords/1692625702",
      "_key": "1692625702",
      "_rev": "_mcq8SYi---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224509",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97139",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.232C>T",
        "NC_000023.11:g.38369811C>T",
        "CM000685.2:g.38369811C>T",
        "NC_000023.10:g.38229064C>T",
        "CM000685.1:g.38229064C>T",
        "NC_000023.9:g.38114008C>T",
        "NG_008471.1:g.22329C>T",
        "ENST00000039007.5:c.232C>T",
        "ENST00000643344.1:c.232C>T",
        "ENST00000039007.4:c.232C>T",
        "ENST00000465127.1:c.172-296310C>T",
        "ENST00000488812.1:n.324C>T",
        "NM_000531.5:c.232C>T",
        "XM_017029556.1:c.232C>T",
        "NM_000531.6(OTC):c.232C>T (p.Gln78Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.232c>t nc_000023.11:g.38369811c>t cm000685.2:g.38369811c>t nc_000023.10:g.38229064c>t cm000685.1:g.38229064c>t nc_000023.9:g.38114008c>t ng_008471.1:g.22329c>t enst00000039007.5:c.232c>t enst00000643344.1:c.232c>t enst00000039007.4:c.232c>t enst00000465127.1:c.172-296310c>t enst00000488812.1:n.324c>t nm_000531.5:c.232c>t xm_017029556.1:c.232c>t nm_000531.6(otc):c.232c>t (p.gln78ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.232C>T (p.Gln78Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.232C>T (p.Gln78Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "5edda82e-8a9d-45f4-89eb-c0650e700705",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013778",
      "_id": "AlleleRecords/1692627599",
      "_key": "1692627599",
      "_rev": "_mcrEstS---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA401362933",
      "classification": "Pathogenic",
      "condition": "glycogen storage disease II",
      "cvId": "2099113",
      "docVersion": "1.0.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.693-2A>C",
        "NC_000017.11:g.80107555A>C",
        "CM000679.2:g.80107555A>C",
        "NC_000017.10:g.78081354A>C",
        "CM000679.1:g.78081354A>C",
        "NC_000017.9:g.75695949A>C",
        "NG_009822.1:g.11000A>C",
        "LRG_673:g.11000A>C",
        "ENST00000570803.6:c.693-2A>C",
        "ENST00000572080.2:c.693-2A>C",
        "ENST00000577106.6:c.693-2A>C",
        "ENST00000302262.8:c.693-2A>C",
        "ENST00000302262.7:c.693-2A>C",
        "ENST00000390015.7:c.693-2A>C",
        "ENST00000570803.5:c.693-2A>C",
        "NM_000152.3:c.693-2A>C",
        "LRG_673t1:c.693-2A>C",
        "NM_001079803.1:c.693-2A>C",
        "NM_001079804.1:c.693-2A>C",
        "XM_005257193.1:c.693-2A>C",
        "XM_005257194.3:c.693-2A>C",
        "NM_000152.4:c.693-2A>C",
        "NM_001079803.2:c.693-2A>C",
        "NM_001079804.2:c.693-2A>C",
        "XM_005257193.2:c.693-2A>C",
        "XM_005257194.4:c.693-2A>C",
        "NM_001079803.3:c.693-2A>C",
        "NM_001079804.3:c.693-2A>C",
        "NM_000152.5(GAA):c.693-2A>C"
      ],
      "hgvsSearch": "nm_000152.5:c.693-2a>c nc_000017.11:g.80107555a>c cm000679.2:g.80107555a>c nc_000017.10:g.78081354a>c cm000679.1:g.78081354a>c nc_000017.9:g.75695949a>c ng_009822.1:g.11000a>c lrg_673:g.11000a>c enst00000570803.6:c.693-2a>c enst00000572080.2:c.693-2a>c enst00000577106.6:c.693-2a>c enst00000302262.8:c.693-2a>c enst00000302262.7:c.693-2a>c enst00000390015.7:c.693-2a>c enst00000570803.5:c.693-2a>c nm_000152.3:c.693-2a>c lrg_673t1:c.693-2a>c nm_001079803.1:c.693-2a>c nm_001079804.1:c.693-2a>c xm_005257193.1:c.693-2a>c xm_005257194.3:c.693-2a>c nm_000152.4:c.693-2a>c nm_001079803.2:c.693-2a>c nm_001079804.2:c.693-2a>c xm_005257193.2:c.693-2a>c xm_005257194.4:c.693-2a>c nm_001079803.3:c.693-2a>c nm_001079804.3:c.693-2a>c nm_000152.5(gaa):c.693-2a>c",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.693-2A>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.693-2A>C variant in GAA occurs within the canonical splice acceptor site of intron 3. SpliceAI predicts loss of the acceptor splice site, as expected, but also predicts an acceptor splice site 40 bp downstream (SpliceAI score = 0.72). All possible splicing consequences are predicted to lead to a frameshift (per SAI-10k-calc, PMID: 37021934) and nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant was diagnosed with infantile onset Pompe disease based on his clinical symptoms of hypotonia, hypertrophic cardiomyopathy, and elevated CK and transaminases. He had no detectable GAA activity in fibroblasts, was CRIM-negative, and started enzyme replacement therapy at 3 months of age (PMID: 39161458) (PP4_Moderate). This individual was compound heterozygous for c.693-2A>C in trans with c.368G>A (p.Gly123Glu) and c.1288G>A (p.Glu430Lys). The allelic data from this patient will be used in the classification of the other variants and it not included here to avoid circular logic. This variant is absent in gnomAD v4.1.2. (PM2_Supporting). There is a ClinVar entry for this variant (Variation ID: 2099113). In summary, this variant meets the criteria to be classified as pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria met, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 2.0): PVS1, PP4_Moderate, PM2_Supporting",
      "unMetCodes": [
        "PM3"
      ],
      "unMetCodesSearch": "pm3",
      "uuid": "15c64fe1-1280-46c4-a4a6-f64694d0663e",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013779",
      "_id": "AlleleRecords/1692629427",
      "_key": "1692629427",
      "_rev": "_mcrNJlC---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224530",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97151",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.274C>T",
        "NC_000023.11:g.38369853C>T",
        "CM000685.2:g.38369853C>T",
        "NC_000023.10:g.38229106C>T",
        "CM000685.1:g.38229106C>T",
        "NC_000023.9:g.38114050C>T",
        "NG_008471.1:g.22371C>T",
        "ENST00000039007.5:c.274C>T",
        "ENST00000643344.1:c.274C>T",
        "ENST00000039007.4:c.274C>T",
        "ENST00000465127.1:c.172-296268C>T",
        "ENST00000488812.1:n.353+13C>T",
        "NM_000531.5:c.274C>T",
        "XM_017029556.1:c.274C>T",
        "NM_000531.6(OTC):c.274C>T (p.Arg92Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.274c>t nc_000023.11:g.38369853c>t cm000685.2:g.38369853c>t nc_000023.10:g.38229106c>t cm000685.1:g.38229106c>t nc_000023.9:g.38114050c>t ng_008471.1:g.22371c>t enst00000039007.5:c.274c>t enst00000643344.1:c.274c>t enst00000039007.4:c.274c>t enst00000465127.1:c.172-296268c>t enst00000488812.1:n.353+13c>t nm_000531.5:c.274c>t xm_017029556.1:c.274c>t nm_000531.6(otc):c.274c>t (p.arg92ter)",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting",
        "PS4_Moderate"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting ps4_moderate",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.274C>T (p.Arg92Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.274C>T (p.Arg92Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 3/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). At least one patient with this variant displayed neonatal onset, hyperammonemia, oroticaciduria, low plasma citrulline which is highly specific for OTC deficiency (1.75pt; PP4_Moderate, PMID: 17041896). This variant has been reported in 3 additional probands with biochemical or clinical evidence of OTC deficiency (PS4_Moderate; PMID: PMID:23278509, 30285816, 12083811). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PP4_Moderate, PS4_Moderate.",
      "uuid": "6caa2ff3-3f67-4eb9-a123-31455ed066a2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013780",
      "_id": "AlleleRecords/1692631318",
      "_key": "1692631318",
      "_rev": "_mcrVmtS---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA8814859",
      "classification": "Likely Benign",
      "condition": "glycogen storage disease II",
      "cvId": "283495",
      "docVersion": "1.0.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.368G>A",
        "NC_000017.11:g.80104954G>A",
        "CM000679.2:g.80104954G>A",
        "NC_000017.10:g.78078753G>A",
        "CM000679.1:g.78078753G>A",
        "NC_000017.9:g.75693348G>A",
        "NG_009822.1:g.8399G>A",
        "LRG_673:g.8399G>A",
        "ENST00000570803.6:c.368G>A",
        "ENST00000572080.2:c.368G>A",
        "ENST00000577106.6:c.368G>A",
        "ENST00000302262.8:c.368G>A",
        "ENST00000302262.7:c.368G>A",
        "ENST00000390015.7:c.368G>A",
        "ENST00000570803.5:c.368G>A",
        "ENST00000577106.5:c.368G>A",
        "NM_000152.3:c.368G>A",
        "LRG_673t1:c.368G>A",
        "NM_001079803.1:c.368G>A",
        "NM_001079804.1:c.368G>A",
        "XM_005257193.1:c.368G>A",
        "XM_005257194.3:c.368G>A",
        "NM_000152.4:c.368G>A",
        "NM_001079803.2:c.368G>A",
        "NM_001079804.2:c.368G>A",
        "XM_005257193.2:c.368G>A",
        "XM_005257194.4:c.368G>A",
        "NM_001079803.3:c.368G>A",
        "NM_001079804.3:c.368G>A",
        "NM_000152.5(GAA):c.368G>A (p.Gly123Glu)"
      ],
      "hgvsSearch": "nm_000152.5:c.368g>a nc_000017.11:g.80104954g>a cm000679.2:g.80104954g>a nc_000017.10:g.78078753g>a cm000679.1:g.78078753g>a nc_000017.9:g.75693348g>a ng_009822.1:g.8399g>a lrg_673:g.8399g>a enst00000570803.6:c.368g>a enst00000572080.2:c.368g>a enst00000577106.6:c.368g>a enst00000302262.8:c.368g>a enst00000302262.7:c.368g>a enst00000390015.7:c.368g>a enst00000570803.5:c.368g>a enst00000577106.5:c.368g>a nm_000152.3:c.368g>a lrg_673t1:c.368g>a nm_001079803.1:c.368g>a nm_001079804.1:c.368g>a xm_005257193.1:c.368g>a xm_005257194.3:c.368g>a nm_000152.4:c.368g>a nm_001079803.2:c.368g>a nm_001079804.2:c.368g>a xm_005257193.2:c.368g>a xm_005257194.4:c.368g>a nm_001079803.3:c.368g>a nm_001079804.3:c.368g>a nm_000152.5(gaa):c.368g>a (p.gly123glu)",
      "metCodes": [
        "BS1",
        "BP4"
      ],
      "metCodesSearch": "bs1 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.368G>A (p.Gly123Glu)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.368G>A variant in GAA results in a missense substitution of glycine by glutamate at amino acid 123 (p.Gly123Glu). The highest population minor allele frequency in gnomAD v4.2.1. is 0.00682 (621/91046 alleles; with 9 homozygotes) in the South Asian population (11 homozygotes total in gnomAD v4.1.2.), which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BS1 (>0.005), and therefore meets this criterion (BS1). The computational predictor REVEL gives a score of 0.185 which is below the threshold of 0.5, evidence that does not predict a damaging effect on GAA function. SpliceAI predicts that the variant has no impact on splicing (BP4). This variant has been identified an in individual with infantile onset Pompe disease (IOPD) who has a rare missense variant, c.1288G>A (p.Glu430Lys), in cis and a variant that has been classified as pathogenic by the ClinGen Lysosomal Diseases VCEP, c.693-2A>C, in trans (PMID: 39161458). The available evidence suggests that the other two variants in this patient are likely to be the variants causing his disease.  There is a ClinVar entry for this variant (Variation ID: 283495). In a summary, this variant meets the criteria to be classified as likely benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 2.0): BS1, BP4",
      "uuid": "cdf8d277-a02f-4953-bc8c-203bbfda47b0",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013781",
      "_id": "AlleleRecords/1692633778",
      "_key": "1692633778",
      "_rev": "_mcreDSe---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224598",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "10988",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.421C>T",
        "NC_000023.11:g.38401309C>T",
        "CM000685.2:g.38401309C>T",
        "NC_000023.10:g.38260562C>T",
        "CM000685.1:g.38260562C>T",
        "NC_000023.9:g.38145506C>T",
        "NG_008471.1:g.53827C>T",
        "ENST00000039007.5:c.421C>T",
        "ENST00000643344.1:c.*171C>T",
        "ENST00000039007.4:c.421C>T",
        "ENST00000465127.1:c.172-264812C>T",
        "ENST00000488812.1:n.458C>T",
        "NM_000531.5:c.421C>T",
        "XM_017029556.1:c.421C>T",
        "NM_000531.6(OTC):c.421C>T (p.Arg141Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.421c>t nc_000023.11:g.38401309c>t cm000685.2:g.38401309c>t nc_000023.10:g.38260562c>t cm000685.1:g.38260562c>t nc_000023.9:g.38145506c>t ng_008471.1:g.53827c>t enst00000039007.5:c.421c>t enst00000643344.1:c.*171c>t enst00000039007.4:c.421c>t enst00000465127.1:c.172-264812c>t enst00000488812.1:n.458c>t nm_000531.5:c.421c>t xm_017029556.1:c.421c>t nm_000531.6(otc):c.421c>t (p.arg141ter)",
      "metCodes": [
        "PM6",
        "PVS1",
        "PP4_Moderate",
        "PS4_Very Strong",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pm6 pvs1 pp4_moderate ps4_very strong pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.421C>T (p.Arg141Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC): c.421C>T (p.Arg141Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 5/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been reported in 8 additional probands with hyperammonemia (PS4_Very Strong; PMID:3170748, PMID: 18616627, PMID: 33867389, PMID: 32447331, PMID: 8956038, PMID: 8365726, PMID: 28266016, PMID: 18204299). At least one patient with this variant displayed Oroticaciduria (+1), Hyperammonemia (+0.25), Aminoaciduria, 5% Hepatic OTC activity (+2), episode of irritability and vomiting, loss of consciousness, which is highly specific for OTC deficiency (Total: +3.25 points PP4_Moderate, PMID: 2741942). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual female with Oroticaciduria, Hyperammonemia, Aminoaciduria, 5% Hepatic OTC activity, episode of irritability and vomiting, loss of consciousness, PM6; PMID: 2741942). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PS4_Very Strong, PP4_Moderate, PM6.",
      "uuid": "519b20d7-264c-418c-89d3-bfefd6032866",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013782",
      "_id": "AlleleRecords/1692636299",
      "_key": "1692636299",
      "_rev": "_mcrmgcy---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2695233306",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.245_246delinsAG",
        "NC_000023.11:g.38369824_38369825delinsAG",
        "CM000685.2:g.38369824_38369825delinsAG",
        "NC_000023.10:g.38229077_38229078delinsAG",
        "CM000685.1:g.38229077_38229078delinsAG",
        "NC_000023.9:g.38114021_38114022delinsAG",
        "NG_008471.1:g.22342_22343delinsAG",
        "ENST00000039007.5:c.245_246delinsAG",
        "ENST00000643344.1:c.245_246delinsAG",
        "ENST00000039007.4:c.245_246delinsAG",
        "ENST00000465127.1:c.172-296297_172-296296delinsAG",
        "ENST00000488812.1:n.337_338delinsAG",
        "NM_000531.5:c.245_246delinsAG",
        "XM_017029556.1:c.245_246delinsAG"
      ],
      "hgvsSearch": "nm_000531.6:c.245_246delinsag nc_000023.11:g.38369824_38369825delinsag cm000685.2:g.38369824_38369825delinsag nc_000023.10:g.38229077_38229078delinsag cm000685.1:g.38229077_38229078delinsag nc_000023.9:g.38114021_38114022delinsag ng_008471.1:g.22342_22343delinsag enst00000039007.5:c.245_246delinsag enst00000643344.1:c.245_246delinsag enst00000039007.4:c.245_246delinsag enst00000465127.1:c.172-296297_172-296296delinsag enst00000488812.1:n.337_338delinsag nm_000531.5:c.245_246delinsag xm_017029556.1:c.245_246delinsag",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.245_246delinsAG",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.245_246delinsAG (p.Leu82Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 3/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). At least one patient with this variant displayed Neonatal onset (HP:0003623), lethargy (HP:0001254), coma (HP:0001259), global developmental delay (HP:0001263), hyperammonemia (HP:0001987), episodic ammonia intoxication (HP:0001951), low plasma citrulline, hyperglutaminemia (+0.75), oroticaciduria (+1) which is highly specific for OTC deficiency (PP4_Moderate; 1.75pt; PMID: 30175132). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PP4_Moderate.",
      "uuid": "80d8d253-82e5-4bf4-a4a6-9f421dd8ad65",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013783",
      "_id": "AlleleRecords/1692639730",
      "_key": "1692639730",
      "_rev": "_mcr371u---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA2695227103",
      "classification": "Likely Pathogenic",
      "condition": "glycogen storage disease II",
      "cvId": "4876552",
      "docVersion": "1.0.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_001079804.3:c.1833_1847delinsACGGGGTAT",
        "NC_000017.11:g.80112656_80112670delinsACGGGGTAT",
        "CM000679.2:g.80112656_80112670delinsACGGGGTAT",
        "NC_000017.10:g.78086455_78086469delinsACGGGGTAT",
        "CM000679.1:g.78086455_78086469delinsACGGGGTAT",
        "NC_000017.9:g.75701050_75701064delinsACGGGGTAT",
        "NG_009822.1:g.16101_16115delinsACGGGGTAT",
        "LRG_673:g.16101_16115delinsACGGGGTAT",
        "ENST00000570803.6:c.1833_1847delinsACGGGGTAT",
        "ENST00000572080.2:c.1833_1847delinsACGGGGTAT",
        "ENST00000577106.6:c.1833_1847delinsACGGGGTAT",
        "ENST00000302262.8:c.1833_1847delinsACGGGGTAT",
        "ENST00000302262.7:c.1833_1847delinsACGGGGTAT",
        "ENST00000390015.7:c.1833_1847delinsACGGGGTAT",
        "ENST00000570716.1:n.273_287delinsACGGGGTAT",
        "ENST00000572080.1:c.221_235delinsACGGGGTAT",
        "ENST00000572803.1:n.447_461delinsACGGGGTAT",
        "NM_000152.3:c.1833_1847delinsACGGGGTAT",
        "LRG_673t1:c.1833_1847delinsACGGGGTAT",
        "NM_001079803.1:c.1833_1847delinsACGGGGTAT",
        "NM_001079804.1:c.1833_1847delinsACGGGGTAT",
        "XM_005257193.1:c.1833_1847delinsACGGGGTAT",
        "XM_005257194.3:c.1833_1847delinsACGGGGTAT",
        "NM_000152.4:c.1833_1847delinsACGGGGTAT",
        "NM_001079803.2:c.1833_1847delinsACGGGGTAT",
        "NM_001079804.2:c.1833_1847delinsACGGGGTAT",
        "XM_005257193.2:c.1833_1847delinsACGGGGTAT",
        "XM_005257194.4:c.1833_1847delinsACGGGGTAT",
        "NM_000152.5:c.1833_1847delinsACGGGGTAT",
        "NM_001079803.3:c.1833_1847delinsACGGGGTAT"
      ],
      "hgvsSearch": "nm_001079804.3:c.1833_1847delinsacggggtat nc_000017.11:g.80112656_80112670delinsacggggtat cm000679.2:g.80112656_80112670delinsacggggtat nc_000017.10:g.78086455_78086469delinsacggggtat cm000679.1:g.78086455_78086469delinsacggggtat nc_000017.9:g.75701050_75701064delinsacggggtat ng_009822.1:g.16101_16115delinsacggggtat lrg_673:g.16101_16115delinsacggggtat enst00000570803.6:c.1833_1847delinsacggggtat enst00000572080.2:c.1833_1847delinsacggggtat enst00000577106.6:c.1833_1847delinsacggggtat enst00000302262.8:c.1833_1847delinsacggggtat enst00000302262.7:c.1833_1847delinsacggggtat enst00000390015.7:c.1833_1847delinsacggggtat enst00000570716.1:n.273_287delinsacggggtat enst00000572080.1:c.221_235delinsacggggtat enst00000572803.1:n.447_461delinsacggggtat nm_000152.3:c.1833_1847delinsacggggtat lrg_673t1:c.1833_1847delinsacggggtat nm_001079803.1:c.1833_1847delinsacggggtat nm_001079804.1:c.1833_1847delinsacggggtat xm_005257193.1:c.1833_1847delinsacggggtat xm_005257194.3:c.1833_1847delinsacggggtat nm_000152.4:c.1833_1847delinsacggggtat nm_001079803.2:c.1833_1847delinsacggggtat nm_001079804.2:c.1833_1847delinsacggggtat xm_005257193.2:c.1833_1847delinsacggggtat xm_005257194.4:c.1833_1847delinsacggggtat nm_000152.5:c.1833_1847delinsacggggtat nm_001079803.3:c.1833_1847delinsacggggtat",
      "metCodes": [
        "PP4_Moderate",
        "PM2_Supporting",
        "PM1",
        "PM3",
        "PM4"
      ],
      "metCodesSearch": "pp4_moderate pm2_supporting pm1 pm3 pm4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_001079804.3:c.1833_1847delinsACGGGGTAT",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1833_1847delinsACGGGGTAT variant in GAA is predicted to cause a change in the length of the protein due to an in-frame insertion of 2 amino acids in a non-repeat region (p.His612_Asp616delinsArgGlyIle) (PM4). This variant has been detected in at least two individuals with Pompe disease. Of those individuals, one was compound heterozygous for the variant and a pathogenic variant (c.-32-13T>G) and was confirmed in trans by parental/family testing (PMID: 16917947). One individual was homozygous for the variant (PMID: 29422078, 23620524) (PM3). At least two patients were noted to have deficient GAA activity, but results were not provided. One of them had infantile-onset Pompe disease and was reported to be on enzyme replacement therapy for Pompe disease; the other patient had late-onset Pompe disease (PMID: 29422078, 23620524, 16917947) (PP4_Moderate). This variant is absent in gnomAD v4.1 (PM2_Supporting). This variant alters amino acids p.Trp613 and p.Asp616, residues that crystallography studies have shown to be important in the active site of GAA and, therefore, have been defined as critical residues by the ClinGen Lysosomal Diseases VCEP (PMID: 29061980) (PM1).\nThere is no ClinVar entry for this variant. In summary, this variant meets the criteria to be classified as likely pathogenic for Pompe disease, based on the GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel. GAA-specific ACMG/AMP criteria applied (Specifications Version 2.0): PM1, PM4, PM3, PP4_Moderate, PM2_Supporting.",
      "uuid": "11cab9c7-3798-413a-8395-52f8e8526f09",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013784",
      "_id": "AlleleRecords/1692641341",
      "_key": "1692641341",
      "_rev": "_mcsAYQK---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412716774",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.219T>G",
        "NC_000023.11:g.38369798T>G",
        "CM000685.2:g.38369798T>G",
        "NC_000023.10:g.38229051T>G",
        "CM000685.1:g.38229051T>G",
        "NC_000023.9:g.38113995T>G",
        "NG_008471.1:g.22316T>G",
        "ENST00000039007.5:c.219T>G",
        "ENST00000643344.1:c.219T>G",
        "ENST00000039007.4:c.219T>G",
        "ENST00000465127.1:c.172-296323T>G",
        "ENST00000488812.1:n.311T>G",
        "NM_000531.5:c.219T>G",
        "XM_017029556.1:c.219T>G"
      ],
      "hgvsSearch": "nm_000531.6:c.219t>g nc_000023.11:g.38369798t>g cm000685.2:g.38369798t>g nc_000023.10:g.38229051t>g cm000685.1:g.38229051t>g nc_000023.9:g.38113995t>g ng_008471.1:g.22316t>g enst00000039007.5:c.219t>g enst00000643344.1:c.219t>g enst00000039007.4:c.219t>g enst00000465127.1:c.172-296323t>g enst00000488812.1:n.311t>g nm_000531.5:c.219t>g xm_017029556.1:c.219t>g",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.219T>G",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.219T>G (p.Tyr73Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.​",
      "uuid": "c7fecc8f-eab9-402b-9689-e9141f414ae9",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013785",
      "_id": "AlleleRecords/1692643377",
      "_key": "1692643377",
      "_rev": "_mcsJ_v6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224504",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97136",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.217-1G>A",
        "NC_000023.11:g.38369795G>A",
        "CM000685.2:g.38369795G>A",
        "NC_000023.10:g.38229048G>A",
        "CM000685.1:g.38229048G>A",
        "NC_000023.9:g.38113992G>A",
        "NG_008471.1:g.22313G>A",
        "ENST00000039007.5:c.217-1G>A",
        "ENST00000643344.1:c.217-1G>A",
        "ENST00000039007.4:c.217-1G>A",
        "ENST00000465127.1:c.172-296326G>A",
        "ENST00000488812.1:n.309-1G>A",
        "NM_000531.5:c.217-1G>A",
        "XM_017029556.1:c.217-1G>A",
        "NM_000531.6(OTC):c.217-1G>A"
      ],
      "hgvsSearch": "nm_000531.6:c.217-1g>a nc_000023.11:g.38369795g>a cm000685.2:g.38369795g>a nc_000023.10:g.38229048g>a cm000685.1:g.38229048g>a nc_000023.9:g.38113992g>a ng_008471.1:g.22313g>a enst00000039007.5:c.217-1g>a enst00000643344.1:c.217-1g>a enst00000039007.4:c.217-1g>a enst00000465127.1:c.172-296326g>a enst00000488812.1:n.309-1g>a nm_000531.5:c.217-1g>a xm_017029556.1:c.217-1g>a nm_000531.6(otc):c.217-1g>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.217-1G>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.217-1G>A variant in OTC gene affects the canonical acceptor splice site of intron 1, which results in skipping of exon 2. Splicing is not in frame and results in nonsense mediated decay (NMD) (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "7b081dda-afc3-4c33-836b-1440a6f1cb98",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013786",
      "_id": "AlleleRecords/1692648116",
      "_key": "1692648116",
      "_rev": "_mcslvyi---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412717046",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.298+1G>C",
        "NC_000023.11:g.38369878G>C",
        "CM000685.2:g.38369878G>C",
        "NC_000023.10:g.38229131G>C",
        "CM000685.1:g.38229131G>C",
        "NC_000023.9:g.38114075G>C",
        "NG_008471.1:g.22396G>C",
        "ENST00000039007.5:c.298+1G>C",
        "ENST00000643344.1:c.298+1G>C",
        "ENST00000039007.4:c.298+1G>C",
        "ENST00000465127.1:c.172-296243G>C",
        "ENST00000488812.1:n.353+38G>C",
        "NM_000531.5:c.298+1G>C",
        "XM_017029556.1:c.298+1G>C"
      ],
      "hgvsSearch": "nm_000531.6:c.298+1g>c nc_000023.11:g.38369878g>c cm000685.2:g.38369878g>c nc_000023.10:g.38229131g>c cm000685.1:g.38229131g>c nc_000023.9:g.38114075g>c ng_008471.1:g.22396g>c enst00000039007.5:c.298+1g>c enst00000643344.1:c.298+1g>c enst00000039007.4:c.298+1g>c enst00000465127.1:c.172-296243g>c enst00000488812.1:n.353+38g>c nm_000531.5:c.298+1g>c xm_017029556.1:c.298+1g>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.298+1G>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.298+1G>C variant in the OTC gene affects the canonical donor/acceptor splice site in the 3nd intron. The variant is predicted by SpliceAI to result in the loss of out-of-frame exon 3 (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting).  To our current knowledge there are no reported individuals harboring this variant in the literature.  In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "9d42b232-bb75-4d0b-ac5a-4329dd6af321",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013787",
      "_id": "AlleleRecords/1692653134",
      "_key": "1692653134",
      "_rev": "_mct_jba---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA1139667389",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "870610",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.298+1del",
        "NC_000023.11:g.38369878del",
        "CM000685.2:g.38369878del",
        "NC_000023.10:g.38229131del",
        "CM000685.1:g.38229131del",
        "NC_000023.9:g.38114075del",
        "NG_008471.1:g.22396del",
        "ENST00000039007.5:c.298+1del",
        "ENST00000643344.1:c.298+1del",
        "ENST00000039007.4:c.298+1del",
        "ENST00000465127.1:c.172-296243del",
        "ENST00000488812.1:n.353+38del",
        "NM_000531.5:c.298+1del",
        "XM_017029556.1:c.298+1del"
      ],
      "hgvsSearch": "nm_000531.6:c.298+1del nc_000023.11:g.38369878del cm000685.2:g.38369878del nc_000023.10:g.38229131del cm000685.1:g.38229131del nc_000023.9:g.38114075del ng_008471.1:g.22396del enst00000039007.5:c.298+1del enst00000643344.1:c.298+1del enst00000039007.4:c.298+1del enst00000465127.1:c.172-296243del enst00000488812.1:n.353+38del nm_000531.5:c.298+1del xm_017029556.1:c.298+1del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.298+1del",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.298+1_298+5del variant in the OTC gene affects the canonical donor/acceptor splice site in the 3rd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.38, -81bp; donor loss, score 0.92, 0bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) Total points (+9).",
      "uuid": "97dc84cc-0834-4a25-b936-5778fd2d5a81",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013788",
      "_id": "AlleleRecords/1692656743",
      "_key": "1692656743",
      "_rev": "_mctQdBm---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2844081564",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.327_330del",
        "NC_000023.11:g.38381370_38381373del",
        "CM000685.2:g.38381370_38381373del",
        "NC_000023.10:g.38240623_38240626del",
        "CM000685.1:g.38240623_38240626del",
        "NC_000023.9:g.38125567_38125570del",
        "NG_008471.1:g.33888_33891del",
        "ENST00000039007.5:c.327_330del",
        "ENST00000643344.1:c.*77_*80del",
        "ENST00000039007.4:c.327_330del",
        "ENST00000465127.1:c.172-284751_172-284748del",
        "ENST00000488812.1:n.364_367del",
        "NM_000531.5:c.327_330del",
        "XM_017029556.1:c.327_330del"
      ],
      "hgvsSearch": "nm_000531.6:c.327_330del nc_000023.11:g.38381370_38381373del cm000685.2:g.38381370_38381373del nc_000023.10:g.38240623_38240626del cm000685.1:g.38240623_38240626del nc_000023.9:g.38125567_38125570del ng_008471.1:g.33888_33891del enst00000039007.5:c.327_330del enst00000643344.1:c.*77_*80del enst00000039007.4:c.327_330del enst00000465127.1:c.172-284751_172-284748del enst00000488812.1:n.364_367del nm_000531.5:c.327_330del xm_017029556.1:c.327_330del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.327_330del",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.327_330del (p.Phe110LeufsTer10) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 4/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0:  PVS1, PM2_Supporting.",
      "uuid": "7e97425a-46c2-476d-82fa-8b5cccfd79c7",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013789",
      "_id": "AlleleRecords/1692658301",
      "_key": "1692658301",
      "_rev": "_mctZI7K---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412718302",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "870327",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.327T>A",
        "NC_000023.11:g.38381370T>A",
        "CM000685.2:g.38381370T>A",
        "NC_000023.10:g.38240623T>A",
        "CM000685.1:g.38240623T>A",
        "NC_000023.9:g.38125567T>A",
        "NG_008471.1:g.33888T>A",
        "ENST00000039007.5:c.327T>A",
        "ENST00000643344.1:c.*77T>A",
        "ENST00000039007.4:c.327T>A",
        "ENST00000465127.1:c.172-284751T>A",
        "ENST00000488812.1:n.364T>A",
        "NM_000531.5:c.327T>A",
        "XM_017029556.1:c.327T>A",
        "NM_000531.6(OTC):c.327T>A (p.Cys109Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.327t>a nc_000023.11:g.38381370t>a cm000685.2:g.38381370t>a nc_000023.10:g.38240623t>a cm000685.1:g.38240623t>a nc_000023.9:g.38125567t>a ng_008471.1:g.33888t>a enst00000039007.5:c.327t>a enst00000643344.1:c.*77t>a enst00000039007.4:c.327t>a enst00000465127.1:c.172-284751t>a enst00000488812.1:n.364t>a nm_000531.5:c.327t>a xm_017029556.1:c.327t>a nm_000531.6(otc):c.327t>a (p.cys109ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.327T>A (p.Cys109Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.327T>A (p.Cys109Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 4/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely Pathogneic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) Total points +9.",
      "uuid": "9a64c04f-960e-4866-a867-7c18a2d277a6",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013790",
      "_id": "AlleleRecords/1692660090",
      "_key": "1692660090",
      "_rev": "_mcti5vm---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224558",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97170",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.330del",
        "NC_000023.11:g.38381373del",
        "CM000685.2:g.38381373del",
        "NC_000023.10:g.38240626del",
        "CM000685.1:g.38240626del",
        "NC_000023.9:g.38125570del",
        "NG_008471.1:g.33891del",
        "ENST00000039007.5:c.330del",
        "ENST00000643344.1:c.*80del",
        "ENST00000039007.4:c.330del",
        "ENST00000465127.1:c.172-284748del",
        "ENST00000488812.1:n.367del",
        "NM_000531.5:c.330del",
        "XM_017029556.1:c.330del",
        "NM_000531.6(OTC):c.330del (p.Thr112fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.330del nc_000023.11:g.38381373del cm000685.2:g.38381373del nc_000023.10:g.38240626del cm000685.1:g.38240626del nc_000023.9:g.38125570del ng_008471.1:g.33891del enst00000039007.5:c.330del enst00000643344.1:c.*80del enst00000039007.4:c.330del enst00000465127.1:c.172-284748del enst00000488812.1:n.367del nm_000531.5:c.330del xm_017029556.1:c.330del nm_000531.6(otc):c.330del (p.thr112fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.330del (p.Thr112fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.330del (p.Thr112ProfsTer9) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 4/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) Total points +9.",
      "uuid": "a9d20261-c2e2-4b64-bf23-e89b5b427cbe",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013791",
      "_id": "AlleleRecords/1692663457",
      "_key": "1692663457",
      "_rev": "_mctzlS2---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2695232718",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.341_342del",
        "NC_000023.11:g.38381384_38381385del",
        "CM000685.2:g.38381384_38381385del",
        "NC_000023.10:g.38240637_38240638del",
        "CM000685.1:g.38240637_38240638del",
        "NC_000023.9:g.38125581_38125582del",
        "NG_008471.1:g.33902_33903del",
        "ENST00000039007.5:c.341_342del",
        "ENST00000643344.1:c.*91_*92del",
        "ENST00000039007.4:c.341_342del",
        "ENST00000465127.1:c.172-284737_172-284736del",
        "ENST00000488812.1:n.378_379del",
        "NM_000531.5:c.341_342del",
        "XM_017029556.1:c.341_342del"
      ],
      "hgvsSearch": "nm_000531.6:c.341_342del nc_000023.11:g.38381384_38381385del cm000685.2:g.38381384_38381385del nc_000023.10:g.38240637_38240638del cm000685.1:g.38240637_38240638del nc_000023.9:g.38125581_38125582del ng_008471.1:g.33902_33903del enst00000039007.5:c.341_342del enst00000643344.1:c.*91_*92del enst00000039007.4:c.341_342del enst00000465127.1:c.172-284737_172-284736del enst00000488812.1:n.378_379del nm_000531.5:c.341_342del xm_017029556.1:c.341_342del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.341_342del",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.341_342del (p.Gln114ArgfsTer8) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 4/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1  (+8 pt), PM2_Supporting (+1pt).",
      "unMetCodes": [
        "PM6",
        "PP4"
      ],
      "unMetCodesSearch": "pm6 pp4",
      "uuid": "eb5e55b5-4c9c-4e22-8661-36e3372496bc",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013792",
      "_id": "AlleleRecords/1692665603",
      "_key": "1692665603",
      "_rev": "_mcu-mgi--A",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224561",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97173",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.359_360del",
        "NC_000023.11:g.38381402_38381403del",
        "CM000685.2:g.38381402_38381403del",
        "NC_000023.10:g.38240655_38240656del",
        "CM000685.1:g.38240655_38240656del",
        "NC_000023.9:g.38125599_38125600del",
        "NG_008471.1:g.33920_33921del",
        "ENST00000039007.5:c.359_360del",
        "ENST00000643344.1:c.*109_*110del",
        "ENST00000039007.4:c.359_360del",
        "ENST00000465127.1:c.172-284719_172-284718del",
        "ENST00000488812.1:n.396_397del",
        "NM_000531.5:c.359_360del",
        "XM_017029556.1:c.359_360del",
        "NM_000531.6(OTC):c.359_360del (p.Val120fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.359_360del nc_000023.11:g.38381402_38381403del cm000685.2:g.38381402_38381403del nc_000023.10:g.38240655_38240656del cm000685.1:g.38240655_38240656del nc_000023.9:g.38125599_38125600del ng_008471.1:g.33920_33921del enst00000039007.5:c.359_360del enst00000643344.1:c.*109_*110del enst00000039007.4:c.359_360del enst00000465127.1:c.172-284719_172-284718del enst00000488812.1:n.396_397del nm_000531.5:c.359_360del xm_017029556.1:c.359_360del nm_000531.6(otc):c.359_360del (p.val120fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.359_360del (p.Val120fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.359_360del (p.Val120GlufsTer2) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 4/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pt), PM2_Supporting (+1 pt).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "11da8e56-7623-43f2-9655-2d5460845119",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013793",
      "_id": "AlleleRecords/1692667274",
      "_key": "1692667274",
      "_rev": "_mcuHN-6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412718633",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.386+1G>C",
        "NC_000023.11:g.38381430G>C",
        "CM000685.2:g.38381430G>C",
        "NC_000023.10:g.38240683G>C",
        "CM000685.1:g.38240683G>C",
        "NC_000023.9:g.38125627G>C",
        "NG_008471.1:g.33948G>C",
        "ENST00000039007.5:c.386+1G>C",
        "ENST00000643344.1:c.*136+1G>C",
        "ENST00000039007.4:c.386+1G>C",
        "ENST00000465127.1:c.172-284691G>C",
        "ENST00000488812.1:n.423+1G>C",
        "NM_000531.5:c.386+1G>C",
        "XM_017029556.1:c.386+1G>C"
      ],
      "hgvsSearch": "nm_000531.6:c.386+1g>c nc_000023.11:g.38381430g>c cm000685.2:g.38381430g>c nc_000023.10:g.38240683g>c cm000685.1:g.38240683g>c nc_000023.9:g.38125627g>c ng_008471.1:g.33948g>c enst00000039007.5:c.386+1g>c enst00000643344.1:c.*136+1g>c enst00000039007.4:c.386+1g>c enst00000465127.1:c.172-284691g>c enst00000488812.1:n.423+1g>c nm_000531.5:c.386+1g>c xm_017029556.1:c.386+1g>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.386+1G>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.386+1G>C variant in the OTC gene affects the canonical donor/acceptor splice site in the 2nd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.28, -88bp; donor loss, score 0.95, -1bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pt), PM2_Supporting (+1 pt).",
      "uuid": "7247fe66-d359-4fa0-8be2-b70d04f13381",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013794",
      "_id": "AlleleRecords/1692668755",
      "_key": "1692668755",
      "_rev": "_mcuP1Bm---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224566",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97179",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.386+1G>T",
        "NC_000023.11:g.38381430G>T",
        "CM000685.2:g.38381430G>T",
        "NC_000023.10:g.38240683G>T",
        "CM000685.1:g.38240683G>T",
        "NC_000023.9:g.38125627G>T",
        "NG_008471.1:g.33948G>T",
        "ENST00000039007.5:c.386+1G>T",
        "ENST00000643344.1:c.*136+1G>T",
        "ENST00000039007.4:c.386+1G>T",
        "ENST00000465127.1:c.172-284691G>T",
        "ENST00000488812.1:n.423+1G>T",
        "NM_000531.5:c.386+1G>T",
        "XM_017029556.1:c.386+1G>T",
        "NM_000531.6(OTC):c.386+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.386+1g>t nc_000023.11:g.38381430g>t cm000685.2:g.38381430g>t nc_000023.10:g.38240683g>t cm000685.1:g.38240683g>t nc_000023.9:g.38125627g>t ng_008471.1:g.33948g>t enst00000039007.5:c.386+1g>t enst00000643344.1:c.*136+1g>t enst00000039007.4:c.386+1g>t enst00000465127.1:c.172-284691g>t enst00000488812.1:n.423+1g>t nm_000531.5:c.386+1g>t xm_017029556.1:c.386+1g>t nm_000531.6(otc):c.386+1g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.386+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.386+1G>T variant in the OTC gene affects the canonical donor/acceptor splice site in the 2nd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.31, -88bp; donor loss, score 0.95, -1bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "557849cd-c224-45be-b7e8-1d7a95761fe8",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013795",
      "_id": "AlleleRecords/1692670316",
      "_key": "1692670316",
      "_rev": "_mcuYXJu--_",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2850445523",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.552_553insGAAC",
        "NC_000023.11:g.38403629_38403630insGAAC",
        "CM000685.2:g.38403629_38403630insGAAC",
        "NC_000023.10:g.38262882_38262883insGAAC",
        "CM000685.1:g.38262882_38262883insGAAC",
        "NC_000023.9:g.38147826_38147827insGAAC",
        "NG_008471.1:g.56147_56148insGAAC",
        "ENST00000039007.5:c.552_553insGAAC",
        "ENST00000643344.1:c.*302_*303insGAAC",
        "ENST00000039007.4:c.552_553insGAAC",
        "ENST00000465127.1:c.172-262492_172-262491insGAAC",
        "ENST00000488812.1:n.589_590insGAAC",
        "NM_000531.5:c.552_553insGAAC",
        "XM_017029556.1:c.552_553insGAAC"
      ],
      "hgvsSearch": "nm_000531.6:c.552_553insgaac nc_000023.11:g.38403629_38403630insgaac cm000685.2:g.38403629_38403630insgaac nc_000023.10:g.38262882_38262883insgaac cm000685.1:g.38262882_38262883insgaac nc_000023.9:g.38147826_38147827insgaac ng_008471.1:g.56147_56148insgaac enst00000039007.5:c.552_553insgaac enst00000643344.1:c.*302_*303insgaac enst00000039007.4:c.552_553insgaac enst00000465127.1:c.172-262492_172-262491insgaac enst00000488812.1:n.589_590insgaac nm_000531.5:c.552_553insgaac xm_017029556.1:c.552_553insgaac",
      "metCodes": [
        "PM6",
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pm6 pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.552_553insGAAC",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.552_553insGAAC (p.Ser185GlufsTer?) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 6/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed childhood onset, hyperammonemia, oroticaciduria, hyperglutaminemia , Elevated circulating alanine aminotransferase concentration, Elevated circulating uracil concentration  which is highly specific for OTC deficiency (1.5pts; PP4_Moderate, PMID: 33272297). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6;\nPMID: 33272297). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt), PM6 (+2 pts), PP4_Moderate (+2).",
      "uuid": "c5da9ad1-9ddc-4c11-9067-e4967a87f698",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013796",
      "_id": "AlleleRecords/1692671798",
      "_key": "1692671798",
      "_rev": "_mcuh_9G---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412725369",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.579G>A",
        "NC_000023.11:g.38403656G>A",
        "CM000685.2:g.38403656G>A",
        "NC_000023.10:g.38262909G>A",
        "CM000685.1:g.38262909G>A",
        "NC_000023.9:g.38147853G>A",
        "NG_008471.1:g.56174G>A",
        "ENST00000039007.5:c.579G>A",
        "ENST00000643344.1:c.*329G>A",
        "ENST00000039007.4:c.579G>A",
        "ENST00000465127.1:c.172-262465G>A",
        "ENST00000488812.1:n.616G>A",
        "NM_000531.5:c.579G>A",
        "XM_017029556.1:c.579G>A"
      ],
      "hgvsSearch": "nm_000531.6:c.579g>a nc_000023.11:g.38403656g>a cm000685.2:g.38403656g>a nc_000023.10:g.38262909g>a cm000685.1:g.38262909g>a nc_000023.9:g.38147853g>a ng_008471.1:g.56174g>a enst00000039007.5:c.579g>a enst00000643344.1:c.*329g>a enst00000039007.4:c.579g>a enst00000465127.1:c.172-262465g>a enst00000488812.1:n.616g>a nm_000531.5:c.579g>a xm_017029556.1:c.579g>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.579G>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.579G>A (p.Trp193Ter) variant in the OTC gene is predicted to cause a premature stop codon in biologically-relevant-exon 6/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8pts), PM2_Supporting (+1 pt).",
      "uuid": "d584cfac-2ecf-4ab7-91b1-3da46f1f6fcc",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013797",
      "_id": "AlleleRecords/1692673457",
      "_key": "1692673457",
      "_rev": "_mcup1uW---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412721652",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.703C>T",
        "NC_000023.11:g.38408781C>T",
        "CM000685.2:g.38408781C>T",
        "NC_000023.10:g.38268034C>T",
        "CM000685.1:g.38268034C>T",
        "NC_000023.9:g.38152978C>T",
        "NG_008471.1:g.61299C>T",
        "ENST00000039007.5:c.703C>T",
        "ENST00000643344.1:c.*453C>T",
        "ENST00000039007.4:c.703C>T",
        "ENST00000465127.1:c.172-257340C>T",
        "NM_000531.5:c.703C>T",
        "XM_017029556.1:c.703C>T"
      ],
      "hgvsSearch": "nm_000531.6:c.703c>t nc_000023.11:g.38408781c>t cm000685.2:g.38408781c>t nc_000023.10:g.38268034c>t cm000685.1:g.38268034c>t nc_000023.9:g.38152978c>t ng_008471.1:g.61299c>t enst00000039007.5:c.703c>t enst00000643344.1:c.*453c>t enst00000039007.4:c.703c>t enst00000465127.1:c.172-257340c>t nm_000531.5:c.703c>t xm_017029556.1:c.703c>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.703C>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.703C>T (p.Gln235Ter) variant in the OTC gene is predicted to cause a premature stop codon in biologically-relevant-exon 7/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "385fdbf0-dbed-4c3b-85d0-ced44740c676",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013798",
      "_id": "AlleleRecords/1692675221",
      "_key": "1692675221",
      "_rev": "_mcuzVD----",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412722112",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.718-1G>A",
        "NC_000023.11:g.38408875G>A",
        "CM000685.2:g.38408875G>A",
        "NC_000023.10:g.38268128G>A",
        "CM000685.1:g.38268128G>A",
        "NC_000023.9:g.38153072G>A",
        "NG_008471.1:g.61393G>A",
        "ENST00000039007.5:c.718-1G>A",
        "ENST00000643344.1:c.*468-1G>A",
        "ENST00000039007.4:c.718-1G>A",
        "ENST00000465127.1:c.172-257246G>A",
        "NM_000531.5:c.718-1G>A",
        "XM_017029556.1:c.718-1G>A"
      ],
      "hgvsSearch": "nm_000531.6:c.718-1g>a nc_000023.11:g.38408875g>a cm000685.2:g.38408875g>a nc_000023.10:g.38268128g>a cm000685.1:g.38268128g>a nc_000023.9:g.38153072g>a ng_008471.1:g.61393g>a enst00000039007.5:c.718-1g>a enst00000643344.1:c.*468-1g>a enst00000039007.4:c.718-1g>a enst00000465127.1:c.172-257246g>a nm_000531.5:c.718-1g>a xm_017029556.1:c.718-1g>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.718-1G>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.718-1G>A variant in the OTC gene is a canonical -1 splice variant, SpliceAI predicts altered splicing and NMD: acceptor loss, score 0.81, 1bp; donor loss, score 0.45, 150bp. This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "c0ebdeca-3bed-457d-9a57-77c819803615",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013799",
      "_id": "AlleleRecords/1692677103",
      "_key": "1692677103",
      "_rev": "_mcu76kG---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412722994",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.794G>A",
        "NC_000023.11:g.38408952G>A",
        "CM000685.2:g.38408952G>A",
        "NC_000023.10:g.38268205G>A",
        "CM000685.1:g.38268205G>A",
        "NC_000023.9:g.38153149G>A",
        "NG_008471.1:g.61470G>A",
        "ENST00000039007.5:c.794G>A",
        "ENST00000643344.1:c.*544G>A",
        "ENST00000039007.4:c.794G>A",
        "ENST00000465127.1:c.172-257169G>A",
        "NM_000531.5:c.794G>A",
        "XM_017029556.1:c.794G>A"
      ],
      "hgvsSearch": "nm_000531.6:c.794g>a nc_000023.11:g.38408952g>a cm000685.2:g.38408952g>a nc_000023.10:g.38268205g>a cm000685.1:g.38268205g>a nc_000023.9:g.38153149g>a ng_008471.1:g.61470g>a enst00000039007.5:c.794g>a enst00000643344.1:c.*544g>a enst00000039007.4:c.794g>a enst00000465127.1:c.172-257169g>a nm_000531.5:c.794g>a xm_017029556.1:c.794g>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.794G>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.794G>A (p.Trp265Ter) variant in the OTC gene is predicted to cause a premature stop codon in biologically-relevant-exon 8/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "77a6e06e-c7f1-481a-92f6-6772b8e95945",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013800",
      "_id": "AlleleRecords/1692678542",
      "_key": "1692678542",
      "_rev": "_mcvE7ey---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2695233319",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.664_667delinsAC",
        "NC_000023.11:g.38408742_38408745delinsAC",
        "CM000685.2:g.38408742_38408745delinsAC",
        "NC_000023.10:g.38267995_38267998delinsAC",
        "CM000685.1:g.38267995_38267998delinsAC",
        "NC_000023.9:g.38152939_38152942delinsAC",
        "NG_008471.1:g.61260_61263delinsAC",
        "ENST00000039007.5:c.664_667delinsAC",
        "ENST00000643344.1:c.*414_*417delinsAC",
        "ENST00000039007.4:c.664_667delinsAC",
        "ENST00000465127.1:c.172-257379_172-257376delinsAC",
        "NM_000531.5:c.664_667delinsAC",
        "XM_017029556.1:c.664_667delinsAC"
      ],
      "hgvsSearch": "nm_000531.6:c.664_667delinsac nc_000023.11:g.38408742_38408745delinsac cm000685.2:g.38408742_38408745delinsac nc_000023.10:g.38267995_38267998delinsac cm000685.1:g.38267995_38267998delinsac nc_000023.9:g.38152939_38152942delinsac ng_008471.1:g.61260_61263delinsac enst00000039007.5:c.664_667delinsac enst00000643344.1:c.*414_*417delinsac enst00000039007.4:c.664_667delinsac enst00000465127.1:c.172-257379_172-257376delinsac nm_000531.5:c.664_667delinsac xm_017029556.1:c.664_667delinsac",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.664_667delinsAC",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.664_667delinsAC (p.Gly222ThrfsTer2) variant is in the OTC gene, SpliceAI predicts altered splicing and NMD: acceptor loss, score 0.92, 1bp; donor loss, score 0.26, 54bp, acceptor gain, score 0.74, 0bp. This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "aa99ba59-942a-459f-b3d8-4f89b2526c90",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013801",
      "_id": "AlleleRecords/1692679934",
      "_key": "1692679934",
      "_rev": "_mcvNY-C---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA2695233326",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.796_805del",
        "NC_000023.11:g.38408954_38408963del",
        "CM000685.2:g.38408954_38408963del",
        "NC_000023.10:g.38268207_38268216del",
        "CM000685.1:g.38268207_38268216del",
        "NC_000023.9:g.38153151_38153160del",
        "NG_008471.1:g.61472_61481del",
        "ENST00000039007.5:c.796_805del",
        "ENST00000643344.1:c.*546_*555del",
        "ENST00000039007.4:c.796_805del",
        "ENST00000465127.1:c.172-257167_172-257158del",
        "NM_000531.5:c.796_805del",
        "XM_017029556.1:c.796_805del"
      ],
      "hgvsSearch": "nm_000531.6:c.796_805del nc_000023.11:g.38408954_38408963del cm000685.2:g.38408954_38408963del nc_000023.10:g.38268207_38268216del cm000685.1:g.38268207_38268216del nc_000023.9:g.38153151_38153160del ng_008471.1:g.61472_61481del enst00000039007.5:c.796_805del enst00000643344.1:c.*546_*555del enst00000039007.4:c.796_805del enst00000465127.1:c.172-257167_172-257158del nm_000531.5:c.796_805del xm_017029556.1:c.796_805del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.796_805del",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.796_805del (p.Ile266AspfsTer20) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 8/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "7e6bfcc9-9dc3-467d-b353-f3757ebc2898",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013802",
      "_id": "AlleleRecords/1692681404",
      "_key": "1692681404",
      "_rev": "_mcvV1Fq---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224753",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97298",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.717+1G>T",
        "NC_000023.11:g.38408796G>T",
        "CM000685.2:g.38408796G>T",
        "NC_000023.10:g.38268049G>T",
        "CM000685.1:g.38268049G>T",
        "NC_000023.9:g.38152993G>T",
        "NG_008471.1:g.61314G>T",
        "ENST00000039007.5:c.717+1G>T",
        "ENST00000643344.1:c.*467+1G>T",
        "ENST00000039007.4:c.717+1G>T",
        "ENST00000465127.1:c.172-257325G>T",
        "NM_000531.5:c.717+1G>T",
        "XM_017029556.1:c.717+1G>T",
        "NM_000531.6(OTC):c.717+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.717+1g>t nc_000023.11:g.38408796g>t cm000685.2:g.38408796g>t nc_000023.10:g.38268049g>t cm000685.1:g.38268049g>t nc_000023.9:g.38152993g>t ng_008471.1:g.61314g>t enst00000039007.5:c.717+1g>t enst00000643344.1:c.*467+1g>t enst00000039007.4:c.717+1g>t enst00000465127.1:c.172-257325g>t nm_000531.5:c.717+1g>t xm_017029556.1:c.717+1g>t nm_000531.6(otc):c.717+1g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.717+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.717+1G>T variant in the OTC gene is a variant predicted to affect the canonical donor splice site of intron 7, which results in skipping of exon 7. Exon 7 encodes 18 amino acids that form alpha-helix 7 which is critical for the three-dimensional structure of OTC [PMID: 9852088, 19475717, 1627356, 23278509, 16786505] . This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "99742b69-4331-43e8-ac62-eaa6b8a366ea",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013803",
      "_id": "AlleleRecords/1692682556",
      "_key": "1692682556",
      "_rev": "_mcveSCC---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224865",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97377",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.991A>T",
        "NC_000023.11:g.38411985A>T",
        "CM000685.2:g.38411985A>T",
        "NC_000023.10:g.38271238A>T",
        "CM000685.1:g.38271238A>T",
        "NC_000023.9:g.38156182A>T",
        "NG_008471.1:g.64503A>T",
        "ENST00000039007.5:c.991A>T",
        "ENST00000643344.1:c.*741A>T",
        "ENST00000039007.4:c.991A>T",
        "ENST00000465127.1:c.172-254136A>T",
        "NM_000531.5:c.991A>T",
        "NM_000531.6(OTC):c.991A>T (p.Lys331Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.991a>t nc_000023.11:g.38411985a>t cm000685.2:g.38411985a>t nc_000023.10:g.38271238a>t cm000685.1:g.38271238a>t nc_000023.9:g.38156182a>t ng_008471.1:g.64503a>t enst00000039007.5:c.991a>t enst00000643344.1:c.*741a>t enst00000039007.4:c.991a>t enst00000465127.1:c.172-254136a>t nm_000531.5:c.991a>t nm_000531.6(otc):c.991a>t (p.lys331ter)",
      "metCodes": [
        "PM2",
        "PVS1"
      ],
      "metCodesSearch": "pm2 pvs1",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.991A>T (p.Lys331Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.991A>T (p.Lys331Ter) variant in the OTC gene is predicted to cause a premature stop codon in biologically-relevant-exon 9/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "e1af94f9-c2a5-42b7-bea1-4a7742354032",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013804",
      "_id": "AlleleRecords/1692685483",
      "_key": "1692685483",
      "_rev": "_mcvmvEy---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412716751",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "915470",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.217-2A>G",
        "NC_000023.11:g.38369794A>G",
        "CM000685.2:g.38369794A>G",
        "NC_000023.10:g.38229047A>G",
        "CM000685.1:g.38229047A>G",
        "NC_000023.9:g.38113991A>G",
        "NG_008471.1:g.22312A>G",
        "ENST00000039007.5:c.217-2A>G",
        "ENST00000643344.1:c.217-2A>G",
        "ENST00000039007.4:c.217-2A>G",
        "ENST00000465127.1:c.172-296327A>G",
        "ENST00000488812.1:n.309-2A>G",
        "NM_000531.5:c.217-2A>G",
        "XM_017029556.1:c.217-2A>G"
      ],
      "hgvsSearch": "nm_000531.6:c.217-2a>g nc_000023.11:g.38369794a>g cm000685.2:g.38369794a>g nc_000023.10:g.38229047a>g cm000685.1:g.38229047a>g nc_000023.9:g.38113991a>g ng_008471.1:g.22312a>g enst00000039007.5:c.217-2a>g enst00000643344.1:c.217-2a>g enst00000039007.4:c.217-2a>g enst00000465127.1:c.172-296327a>g enst00000488812.1:n.309-2a>g nm_000531.5:c.217-2a>g xm_017029556.1:c.217-2a>g",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.217-2A>G",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.217-2A>G variant in the OTC gene affects the canonical donor splice site in the 2nd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.88, 2bp; donor loss, score 0.15, 83bp at intron 2 and result in altered splicing (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "2b21d027-8469-4caa-bdf0-e00c318a4af2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013805",
      "_id": "AlleleRecords/1692688170",
      "_key": "1692688170",
      "_rev": "_mcvvO-----",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412722685",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "870326",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.766G>T",
        "NC_000023.11:g.38408924G>T",
        "CM000685.2:g.38408924G>T",
        "NC_000023.10:g.38268177G>T",
        "CM000685.1:g.38268177G>T",
        "NC_000023.9:g.38153121G>T",
        "NG_008471.1:g.61442G>T",
        "ENST00000039007.5:c.766G>T",
        "ENST00000643344.1:c.*516G>T",
        "ENST00000039007.4:c.766G>T",
        "ENST00000465127.1:c.172-257197G>T",
        "NM_000531.5:c.766G>T",
        "XM_017029556.1:c.766G>T",
        "NM_000531.6(OTC):c.766G>T (p.Gly256Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.766g>t nc_000023.11:g.38408924g>t cm000685.2:g.38408924g>t nc_000023.10:g.38268177g>t cm000685.1:g.38268177g>t nc_000023.9:g.38153121g>t ng_008471.1:g.61442g>t enst00000039007.5:c.766g>t enst00000643344.1:c.*516g>t enst00000039007.4:c.766g>t enst00000465127.1:c.172-257197g>t nm_000531.5:c.766g>t xm_017029556.1:c.766g>t nm_000531.6(otc):c.766g>t (p.gly256ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.766G>T (p.Gly256Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.766G>T(p.Gly256Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 8 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "d7826e6a-4138-40f8-84b2-4e752e31ed30",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013806",
      "_id": "AlleleRecords/1692690967",
      "_key": "1692690967",
      "_rev": "_mcv3rkm---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412725724",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.894G>A",
        "NC_000023.11:g.38411888G>A",
        "CM000685.2:g.38411888G>A",
        "NC_000023.10:g.38271141G>A",
        "CM000685.1:g.38271141G>A",
        "NC_000023.9:g.38156085G>A",
        "NG_008471.1:g.64406G>A",
        "ENST00000039007.5:c.894G>A",
        "ENST00000643344.1:c.*644G>A",
        "ENST00000039007.4:c.894G>A",
        "ENST00000465127.1:c.172-254233G>A",
        "NM_000531.5:c.894G>A"
      ],
      "hgvsSearch": "nm_000531.6:c.894g>a nc_000023.11:g.38411888g>a cm000685.2:g.38411888g>a nc_000023.10:g.38271141g>a cm000685.1:g.38271141g>a nc_000023.9:g.38156085g>a ng_008471.1:g.64406g>a enst00000039007.5:c.894g>a enst00000643344.1:c.*644g>a enst00000039007.4:c.894g>a enst00000465127.1:c.172-254233g>a nm_000531.5:c.894g>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.894G>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.894G>A(p.Trp298Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 9 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. This variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "cd834cf1-cd30-4413-ba47-97fb35f1f091",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013807",
      "_id": "AlleleRecords/1692693548",
      "_key": "1692693548",
      "_rev": "_mcwAIcu---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412726302",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.940G>T",
        "NC_000023.11:g.38411934G>T",
        "CM000685.2:g.38411934G>T",
        "NC_000023.10:g.38271187G>T",
        "CM000685.1:g.38271187G>T",
        "NC_000023.9:g.38156131G>T",
        "NG_008471.1:g.64452G>T",
        "ENST00000039007.5:c.940G>T",
        "ENST00000643344.1:c.*690G>T",
        "ENST00000039007.4:c.940G>T",
        "ENST00000465127.1:c.172-254187G>T",
        "NM_000531.5:c.940G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.940g>t nc_000023.11:g.38411934g>t cm000685.2:g.38411934g>t nc_000023.10:g.38271187g>t cm000685.1:g.38271187g>t nc_000023.9:g.38156131g>t ng_008471.1:g.64452g>t enst00000039007.5:c.940g>t enst00000643344.1:c.*690g>t enst00000039007.4:c.940g>t enst00000465127.1:c.172-254187g>t nm_000531.5:c.940g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.940G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6:c.940G>T(p.Glu314Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 9 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "81dae7c7-d258-4b7b-97e3-c857f28ea726",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013808",
      "_id": "AlleleRecords/1692696218",
      "_key": "1692696218",
      "_rev": "_mcwIm_u---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224746",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97294",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.700G>T",
        "NC_000023.11:g.38408778G>T",
        "CM000685.2:g.38408778G>T",
        "NC_000023.10:g.38268031G>T",
        "CM000685.1:g.38268031G>T",
        "NC_000023.9:g.38152975G>T",
        "NG_008471.1:g.61296G>T",
        "ENST00000039007.5:c.700G>T",
        "ENST00000643344.1:c.*450G>T",
        "ENST00000039007.4:c.700G>T",
        "ENST00000465127.1:c.172-257343G>T",
        "NM_000531.5:c.700G>T",
        "XM_017029556.1:c.700G>T",
        "NM_000531.6(OTC):c.700G>T (p.Glu234Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.700g>t nc_000023.11:g.38408778g>t cm000685.2:g.38408778g>t nc_000023.10:g.38268031g>t cm000685.1:g.38268031g>t nc_000023.9:g.38152975g>t ng_008471.1:g.61296g>t enst00000039007.5:c.700g>t enst00000643344.1:c.*450g>t enst00000039007.4:c.700g>t enst00000465127.1:c.172-257343g>t nm_000531.5:c.700g>t xm_017029556.1:c.700g>t nm_000531.6(otc):c.700g>t (p.glu234ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.700G>T (p.Glu234Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.700G>T(p.Glu234Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 7 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEPVariant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "2ddfca78-f5ce-4d18-a744-019c9728a82a",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013809",
      "_id": "AlleleRecords/1692699083",
      "_key": "1692699083",
      "_rev": "_mcwRCIO---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412724187",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.538C>T",
        "NC_000023.11:g.38401426C>T",
        "CM000685.2:g.38401426C>T",
        "NC_000023.10:g.38260679C>T",
        "CM000685.1:g.38260679C>T",
        "NC_000023.9:g.38145623C>T",
        "NG_008471.1:g.53944C>T",
        "ENST00000039007.5:c.538C>T",
        "ENST00000643344.1:c.*288C>T",
        "ENST00000039007.4:c.538C>T",
        "ENST00000465127.1:c.172-264695C>T",
        "ENST00000488812.1:n.575C>T",
        "NM_000531.5:c.538C>T",
        "XM_017029556.1:c.538C>T"
      ],
      "hgvsSearch": "nm_000531.6:c.538c>t nc_000023.11:g.38401426c>t cm000685.2:g.38401426c>t nc_000023.10:g.38260679c>t cm000685.1:g.38260679c>t nc_000023.9:g.38145623c>t ng_008471.1:g.53944c>t enst00000039007.5:c.538c>t enst00000643344.1:c.*288c>t enst00000039007.4:c.538c>t enst00000465127.1:c.172-264695c>t enst00000488812.1:n.575c>t nm_000531.5:c.538c>t xm_017029556.1:c.538c>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.538C>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.538C>T(p.Gln180Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 5 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEPVariant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "d06632e0-4c59-4a4b-9c06-468147ea9e0b",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013810",
      "_id": "AlleleRecords/1692701721",
      "_key": "1692701721",
      "_rev": "_mcwZfWu---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224431",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97090",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.1005+2T>C",
        "NC_000023.11:g.38412001T>C",
        "CM000685.2:g.38412001T>C",
        "NC_000023.10:g.38271254T>C",
        "CM000685.1:g.38271254T>C",
        "NC_000023.9:g.38156198T>C",
        "NG_008471.1:g.64519T>C",
        "ENST00000039007.5:c.1005+2T>C",
        "ENST00000643344.1:c.*755+2T>C",
        "ENST00000039007.4:c.1005+2T>C",
        "ENST00000465127.1:c.172-254120T>C",
        "NM_000531.5:c.1005+2T>C",
        "NM_000531.6(OTC):c.1005+2T>C"
      ],
      "hgvsSearch": "nm_000531.6:c.1005+2t>c nc_000023.11:g.38412001t>c cm000685.2:g.38412001t>c nc_000023.10:g.38271254t>c cm000685.1:g.38271254t>c nc_000023.9:g.38156198t>c ng_008471.1:g.64519t>c enst00000039007.5:c.1005+2t>c enst00000643344.1:c.*755+2t>c enst00000039007.4:c.1005+2t>c enst00000465127.1:c.172-254120t>c nm_000531.5:c.1005+2t>c nm_000531.6(otc):c.1005+2t>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.1005+2T>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.1005+2T>C variant in the OTC gene affects the canonical donor splice site in the 9th intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.71, -139bp; donor loss, score 0.93, -2bp at intron 9 and result in altered splicing (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "4b2e2568-8600-40f7-af91-4c75721af0ec",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013811",
      "_id": "AlleleRecords/1692705056",
      "_key": "1692705056",
      "_rev": "_mcwh8ku---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224859",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97373",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.962C>A",
        "NC_000023.11:g.38411956C>A",
        "CM000685.2:g.38411956C>A",
        "NC_000023.10:g.38271209C>A",
        "CM000685.1:g.38271209C>A",
        "NC_000023.9:g.38156153C>A",
        "NG_008471.1:g.64474C>A",
        "ENST00000039007.5:c.962C>A",
        "ENST00000643344.1:c.*712C>A",
        "ENST00000039007.4:c.962C>A",
        "ENST00000465127.1:c.172-254165C>A",
        "NM_000531.5:c.962C>A",
        "NM_000531.6(OTC):c.962C>A (p.Ser321Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.962c>a nc_000023.11:g.38411956c>a cm000685.2:g.38411956c>a nc_000023.10:g.38271209c>a cm000685.1:g.38271209c>a nc_000023.9:g.38156153c>a ng_008471.1:g.64474c>a enst00000039007.5:c.962c>a enst00000643344.1:c.*712c>a enst00000039007.4:c.962c>a enst00000465127.1:c.172-254165c>a nm_000531.5:c.962c>a nm_000531.6(otc):c.962c>a (p.ser321ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.962C>A (p.Ser321Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.962C>A (p.Ser321Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 9 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "a62dd389-e42c-41b4-9f74-1a2516f7e246",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013812",
      "_id": "AlleleRecords/1692708496",
      "_key": "1692708496",
      "_rev": "_mcwqZmu---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224811",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97341",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.835C>T",
        "NC_000023.11:g.38408993C>T",
        "CM000685.2:g.38408993C>T",
        "NC_000023.10:g.38268246C>T",
        "CM000685.1:g.38268246C>T",
        "NC_000023.9:g.38153190C>T",
        "NG_008471.1:g.61511C>T",
        "ENST00000039007.5:c.835C>T",
        "ENST00000643344.1:c.*585C>T",
        "ENST00000039007.4:c.835C>T",
        "ENST00000465127.1:c.172-257128C>T",
        "NM_000531.5:c.835C>T",
        "XM_017029556.1:c.835C>T",
        "NM_000531.6(OTC):c.835C>T (p.Gln279Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.835c>t nc_000023.11:g.38408993c>t cm000685.2:g.38408993c>t nc_000023.10:g.38268246c>t cm000685.1:g.38268246c>t nc_000023.9:g.38153190c>t ng_008471.1:g.61511c>t enst00000039007.5:c.835c>t enst00000643344.1:c.*585c>t enst00000039007.4:c.835c>t enst00000465127.1:c.172-257128c>t nm_000531.5:c.835c>t xm_017029556.1:c.835c>t nm_000531.6(otc):c.835c>t (p.gln279ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.835C>T (p.Gln279Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.835C>T (p.Gln279Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 8 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "dcf670fd-8c53-4d03-ad24-e9dec76a23e9",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013813",
      "_id": "AlleleRecords/1692711867",
      "_key": "1692711867",
      "_rev": "_mcwy2oa---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224796",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97331",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.795G>A",
        "NC_000023.11:g.38408953G>A",
        "CM000685.2:g.38408953G>A",
        "NC_000023.10:g.38268206G>A",
        "CM000685.1:g.38268206G>A",
        "NC_000023.9:g.38153150G>A",
        "NG_008471.1:g.61471G>A",
        "ENST00000039007.5:c.795G>A",
        "ENST00000643344.1:c.*545G>A",
        "ENST00000039007.4:c.795G>A",
        "ENST00000465127.1:c.172-257168G>A",
        "NM_000531.5:c.795G>A",
        "XM_017029556.1:c.795G>A",
        "NM_000531.6(OTC):c.795G>A (p.Trp265Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.795g>a nc_000023.11:g.38408953g>a cm000685.2:g.38408953g>a nc_000023.10:g.38268206g>a cm000685.1:g.38268206g>a nc_000023.9:g.38153150g>a ng_008471.1:g.61471g>a enst00000039007.5:c.795g>a enst00000643344.1:c.*545g>a enst00000039007.4:c.795g>a enst00000465127.1:c.172-257168g>a nm_000531.5:c.795g>a xm_017029556.1:c.795g>a nm_000531.6(otc):c.795g>a (p.trp265ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.795G>A (p.Trp265Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.795G>A (p.Trp265Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 8 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "3f493ccd-0e2b-4eac-8abd-5767e29cc756",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013814",
      "_id": "AlleleRecords/1692715665",
      "_key": "1692715665",
      "_rev": "_mcw7TmK---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224606",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97201",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.437C>G",
        "NC_000023.11:g.38401325C>G",
        "CM000685.2:g.38401325C>G",
        "NC_000023.10:g.38260578C>G",
        "CM000685.1:g.38260578C>G",
        "NC_000023.9:g.38145522C>G",
        "NG_008471.1:g.53843C>G",
        "ENST00000039007.5:c.437C>G",
        "ENST00000643344.1:c.*187C>G",
        "ENST00000039007.4:c.437C>G",
        "ENST00000465127.1:c.172-264796C>G",
        "ENST00000488812.1:n.474C>G",
        "NM_000531.5:c.437C>G",
        "XM_017029556.1:c.437C>G",
        "NM_000531.6(OTC):c.437C>G (p.Ser146Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.437c>g nc_000023.11:g.38401325c>g cm000685.2:g.38401325c>g nc_000023.10:g.38260578c>g cm000685.1:g.38260578c>g nc_000023.9:g.38145522c>g ng_008471.1:g.53843c>g enst00000039007.5:c.437c>g enst00000643344.1:c.*187c>g enst00000039007.4:c.437c>g enst00000465127.1:c.172-264796c>g enst00000488812.1:n.474c>g nm_000531.5:c.437c>g xm_017029556.1:c.437c>g nm_000531.6(otc):c.437c>g (p.ser146ter)",
      "metCodes": [
        "PM2",
        "PVS1"
      ],
      "metCodesSearch": "pm2 pvs1",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.437C>G (p.Ser146Ter)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.437C>G (p.Ser146Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 5 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1).",
      "uuid": "b069fdce-4433-42b6-9808-5d8071060985",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000006692",
      "_id": "AlleleRecords/1765015931",
      "_key": "1765015931",
      "_rev": "_mcqRyOK---",
      "affiliationId": "50009",
      "approvedDate": "2026-11-17",
      "caId": "CA198786",
      "classification": "Uncertain Significance",
      "condition": "glycogen storage disease II",
      "cvId": "188480",
      "docVersion": "1.1.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.1375G>A",
        "NC_000017.11:g.80109993G>A",
        "CM000679.2:g.80109993G>A",
        "NC_000017.10:g.78083792G>A",
        "CM000679.1:g.78083792G>A",
        "NC_000017.9:g.75698387G>A",
        "NG_009822.1:g.13438G>A",
        "LRG_673:g.13438G>A",
        "ENST00000570803.6:c.1375G>A",
        "ENST00000572080.2:c.1375G>A",
        "ENST00000577106.6:c.1375G>A",
        "ENST00000302262.8:c.1375G>A",
        "ENST00000302262.7:c.1375G>A",
        "ENST00000390015.7:c.1375G>A",
        "NM_000152.3:c.1375G>A",
        "LRG_673t1:c.1375G>A",
        "NM_001079803.1:c.1375G>A",
        "NM_001079804.1:c.1375G>A",
        "XM_005257193.1:c.1375G>A",
        "XM_005257194.3:c.1375G>A",
        "NM_000152.4:c.1375G>A",
        "NM_001079803.2:c.1375G>A",
        "NM_001079804.2:c.1375G>A",
        "XM_005257193.2:c.1375G>A",
        "XM_005257194.4:c.1375G>A",
        "NM_001079803.3:c.1375G>A",
        "NM_001079804.3:c.1375G>A",
        "NM_000152.5(GAA):c.1375G>A (p.Asp459Asn)"
      ],
      "hgvsSearch": "nm_000152.5:c.1375g>a nc_000017.11:g.80109993g>a cm000679.2:g.80109993g>a nc_000017.10:g.78083792g>a cm000679.1:g.78083792g>a nc_000017.9:g.75698387g>a ng_009822.1:g.13438g>a lrg_673:g.13438g>a enst00000570803.6:c.1375g>a enst00000572080.2:c.1375g>a enst00000577106.6:c.1375g>a enst00000302262.8:c.1375g>a enst00000302262.7:c.1375g>a enst00000390015.7:c.1375g>a nm_000152.3:c.1375g>a lrg_673t1:c.1375g>a nm_001079803.1:c.1375g>a nm_001079804.1:c.1375g>a xm_005257193.1:c.1375g>a xm_005257194.3:c.1375g>a nm_000152.4:c.1375g>a nm_001079803.2:c.1375g>a nm_001079804.2:c.1375g>a xm_005257193.2:c.1375g>a xm_005257194.4:c.1375g>a nm_001079803.3:c.1375g>a nm_001079804.3:c.1375g>a nm_000152.5(gaa):c.1375g>a (p.asp459asn)",
      "metCodes": [
        "PP4_Moderate",
        "PM2_Supporting",
        "PM3"
      ],
      "metCodesSearch": "pp4_moderate pm2_supporting pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.1375G>A (p.Asp459Asn)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1375G>A variant in GAA is a missense variant predicted to cause substitution of Asp by Asn at amino acid 459 (p.Asp459Asn). The highest population minor allele frequency in gnomAD v4.1.2. is 0.0003300 (2/6060 alleles) in the Middle Eastern population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting). At least 4 patients have been identified with this variant. One had documented laboratory values showing GAA deficiency (<10% activity in fibroblasts) and was on enzyme replacement therapy (PMID: 21757382) and one within affected range in dried blood spot (Clinical diagnostic laboratory) (PP4_Moderate). Of these patients, one was compound heterozygous for the variant and another variant in GAA that has been classified as pathogenic by the ClinGen Lysosomal Diseases Variant Curation Expert Panel, and confirmed to be in trans, c.2173C>T (p.Arg725Trp) (ClinVar Variation ID: 4024, SCV004227911.1). 1 point (PM3).  Additional patients had evidence of pseudodeficiency variants with  (PMID: 21484825, 28302345). The computational predictor REVEL gives a score of 0.531 which is neither above nor below the thresholds predicting a damaging (>0.7) or benign (<0.5) impact on GAA function. There is a ClinVar entry for this variant (Variation ID: 188480). In summary, this variant meets the criteria to be classified as Uncertain significance for Pompe disease based on the GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 2.0): PM2_supporting, PP4_Moderate, PM3.",
      "unMetCodes": [
        "PP3",
        "BP4"
      ],
      "unMetCodesSearch": "pp3 bp4",
      "uuid": "a13f5909-eb8f-4d45-a198-4758c4612e8e",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000010288",
      "_id": "AlleleRecords/298442041",
      "_key": "298442041",
      "_rev": "_mctqvR----",
      "affiliationId": "50009",
      "approvedDate": "2026-11-17",
      "caId": "CA401366926",
      "classification": "Likely Pathogenic",
      "condition": "glycogen storage disease II",
      "cvId": "2160730",
      "docVersion": "1.1.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.1477C>T",
        "NC_000017.11:g.80110766C>T",
        "CM000679.2:g.80110766C>T",
        "NC_000017.10:g.78084565C>T",
        "CM000679.1:g.78084565C>T",
        "NC_000017.9:g.75699160C>T",
        "NG_009822.1:g.14211C>T",
        "LRG_673:g.14211C>T",
        "ENST00000570803.6:c.1477C>T",
        "ENST00000572080.2:c.1477C>T",
        "ENST00000577106.6:c.1477C>T",
        "ENST00000302262.8:c.1477C>T",
        "ENST00000302262.7:c.1477C>T",
        "ENST00000390015.7:c.1477C>T",
        "NM_000152.3:c.1477C>T",
        "LRG_673t1:c.1477C>T",
        "NM_001079803.1:c.1477C>T",
        "NM_001079804.1:c.1477C>T",
        "XM_005257193.1:c.1477C>T",
        "XM_005257194.3:c.1477C>T",
        "NM_000152.4:c.1477C>T",
        "NM_001079803.2:c.1477C>T",
        "NM_001079804.2:c.1477C>T",
        "XM_005257193.2:c.1477C>T",
        "XM_005257194.4:c.1477C>T",
        "NM_001079803.3:c.1477C>T",
        "NM_001079804.3:c.1477C>T",
        "NM_000152.5(GAA):c.1477C>T (p.Pro493Ser)"
      ],
      "hgvsSearch": "nm_000152.5:c.1477c>t nc_000017.11:g.80110766c>t cm000679.2:g.80110766c>t nc_000017.10:g.78084565c>t cm000679.1:g.78084565c>t nc_000017.9:g.75699160c>t ng_009822.1:g.14211c>t lrg_673:g.14211c>t enst00000570803.6:c.1477c>t enst00000572080.2:c.1477c>t enst00000577106.6:c.1477c>t enst00000302262.8:c.1477c>t enst00000302262.7:c.1477c>t enst00000390015.7:c.1477c>t nm_000152.3:c.1477c>t lrg_673t1:c.1477c>t nm_001079803.1:c.1477c>t nm_001079804.1:c.1477c>t xm_005257193.1:c.1477c>t xm_005257194.3:c.1477c>t nm_000152.4:c.1477c>t nm_001079803.2:c.1477c>t nm_001079804.2:c.1477c>t xm_005257193.2:c.1477c>t xm_005257194.4:c.1477c>t nm_001079803.3:c.1477c>t nm_001079804.3:c.1477c>t nm_000152.5(gaa):c.1477c>t (p.pro493ser)",
      "metCodes": [
        "PP4_Moderate",
        "PM2_Supporting",
        "PS3_Supporting",
        "PM5_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pp4_moderate pm2_supporting ps3_supporting pm5_supporting pp3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.1477C>T (p.Pro493Ser)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1477C>T variant in GAA is a missense variant predicted to cause substitution of proline by serine at amino acid 493 (p.Pro493Ser). This variant has been detected in at least 1 patient reported to have Pompe disease with reported laboratory values demonstrating deficient GAA activity (Duke University; PMID: 31904026, 32518148) (PP4_moderate). This variant has been detected in at least one individual with Pompe disease. This individual was compound heterozygous for the variant, c.1477C>T (p.Pro493Ser), and two other variants: a variant classified as pathogenic by the ClinGen LD VCEP, c.1978C>T (p.Arg660Cys) (ClinVar Variation ID: 558604, SCV002540656.1), and a variant not classified by the by the ClinGen LD VCEP, c.2221G>A (p.Asp741Asn) (ClinVar Variation ID: 571521) (Duke University; PMID: 31904026, 32518148). Based on parental testing the c.1477C>T (p.Pro493Ser) variant was in cis with c.2221G>A (p.Asp741Asn) and in trans with the c.1978C>T (p.Arg660Cys). Because the impact of the variant cannot be assessed as it is in cis with another variant, no PM3 points were given (PM3_not met). Another missense variant, c.1478C>T, p.Pro493Leu (ClinVar Variation ID: 379593) in the same codon has been classified as likely pathogenic for Pompe disease by the ClinGen Lysosomal Diseases VCEP (PM5_supporting). This variant is absent in gnomAD v4.1.2 (PM2_Supporting). Residual in vitro enzyme activity for the variant in 2 replicates resulted in a mean of 12.3% wild type GAA activity (within the pathogenic control range of <15%), indicating that this variant may impact protein function (Duke University) (PS3_Supporting). The computational predictor REVEL gives a score of 0.781 which is above the threshold predicting a damaging (>0.7) impact on GAA function (PP3_met). There is a ClinVar entry for this variant (Variation ID: 2160730; 1 star review status) with one submitter classifying the variant as likely pathogenic, and one as a variant of uncertain significance. In summary, this variant meets the criteria to be classified as Likely Pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PP4_Moderate, PP3, PM2_supporting, PM5_supporting, PS3_supporting.",
      "unMetCodes": [
        "PM3"
      ],
      "unMetCodesSearch": "pm3",
      "uuid": "9bac4cac-ccd2-43d4-be60-88c23625224d",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013759",
      "_id": "AlleleRecords/1692346808",
      "_key": "1692346808",
      "_rev": "_mcVjSyq---",
      "affiliationId": "50107",
      "approvedDate": "2026-11-16",
      "caId": "CA217184",
      "classification": "Likely Pathogenic",
      "condition": "Alexander disease",
      "cvId": "66479",
      "docVersion": "1.0.0",
      "ep": "Leukodystrophy and Leukoencephalopathy VCEP",
      "gene": "GFAP",
      "geneNcbiId": "2670",
      "hgvs": [
        "NM_002055.5:c.269T>C",
        "NC_000017.11:g.44915218A>G",
        "CM000679.2:g.44915218A>G",
        "NC_000017.10:g.42992586A>G",
        "CM000679.1:g.42992586A>G",
        "NC_000017.9:g.40348112A>G",
        "NG_008401.1:g.5329T>C",
        "ENST00000253408.11:c.269T>C",
        "ENST00000435360.8:c.269T>C",
        "ENST00000253408.10:c.269T>C",
        "ENST00000435360.7:c.269T>C",
        "ENST00000586793.6:c.269T>C",
        "ENST00000588735.3:c.269T>C",
        "ENST00000591327.2:n.282T>C",
        "ENST00000592320.6:c.269T>C",
        "ENST00000638281.1:c.269T>C",
        "ENST00000639277.1:c.269T>C",
        "ENST00000640552.1:n.283T>C",
        "ENST00000253408.9:c.269T>C",
        "ENST00000376990.8:c.269T>C",
        "ENST00000435360.6:c.269T>C",
        "ENST00000585728.5:c.182-83T>C",
        "ENST00000586793.5:c.269T>C",
        "ENST00000588037.1:c.269T>C",
        "ENST00000588316.1:c.269T>C",
        "ENST00000588735.1:c.82+187T>C",
        "ENST00000588957.5:c.-272+599T>C",
        "ENST00000591327.1:n.283T>C",
        "ENST00000592320.5:c.269T>C",
        "NM_001131019.2:c.269T>C",
        "NM_001242376.1:c.269T>C",
        "NM_002055.4:c.269T>C",
        "NM_001363846.1:c.269T>C",
        "XM_024450690.1:c.269T>C",
        "XM_024450691.1:c.269T>C",
        "XM_024450692.1:c.269T>C",
        "XM_024450693.1:c.269T>C",
        "NM_001131019.3:c.269T>C",
        "NM_001242376.2:c.269T>C",
        "NM_001242376.3:c.269T>C",
        "NM_001363846.2:c.269T>C",
        "NM_002055.5(GFAP):c.269T>C (p.Leu90Pro)"
      ],
      "hgvsSearch": "nm_002055.5:c.269t>c nc_000017.11:g.44915218a>g cm000679.2:g.44915218a>g nc_000017.10:g.42992586a>g cm000679.1:g.42992586a>g nc_000017.9:g.40348112a>g ng_008401.1:g.5329t>c enst00000253408.11:c.269t>c enst00000435360.8:c.269t>c enst00000253408.10:c.269t>c enst00000435360.7:c.269t>c enst00000586793.6:c.269t>c enst00000588735.3:c.269t>c enst00000591327.2:n.282t>c enst00000592320.6:c.269t>c enst00000638281.1:c.269t>c enst00000639277.1:c.269t>c enst00000640552.1:n.283t>c enst00000253408.9:c.269t>c enst00000376990.8:c.269t>c enst00000435360.6:c.269t>c enst00000585728.5:c.182-83t>c enst00000586793.5:c.269t>c enst00000588037.1:c.269t>c enst00000588316.1:c.269t>c enst00000588735.1:c.82+187t>c enst00000588957.5:c.-272+599t>c enst00000591327.1:n.283t>c enst00000592320.5:c.269t>c nm_001131019.2:c.269t>c nm_001242376.1:c.269t>c nm_002055.4:c.269t>c nm_001363846.1:c.269t>c xm_024450690.1:c.269t>c xm_024450691.1:c.269t>c xm_024450692.1:c.269t>c xm_024450693.1:c.269t>c nm_001131019.3:c.269t>c nm_001242376.2:c.269t>c nm_001242376.3:c.269t>c nm_001363846.2:c.269t>c nm_002055.5(gfap):c.269t>c (p.leu90pro)",
      "metCodes": [
        "PM6",
        "PM2_Supporting",
        "PS4_Supporting",
        "PP4_Strong"
      ],
      "metCodesSearch": "pm6 pm2_supporting ps4_supporting pp4_strong",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0008752",
      "preferredVarTitle": "NM_002055.5(GFAP):c.269T>C (p.Leu90Pro)",
      "publishedDate": "2026-11-16",
      "retracted": false,
      "summaryDesc": "The c.269T>C (NM_002055.5) variant in GFAP is a missense variant predicted to cause substitution of Leucine by Proline at amino acid 90 (p.Leu90Pro). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual with a “definite” diagnosis of Alexander Disease per ClinGen Leukodystrophy and Leukoencephalopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GFAP Version 1.0.0 (PM6, PS4_Supporting; PMID: 15030911). This variant was identified in one other patient with a \"definite\" diagnosis of Alexander Disease and displayed elevated GFAP levels in plasma when compared to age-matched controls which is highly specific for Alexander Disease (PP4_Strong, PMID: 41513585, Internal lab contributors). This variant is absent from gnomAD v[4.1.2] (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for Autosomal Dominant Alexander disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Leukodystrophy and Leukoencephalopathy Expert Panel: PM6, PS4_Supporting, PM2_Supporting, PP4_Strong. (ClinGen Leukodystrophy and Leukoencephalopathy VCEP Specifications Version 1.0.0).",
      "unMetCodes": [
        "PS1",
        "PS2",
        "PM1",
        "BS1",
        "PM5",
        "BA1"
      ],
      "unMetCodesSearch": "ps1 ps2 pm1 bs1 pm5 ba1",
      "uuid": "3cda4b18-5fef-4556-a924-e1c13525e1df",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013760",
      "_id": "AlleleRecords/1692349755",
      "_key": "1692349755",
      "_rev": "_mcV05sK---",
      "affiliationId": "50107",
      "approvedDate": "2026-11-16",
      "caId": "CA217185",
      "classification": "Uncertain Significance",
      "condition": "Alexander disease",
      "cvId": "66480",
      "docVersion": "1.0.0",
      "ep": "Leukodystrophy and Leukoencephalopathy VCEP",
      "gene": "GFAP",
      "geneNcbiId": "2670",
      "hgvs": [
        "NM_002055.5:c.290T>C",
        "NC_000017.11:g.44915197A>G",
        "CM000679.2:g.44915197A>G",
        "NC_000017.10:g.42992565A>G",
        "CM000679.1:g.42992565A>G",
        "NC_000017.9:g.40348091A>G",
        "NG_008401.1:g.5350T>C",
        "ENST00000253408.11:c.290T>C",
        "ENST00000435360.8:c.290T>C",
        "ENST00000253408.10:c.290T>C",
        "ENST00000435360.7:c.290T>C",
        "ENST00000586793.6:c.290T>C",
        "ENST00000588735.3:c.290T>C",
        "ENST00000591327.2:n.303T>C",
        "ENST00000592320.6:c.290T>C",
        "ENST00000638281.1:c.290T>C",
        "ENST00000639277.1:c.290T>C",
        "ENST00000640552.1:n.304T>C",
        "ENST00000253408.9:c.290T>C",
        "ENST00000376990.8:c.290T>C",
        "ENST00000435360.6:c.290T>C",
        "ENST00000585728.5:c.182-62T>C",
        "ENST00000586793.5:c.290T>C",
        "ENST00000588037.1:c.290T>C",
        "ENST00000588316.1:c.290T>C",
        "ENST00000588735.1:c.82+208T>C",
        "ENST00000588957.5:c.-272+620T>C",
        "ENST00000591327.1:n.304T>C",
        "ENST00000592320.5:c.290T>C",
        "NM_001131019.2:c.290T>C",
        "NM_001242376.1:c.290T>C",
        "NM_002055.4:c.290T>C",
        "NM_001363846.1:c.290T>C",
        "XM_024450690.1:c.290T>C",
        "XM_024450691.1:c.290T>C",
        "XM_024450692.1:c.290T>C",
        "XM_024450693.1:c.290T>C",
        "NM_001131019.3:c.290T>C",
        "NM_001242376.2:c.290T>C",
        "NM_001242376.3:c.290T>C",
        "NM_001363846.2:c.290T>C",
        "NM_002055.5(GFAP):c.290T>C (p.Leu97Pro)"
      ],
      "hgvsSearch": "nm_002055.5:c.290t>c nc_000017.11:g.44915197a>g cm000679.2:g.44915197a>g nc_000017.10:g.42992565a>g cm000679.1:g.42992565a>g nc_000017.9:g.40348091a>g ng_008401.1:g.5350t>c enst00000253408.11:c.290t>c enst00000435360.8:c.290t>c enst00000253408.10:c.290t>c enst00000435360.7:c.290t>c enst00000586793.6:c.290t>c enst00000588735.3:c.290t>c enst00000591327.2:n.303t>c enst00000592320.6:c.290t>c enst00000638281.1:c.290t>c enst00000639277.1:c.290t>c enst00000640552.1:n.304t>c enst00000253408.9:c.290t>c enst00000376990.8:c.290t>c enst00000435360.6:c.290t>c enst00000585728.5:c.182-62t>c enst00000586793.5:c.290t>c enst00000588037.1:c.290t>c enst00000588316.1:c.290t>c enst00000588735.1:c.82+208t>c enst00000588957.5:c.-272+620t>c enst00000591327.1:n.304t>c enst00000592320.5:c.290t>c nm_001131019.2:c.290t>c nm_001242376.1:c.290t>c nm_002055.4:c.290t>c nm_001363846.1:c.290t>c xm_024450690.1:c.290t>c xm_024450691.1:c.290t>c xm_024450692.1:c.290t>c xm_024450693.1:c.290t>c nm_001131019.3:c.290t>c nm_001242376.2:c.290t>c nm_001242376.3:c.290t>c nm_001363846.2:c.290t>c nm_002055.5(gfap):c.290t>c (p.leu97pro)",
      "metCodes": [
        "PM6",
        "PM2_Supporting",
        "PS4_Moderate"
      ],
      "metCodesSearch": "pm6 pm2_supporting ps4_moderate",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0008752",
      "preferredVarTitle": "NM_002055.5(GFAP):c.290T>C (p.Leu97Pro)",
      "publishedDate": "2026-11-16",
      "retracted": false,
      "summaryDesc": "The c.290T>C (NM_002055.5) variant in GFAP is a missense variant predicted to cause substitution of Leucine by Proline at amino acid 97 (p.Leu97Pro). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual with a “definite” diagnosis of Alexander Disease per ClinGen Leukodystrophy and Leukoencephalopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GFAP Version 1.0.0 (PM6; PMID: 12368989). This variant has also been reported in 1 proband meeting \"probable” diagnosis of Alexander Disease per ClinGen Leukodystrophy and Leukoencephalopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GFAP Version 1.0.0 (PS4_Moderate; Internal lab contributors). This variant is absent from gnomAD v[4.1.2] (PM2_Supporting). In summary, this variant meets the criteria to be classified as variant of uncertain significance for Autosomal Dominant Alexander disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Leukodystrophy and Leukoencephalopathy Expert Panel: PS4_Moderate, PM6, PM2_Supporting (ClinGen Leukodystrophy and Leukoencephalopathy VCEP Specifications Version 1.0.0).",
      "unMetCodes": [
        "PS1",
        "PM1",
        "PM5"
      ],
      "unMetCodesSearch": "ps1 pm1 pm5",
      "uuid": "77a137ce-aea0-4bd7-b82c-5dd8bcb363ba",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013761",
      "_id": "AlleleRecords/1692367516",
      "_key": "1692367516",
      "_rev": "_mcXS892---",
      "affiliationId": "50136",
      "approvedDate": "2026-11-16",
      "caId": "CA259458",
      "classification": "Uncertain Significance",
      "condition": "galactosemia",
      "cvId": "25233",
      "docVersion": "1.0.0",
      "ep": "Galactosemia VCEP",
      "gene": "GALT",
      "geneNcbiId": "2592",
      "hgvs": [
        "NM_000155.4:c.630G>A",
        "NC_000009.12:g.34648399G>A",
        "CM000671.2:g.34648399G>A",
        "NC_000009.11:g.34648396G>A",
        "CM000671.1:g.34648396G>A",
        "NC_000009.10:g.34638396G>A",
        "NG_009029.1:g.6762G>A",
        "NG_028966.1:g.1215G>A",
        "NG_009029.2:g.6811G>A",
        "ENST00000691183.1:c.*218G>A",
        "ENST00000378842.8:c.630G>A",
        "ENST00000378842.7:c.630G>A",
        "ENST00000450095.6:c.303G>A",
        "ENST00000472111.5:n.886G>A",
        "ENST00000473506.6:c.*218G>A",
        "ENST00000473529.5:n.789G>A",
        "ENST00000487381.5:n.1015G>A",
        "ENST00000489643.6:n.405G>A",
        "ENST00000554085.5:c.*374G>A",
        "ENST00000554550.5:c.*250G>A",
        "ENST00000554638.5:n.1102G>A",
        "ENST00000555020.5:n.786G>A",
        "ENST00000555086.5:n.634G>A",
        "ENST00000555214.5:n.451G>A",
        "ENST00000556244.1:c.617G>A",
        "ENST00000556278.1:c.375G>A",
        "ENST00000556494.5:n.751G>A",
        "ENST00000557706.5:n.1192G>A",
        "NM_000155.3:c.630G>A",
        "NM_001258332.1:c.303G>A",
        "NM_001258332.2:c.303G>A",
        "NM_000155.4(GALT):c.630G>A (p.Lys210=)"
      ],
      "hgvsSearch": "nm_000155.4:c.630g>a nc_000009.12:g.34648399g>a cm000671.2:g.34648399g>a nc_000009.11:g.34648396g>a cm000671.1:g.34648396g>a nc_000009.10:g.34638396g>a ng_009029.1:g.6762g>a ng_028966.1:g.1215g>a ng_009029.2:g.6811g>a enst00000691183.1:c.*218g>a enst00000378842.8:c.630g>a enst00000378842.7:c.630g>a enst00000450095.6:c.303g>a enst00000472111.5:n.886g>a enst00000473506.6:c.*218g>a enst00000473529.5:n.789g>a enst00000487381.5:n.1015g>a enst00000489643.6:n.405g>a enst00000554085.5:c.*374g>a enst00000554550.5:c.*250g>a enst00000554638.5:n.1102g>a enst00000555020.5:n.786g>a enst00000555086.5:n.634g>a enst00000555214.5:n.451g>a enst00000556244.1:c.617g>a enst00000556278.1:c.375g>a enst00000556494.5:n.751g>a enst00000557706.5:n.1192g>a nm_000155.3:c.630g>a nm_001258332.1:c.303g>a nm_001258332.2:c.303g>a nm_000155.4(galt):c.630g>a (p.lys210=)",
      "metCodes": [
        "PM2_Supporting",
        "BP7",
        "BP4"
      ],
      "metCodesSearch": "pm2_supporting bp7 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0018116",
      "preferredVarTitle": "NM_000155.4(GALT):c.630G>A (p.Lys210=)",
      "publishedDate": "2026-11-16",
      "retracted": false,
      "summaryDesc": "The c.630G>A variant is a synonymous (silent) variant (p.Lys210=) that is not predicted by SpliceAI to impact splicing.  This variant is present in 1 allele in gnomAD v4.1.1 with an overall minor allele frequency of 0.0000006195.  Therefore a filtering allele frequency cannot be calculated, but the overall minor allele frequency is lower than the ClinGen Galactosemia threshold (≤ 0.0005) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting).  This variant was reported in an infant with cholestasis with 29% GALT activity (PMID:  23022339).   In summary, this variant meets the criteria to be classified as a variant of uncertain significance for galactosemia based on the ACMG/AMP criteria applied, as specified by the ClinGen Galactosemia VCEP: PM2_supporting, BP4, BP7.",
      "uuid": "eefdd9a2-a924-4d97-8438-4265d7eb12e7",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013757",
      "_id": "AlleleRecords/1687942033",
      "_key": "1687942033",
      "_rev": "_mbbXl3y---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224775",
      "classification": "Uncertain Significance",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97315",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.77+3_77+6del",
        "NC_000023.11:g.38352776_38352779del",
        "CM000685.2:g.38352776_38352779del",
        "NC_000023.10:g.38212029_38212032del",
        "CM000685.1:g.38212029_38212032del",
        "NC_000023.9:g.38096973_38096976del",
        "NG_008471.1:g.5294_5297del",
        "ENST00000039007.5:c.77+3_77+6del",
        "ENST00000643344.1:c.77+3_77+6del",
        "ENST00000039007.4:c.77+3_77+6del",
        "ENST00000465127.1:c.172-313345_172-313342del",
        "ENST00000488812.1:n.169+3_169+6del",
        "NM_000531.5:c.77+3_77+6del",
        "XM_017029556.1:c.77+3_77+6del"
      ],
      "hgvsSearch": "nm_000531.6:c.77+3_77+6del nc_000023.11:g.38352776_38352779del cm000685.2:g.38352776_38352779del nc_000023.10:g.38212029_38212032del cm000685.1:g.38212029_38212032del nc_000023.9:g.38096973_38096976del ng_008471.1:g.5294_5297del enst00000039007.5:c.77+3_77+6del enst00000643344.1:c.77+3_77+6del enst00000039007.4:c.77+3_77+6del enst00000465127.1:c.172-313345_172-313342del enst00000488812.1:n.169+3_169+6del nm_000531.5:c.77+3_77+6del xm_017029556.1:c.77+3_77+6del",
      "metCodes": [
        "PM2_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pp3",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.77+3_77+6del",
      "publishedDate": "2026-11-13",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.77+3_77+6del variant in the OTC gene affects the 1st intron. The variant is predicted by SpliceAI to result in donor loss, score 0.83, -2bp (PP3). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). It has been reported in one female (Patient #9) in a list of deleterious mutations in the OTC gene, but no phenotype nor biochemical evidence was provided (PMID: 11793468), such that neither PS4 nor PP4 are met. In summary, this variant meets the criteria for being classified as a variant of uncertain significance for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PP3 (+1 points), PM2_Supporting (+1 points).",
      "unMetCodes": [
        "PS4",
        "PP4"
      ],
      "unMetCodesSearch": "ps4 pp4",
      "uuid": "a1f868b7-5acb-4855-8b31-cc2ba32d417c",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013758",
      "_id": "AlleleRecords/1687944607",
      "_key": "1687944607",
      "_rev": "_mbbgB4W---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224782",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97320",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.78-1G>C",
        "NC_000023.11:g.38367290G>C",
        "CM000685.2:g.38367290G>C",
        "NC_000023.10:g.38226543G>C",
        "CM000685.1:g.38226543G>C",
        "NC_000023.9:g.38111487G>C",
        "NG_008471.1:g.19808G>C",
        "ENST00000039007.5:c.78-1G>C",
        "ENST00000643344.1:c.78-1G>C",
        "ENST00000039007.4:c.78-1G>C",
        "ENST00000465127.1:c.172-298831G>C",
        "ENST00000488812.1:n.170-1G>C",
        "NM_000531.5:c.78-1G>C",
        "XM_017029556.1:c.78-1G>C",
        "NM_000531.6(OTC):c.78-1G>C"
      ],
      "hgvsSearch": "nm_000531.6:c.78-1g>c nc_000023.11:g.38367290g>c cm000685.2:g.38367290g>c nc_000023.10:g.38226543g>c cm000685.1:g.38226543g>c nc_000023.9:g.38111487g>c ng_008471.1:g.19808g>c enst00000039007.5:c.78-1g>c enst00000643344.1:c.78-1g>c enst00000039007.4:c.78-1g>c enst00000465127.1:c.172-298831g>c enst00000488812.1:n.170-1g>c nm_000531.5:c.78-1g>c xm_017029556.1:c.78-1g>c nm_000531.6(otc):c.78-1g>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.78-1G>C",
      "publishedDate": "2026-11-13",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.78-1G>C variant in the OTC gene is a a canonical splice site variant predicted to cause skipping of biologically relevant exon 2, leading to frameshift and nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). One patient with this variant has been reported (PMID: 16786505) with neonatal OTC, but no other information is provided, therefore PP4 cannot be met. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (8 points), PM2_Supporting (+1 point).",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "d58e8795-42cf-4ff1-a878-bf6a9b141a8f",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000003939",
      "_id": "AlleleRecords/1573024260",
      "_key": "1573024260",
      "_rev": "_mbFCYv2---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA212568",
      "classification": "Likely Pathogenic",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "4468",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.2:c.4748T>G",
        "NC_000014.9:g.95096172A>C",
        "CM000676.2:g.95096172A>C",
        "NC_000014.8:g.95562509A>C",
        "CM000676.1:g.95562509A>C",
        "NC_000014.7:g.94632262A>C",
        "NG_016311.1:g.66251T>G",
        "LRG_492:g.66251T>G",
        "ENST00000529720.2:c.4748T>G",
        "ENST00000531162.7:c.4748T>G",
        "ENST00000674628.2:c.4748T>G",
        "ENST00000675540.2:c.*1398T>G",
        "ENST00000696733.1:c.4748T>G",
        "ENST00000696734.1:c.4748T>G",
        "ENST00000696735.1:n.1735T>G",
        "ENST00000696736.1:c.4748T>G",
        "ENST00000696737.1:c.4748T>G",
        "ENST00000696920.1:n.5011T>G",
        "ENST00000696921.1:n.5854T>G",
        "ENST00000696922.1:n.5157T>G",
        "ENST00000696923.1:c.4748T>G",
        "ENST00000696924.1:c.4748T>G",
        "ENST00000696925.1:n.5157T>G",
        "ENST00000343455.8:c.4748T>G",
        "ENST00000393063.6:c.4748T>G",
        "ENST00000526495.6:c.4748T>G",
        "ENST00000532939.3:c.4748T>G",
        "ENST00000556045.6:c.4748T>G",
        "ENST00000675540.1:c.2493T>G",
        "ENST00000675995.1:c.*3064T>G",
        "ENST00000343455.7:c.4748T>G",
        "ENST00000393063.5:c.4748T>G",
        "ENST00000526495.5:c.4748T>G",
        "ENST00000527414.5:c.4748T>G",
        "ENST00000532939.2:c.783T>G",
        "ENST00000541352.5:c.4748T>G",
        "ENST00000556045.5:c.1442T>G",
        "NM_001195573.1:c.4748T>G",
        "NM_001271282.2:c.4748T>G",
        "NM_001291628.1:c.4748T>G",
        "NM_030621.4:c.4748T>G",
        "LRG_492t1:c.4748T>G",
        "XM_011536599.1:c.4748T>G",
        "XM_011536600.1:c.4748T>G",
        "XM_011536601.1:c.4748T>G",
        "XM_011536602.1:c.4748T>G",
        "XM_011536603.1:c.4748T>G",
        "XM_011536604.1:c.4343T>G",
        "XM_011536605.1:c.3269T>G",
        "XM_011536599.2:c.4748T>G",
        "XM_011536600.3:c.4748T>G",
        "XM_011536601.3:c.4748T>G",
        "XM_011536602.3:c.4748T>G",
        "XM_011536604.2:c.4343T>G",
        "XM_011536605.2:c.3269T>G",
        "XM_017021120.2:c.4748T>G",
        "XM_017021121.2:c.4748T>G",
        "XM_017021122.2:c.4343T>G",
        "XM_017021123.2:c.4343T>G",
        "NM_001271282.3:c.4748T>G",
        "NM_001291628.2:c.4748T>G",
        "NM_177438.3:c.4748T>G",
        "NM_001395677.1:c.4748T>G",
        "NM_001395678.1:c.4748T>G",
        "NM_001395679.1:c.4748T>G",
        "NM_001395680.1:c.4748T>G",
        "NM_001395682.1:c.4748T>G",
        "NM_001395683.1:c.4748T>G",
        "NM_001395684.1:c.4748T>G",
        "NM_001395685.1:c.4748T>G",
        "NM_001395686.1:c.4466T>G",
        "NM_001395687.1:c.4343T>G",
        "NM_001395688.1:c.4343T>G",
        "NM_001395689.1:c.4343T>G",
        "NM_001395690.1:c.4343T>G",
        "NM_001395691.1:c.4181T>G",
        "NM_001395692.1:c.4748T>G",
        "NM_001395693.1:c.4748T>G",
        "NM_001395694.1:c.4748T>G",
        "NM_001395695.1:c.4748T>G",
        "NM_001395696.1:c.4343T>G",
        "NM_001395697.1:c.3065T>G",
        "NR_172715.1:n.5166T>G",
        "NR_172716.1:n.5350T>G",
        "NR_172717.1:n.5260T>G",
        "NR_172718.1:n.5183T>G",
        "NR_172719.1:n.5016T>G",
        "NR_172720.1:n.5093T>G",
        "NM_177438.2(DICER1):c.4748T>G (p.Leu1583Arg)"
      ],
      "hgvsSearch": "nm_177438.2:c.4748t>g nc_000014.9:g.95096172a>c cm000676.2:g.95096172a>c nc_000014.8:g.95562509a>c cm000676.1:g.95562509a>c nc_000014.7:g.94632262a>c ng_016311.1:g.66251t>g lrg_492:g.66251t>g enst00000529720.2:c.4748t>g enst00000531162.7:c.4748t>g enst00000674628.2:c.4748t>g enst00000675540.2:c.*1398t>g enst00000696733.1:c.4748t>g enst00000696734.1:c.4748t>g enst00000696735.1:n.1735t>g enst00000696736.1:c.4748t>g enst00000696737.1:c.4748t>g enst00000696920.1:n.5011t>g enst00000696921.1:n.5854t>g enst00000696922.1:n.5157t>g enst00000696923.1:c.4748t>g enst00000696924.1:c.4748t>g enst00000696925.1:n.5157t>g enst00000343455.8:c.4748t>g enst00000393063.6:c.4748t>g enst00000526495.6:c.4748t>g enst00000532939.3:c.4748t>g enst00000556045.6:c.4748t>g enst00000675540.1:c.2493t>g enst00000675995.1:c.*3064t>g enst00000343455.7:c.4748t>g enst00000393063.5:c.4748t>g enst00000526495.5:c.4748t>g enst00000527414.5:c.4748t>g enst00000532939.2:c.783t>g enst00000541352.5:c.4748t>g enst00000556045.5:c.1442t>g nm_001195573.1:c.4748t>g nm_001271282.2:c.4748t>g nm_001291628.1:c.4748t>g nm_030621.4:c.4748t>g lrg_492t1:c.4748t>g xm_011536599.1:c.4748t>g xm_011536600.1:c.4748t>g xm_011536601.1:c.4748t>g xm_011536602.1:c.4748t>g xm_011536603.1:c.4748t>g xm_011536604.1:c.4343t>g xm_011536605.1:c.3269t>g xm_011536599.2:c.4748t>g xm_011536600.3:c.4748t>g xm_011536601.3:c.4748t>g xm_011536602.3:c.4748t>g xm_011536604.2:c.4343t>g xm_011536605.2:c.3269t>g xm_017021120.2:c.4748t>g xm_017021121.2:c.4748t>g xm_017021122.2:c.4343t>g xm_017021123.2:c.4343t>g nm_001271282.3:c.4748t>g nm_001291628.2:c.4748t>g nm_177438.3:c.4748t>g nm_001395677.1:c.4748t>g nm_001395678.1:c.4748t>g nm_001395679.1:c.4748t>g nm_001395680.1:c.4748t>g nm_001395682.1:c.4748t>g nm_001395683.1:c.4748t>g nm_001395684.1:c.4748t>g nm_001395685.1:c.4748t>g nm_001395686.1:c.4466t>g nm_001395687.1:c.4343t>g nm_001395688.1:c.4343t>g nm_001395689.1:c.4343t>g nm_001395690.1:c.4343t>g nm_001395691.1:c.4181t>g nm_001395692.1:c.4748t>g nm_001395693.1:c.4748t>g nm_001395694.1:c.4748t>g nm_001395695.1:c.4748t>g nm_001395696.1:c.4343t>g nm_001395697.1:c.3065t>g nr_172715.1:n.5166t>g nr_172716.1:n.5350t>g nr_172717.1:n.5260t>g nr_172718.1:n.5183t>g nr_172719.1:n.5016t>g nr_172720.1:n.5093t>g nm_177438.2(dicer1):c.4748t>g (p.leu1583arg)",
      "metCodes": [
        "PM2_Supporting",
        "PS4_Supporting",
        "PP1_Moderate",
        "PS3_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting ps4_supporting pp1_moderate ps3_supporting pp3",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.2(DICER1):c.4748T>G (p.Leu1583Arg)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.4748T>G variant in DICER1 is a missense variant predicted to replace leucine with arginine at codon 1583 (p.Leu1583Arg). This variant received a total of 1 phenotype point(s) across 1 family meeting DICER1 VCEP phenotype specificity scoring criteria of 1-1.5 points (PS4_Supporting; PMID: 19556464). The variant has been reported to segregate with PPB and lung cysts in 3 affected family members (5 meioses) from 1 family (PP1_Moderate; PMID: 19556464). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). In vitro cleavage assays carried out using immunopurified DICER1 variant Leu1583Arg showed that this variant reduces the capacity of the protein to produce 5p/3p microRNAs from a pre-miRNA, indicating that this variant impacts protein function (PS3_Supporting; Wu 2018, McGill University). The computational predictor REVEL gives a score of 0.894, which is above the threshold of 0.750, evidence that correlates with impact to DICER1 function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PS4_Supporting, PP1_Moderate, PM2_Supporting, PS3_Supporting, PP3. (VCEP specifications version 1.4.0) Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 6, which equates to a classification of Likely Pathogenic.",
      "unMetCodes": [
        "PS1",
        "PS2",
        "PM1",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "PM5",
        "BP4",
        "BP2",
        "BA1"
      ],
      "unMetCodesSearch": "ps1 ps2 pm1 pp4 bs2 bs1 bs4 bs3 pm5 bp4 bp2 ba1",
      "uuid": "f699f55d-24ea-4c9b-882c-9ad1dc4b7531",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000003974",
      "_id": "AlleleRecords/1573024401",
      "_key": "1573024401",
      "_rev": "_mbFK2FW--_",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA891844309",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "566588",
      "docVersion": "2.1.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "hgvs": [
        "NM_177438.3:c.1719AGA[1]",
        "NC_000014.9:g.95116486_95116488del",
        "CM000676.2:g.95116486_95116488del",
        "NC_000014.8:g.95582823_95582825del",
        "CM000676.1:g.95582823_95582825del",
        "NC_000014.7:g.94652576_94652578del",
        "NG_016311.1:g.45940_45942del",
        "LRG_492:g.45940_45942del",
        "ENST00000529720.2:c.1722_1724del",
        "ENST00000531162.7:c.1722_1724del",
        "ENST00000674628.2:c.1722_1724del",
        "ENST00000675540.2:c.1722_1724del",
        "ENST00000696733.1:c.1722_1724del",
        "ENST00000696734.1:c.1722_1724del",
        "ENST00000696736.1:c.1722_1724del",
        "ENST00000696737.1:c.1722_1724del",
        "ENST00000696920.1:n.1985_1987del",
        "ENST00000696921.1:n.2828_2830del",
        "ENST00000696922.1:n.2131_2133del",
        "ENST00000696923.1:c.1722_1724del",
        "ENST00000696924.1:c.1722_1724del",
        "ENST00000696925.1:n.2131_2133del",
        "ENST00000696927.1:n.1317_1319del",
        "ENST00000696928.1:n.1919_1921del",
        "ENST00000343455.8:c.1722_1724del",
        "ENST00000393063.6:c.1722_1724del",
        "ENST00000526495.6:c.1722_1724del",
        "ENST00000532939.3:c.1722_1724del",
        "ENST00000556045.6:c.1722_1724del",
        "ENST00000675995.1:c.*38_*40del",
        "ENST00000343455.7:c.1722_1724del",
        "ENST00000393063.5:c.1722_1724del",
        "ENST00000526495.5:c.1722_1724del",
        "ENST00000527414.5:c.1722_1724del",
        "ENST00000532458.1:n.311_313del",
        "ENST00000541352.5:c.1722_1724del",
        "NM_001195573.1:c.1722_1724del",
        "NM_001271282.2:c.1722_1724del",
        "NM_001291628.1:c.1722_1724del",
        "NM_030621.4:c.1722_1724del",
        "NM_177438.2:c.1722_1724del",
        "LRG_492t1:c.1722_1724del",
        "XM_011536599.1:c.1722_1724del",
        "XM_011536600.1:c.1722_1724del",
        "XM_011536601.1:c.1722_1724del",
        "XM_011536602.1:c.1722_1724del",
        "XM_011536603.1:c.1722_1724del",
        "XM_011536604.1:c.1317_1319del",
        "XM_011536605.1:c.243_245del",
        "XM_011536599.2:c.1722_1724del",
        "XM_011536600.3:c.1722_1724del",
        "XM_011536601.3:c.1722_1724del",
        "XM_011536602.3:c.1722_1724del",
        "XM_011536604.2:c.1317_1319del",
        "XM_011536605.2:c.243_245del",
        "XM_017021120.2:c.1722_1724del",
        "XM_017021121.2:c.1722_1724del",
        "XM_017021122.2:c.1317_1319del",
        "XM_017021123.2:c.1317_1319del",
        "NM_001271282.3:c.1722_1724del",
        "NM_001291628.2:c.1722_1724del",
        "NM_177438.3:c.1722_1724del",
        "NM_001395677.1:c.1722_1724del",
        "NM_001395678.1:c.1722_1724del",
        "NM_001395679.1:c.1722_1724del",
        "NM_001395680.1:c.1722_1724del",
        "NM_001395682.1:c.1722_1724del",
        "NM_001395683.1:c.1722_1724del",
        "NM_001395684.1:c.1722_1724del",
        "NM_001395685.1:c.1722_1724del",
        "NM_001395686.1:c.1440_1442del",
        "NM_001395687.1:c.1317_1319del",
        "NM_001395688.1:c.1317_1319del",
        "NM_001395689.1:c.1317_1319del",
        "NM_001395690.1:c.1317_1319del",
        "NM_001395691.1:c.1155_1157del",
        "NM_001395692.1:c.1722_1724del",
        "NM_001395693.1:c.1722_1724del",
        "NM_001395694.1:c.1722_1724del",
        "NM_001395695.1:c.1722_1724del",
        "NM_001395696.1:c.1317_1319del",
        "NM_001395697.1:c.39_41del",
        "NM_001395698.1:c.1317_1319del",
        "NR_172715.1:n.2140_2142del",
        "NR_172716.1:n.2067_2069del",
        "NR_172717.1:n.2234_2236del",
        "NR_172718.1:n.2234_2236del",
        "NR_172719.1:n.2067_2069del",
        "NR_172720.1:n.2067_2069del",
        "NM_177438.3(DICER1):c.1719AGA[1] (p.Glu574del)"
      ],
      "hgvsSearch": "nm_177438.3:c.1719aga[1] nc_000014.9:g.95116486_95116488del cm000676.2:g.95116486_95116488del nc_000014.8:g.95582823_95582825del cm000676.1:g.95582823_95582825del nc_000014.7:g.94652576_94652578del ng_016311.1:g.45940_45942del lrg_492:g.45940_45942del enst00000529720.2:c.1722_1724del enst00000531162.7:c.1722_1724del enst00000674628.2:c.1722_1724del enst00000675540.2:c.1722_1724del enst00000696733.1:c.1722_1724del enst00000696734.1:c.1722_1724del enst00000696736.1:c.1722_1724del enst00000696737.1:c.1722_1724del enst00000696920.1:n.1985_1987del enst00000696921.1:n.2828_2830del enst00000696922.1:n.2131_2133del enst00000696923.1:c.1722_1724del enst00000696924.1:c.1722_1724del enst00000696925.1:n.2131_2133del enst00000696927.1:n.1317_1319del enst00000696928.1:n.1919_1921del enst00000343455.8:c.1722_1724del enst00000393063.6:c.1722_1724del enst00000526495.6:c.1722_1724del enst00000532939.3:c.1722_1724del enst00000556045.6:c.1722_1724del enst00000675995.1:c.*38_*40del enst00000343455.7:c.1722_1724del enst00000393063.5:c.1722_1724del enst00000526495.5:c.1722_1724del enst00000527414.5:c.1722_1724del enst00000532458.1:n.311_313del enst00000541352.5:c.1722_1724del nm_001195573.1:c.1722_1724del nm_001271282.2:c.1722_1724del nm_001291628.1:c.1722_1724del nm_030621.4:c.1722_1724del nm_177438.2:c.1722_1724del lrg_492t1:c.1722_1724del xm_011536599.1:c.1722_1724del xm_011536600.1:c.1722_1724del xm_011536601.1:c.1722_1724del xm_011536602.1:c.1722_1724del xm_011536603.1:c.1722_1724del xm_011536604.1:c.1317_1319del xm_011536605.1:c.243_245del xm_011536599.2:c.1722_1724del xm_011536600.3:c.1722_1724del xm_011536601.3:c.1722_1724del xm_011536602.3:c.1722_1724del xm_011536604.2:c.1317_1319del xm_011536605.2:c.243_245del xm_017021120.2:c.1722_1724del xm_017021121.2:c.1722_1724del xm_017021122.2:c.1317_1319del xm_017021123.2:c.1317_1319del nm_001271282.3:c.1722_1724del nm_001291628.2:c.1722_1724del nm_177438.3:c.1722_1724del nm_001395677.1:c.1722_1724del nm_001395678.1:c.1722_1724del nm_001395679.1:c.1722_1724del nm_001395680.1:c.1722_1724del nm_001395682.1:c.1722_1724del nm_001395683.1:c.1722_1724del nm_001395684.1:c.1722_1724del nm_001395685.1:c.1722_1724del nm_001395686.1:c.1440_1442del nm_001395687.1:c.1317_1319del nm_001395688.1:c.1317_1319del nm_001395689.1:c.1317_1319del nm_001395690.1:c.1317_1319del nm_001395691.1:c.1155_1157del nm_001395692.1:c.1722_1724del nm_001395693.1:c.1722_1724del nm_001395694.1:c.1722_1724del nm_001395695.1:c.1722_1724del nm_001395696.1:c.1317_1319del nm_001395697.1:c.39_41del nm_001395698.1:c.1317_1319del nr_172715.1:n.2140_2142del nr_172716.1:n.2067_2069del nr_172717.1:n.2234_2236del nr_172718.1:n.2234_2236del nr_172719.1:n.2067_2069del nr_172720.1:n.2067_2069del nm_177438.3(dicer1):c.1719aga[1] (p.glu574del)",
      "metCodes": [
        "PM2_Supporting",
        "PM4_Supporting"
      ],
      "metCodesSearch": "pm2_supporting pm4_supporting",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.1719AGA[1] (p.Glu574del)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.1719_1721del variant is predicted to cause a change in the length of the protein (p.Glu574del) due to an in-frame deletion of 1 amino acid in a non-repeat region outside of the RNase IIIb domain (p.D606-p.D609; p.E1418-p.E1420; p.E1422-p.E1425) (PM4_Supporting). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PM2_Supporting, PM4_Supporting. (VCEP specifications version 1.4.0) Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 2, which equates to a classification of VUS.",
      "unMetCodes": [
        "PM6",
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PM1",
        "PP1",
        "PP2",
        "PP3",
        "BS2",
        "PM3",
        "BS1",
        "BS3",
        "PM5",
        "BP2",
        "BA1"
      ],
      "unMetCodesSearch": "pm6 pvs1 ps1 ps2 ps3 ps4 pm1 pp1 pp2 pp3 bs2 pm3 bs1 bs3 pm5 bp2 ba1",
      "uuid": "51d564bf-3ca1-4093-a72c-b12859f185ad",
      "versionsList": [
        "2.1.0",
        "2.0.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000003979",
      "_id": "AlleleRecords/1573024421",
      "_key": "1573024421",
      "_rev": "_mbFTSxa---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA10583187",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "242130",
      "docVersion": "2.1.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.2:c.5107C>T",
        "NC_000014.9:g.95094145G>A",
        "CM000676.2:g.95094145G>A",
        "NC_000014.8:g.95560482G>A",
        "CM000676.1:g.95560482G>A",
        "NC_000014.7:g.94630235G>A",
        "NG_016311.1:g.68278C>T",
        "LRG_492:g.68278C>T",
        "ENST00000529720.2:c.5107C>T",
        "ENST00000531162.7:c.5107C>T",
        "ENST00000674628.2:c.5107C>T",
        "ENST00000675540.2:c.*1757C>T",
        "ENST00000696733.1:c.5107C>T",
        "ENST00000696734.1:c.5107C>T",
        "ENST00000696735.1:n.2094C>T",
        "ENST00000696736.1:c.5107C>T",
        "ENST00000696920.1:n.5370C>T",
        "ENST00000696921.1:n.6213C>T",
        "ENST00000696922.1:n.5516C>T",
        "ENST00000696923.1:c.5107C>T",
        "ENST00000696924.1:c.5107C>T",
        "ENST00000696925.1:n.5516C>T",
        "ENST00000343455.8:c.5107C>T",
        "ENST00000393063.6:c.5107C>T",
        "ENST00000526495.6:c.5107C>T",
        "ENST00000556045.6:c.5107C>T",
        "ENST00000675540.1:c.2852C>T",
        "ENST00000675995.1:c.*3423C>T",
        "ENST00000343455.7:c.5107C>T",
        "ENST00000393063.5:c.5107C>T",
        "ENST00000526495.5:c.5107C>T",
        "ENST00000527414.5:c.5107C>T",
        "ENST00000541352.5:c.5107C>T",
        "ENST00000556045.5:c.1801C>T",
        "NM_001195573.1:c.5107C>T",
        "NM_001271282.2:c.5107C>T",
        "NM_001291628.1:c.5107C>T",
        "NM_030621.4:c.5107C>T",
        "LRG_492t1:c.5107C>T",
        "XM_011536599.1:c.5107C>T",
        "XM_011536600.1:c.5107C>T",
        "XM_011536601.1:c.5107C>T",
        "XM_011536602.1:c.5107C>T",
        "XM_011536603.1:c.5107C>T",
        "XM_011536604.1:c.4702C>T",
        "XM_011536605.1:c.3628C>T",
        "XM_011536599.2:c.5107C>T",
        "XM_011536600.3:c.5107C>T",
        "XM_011536601.3:c.5107C>T",
        "XM_011536602.3:c.5107C>T",
        "XM_011536604.2:c.4702C>T",
        "XM_011536605.2:c.3628C>T",
        "XM_017021120.2:c.5107C>T",
        "XM_017021121.2:c.5107C>T",
        "XM_017021122.2:c.4702C>T",
        "XM_017021123.2:c.4702C>T",
        "NM_001271282.3:c.5107C>T",
        "NM_001291628.2:c.5107C>T",
        "NM_177438.3:c.5107C>T",
        "NM_001395677.1:c.5107C>T",
        "NM_001395678.1:c.5107C>T",
        "NM_001395679.1:c.5107C>T",
        "NM_001395680.1:c.5107C>T",
        "NM_001395682.1:c.5107C>T",
        "NM_001395683.1:c.5107C>T",
        "NM_001395684.1:c.5107C>T",
        "NM_001395685.1:c.5107C>T",
        "NM_001395686.1:c.4825C>T",
        "NM_001395687.1:c.4702C>T",
        "NM_001395688.1:c.4702C>T",
        "NM_001395689.1:c.4702C>T",
        "NM_001395690.1:c.4702C>T",
        "NM_001395691.1:c.4540C>T",
        "NM_001395697.1:c.3424C>T",
        "NR_172715.1:n.5525C>T",
        "NR_172716.1:n.5709C>T",
        "NR_172717.1:n.5619C>T",
        "NR_172718.1:n.5542C>T",
        "NR_172719.1:n.5375C>T",
        "NR_172720.1:n.5452C>T",
        "NM_177438.2(DICER1):c.5107C>T (p.Arg1703Cys)"
      ],
      "hgvsSearch": "nm_177438.2:c.5107c>t nc_000014.9:g.95094145g>a cm000676.2:g.95094145g>a nc_000014.8:g.95560482g>a cm000676.1:g.95560482g>a nc_000014.7:g.94630235g>a ng_016311.1:g.68278c>t lrg_492:g.68278c>t enst00000529720.2:c.5107c>t enst00000531162.7:c.5107c>t enst00000674628.2:c.5107c>t enst00000675540.2:c.*1757c>t enst00000696733.1:c.5107c>t enst00000696734.1:c.5107c>t enst00000696735.1:n.2094c>t enst00000696736.1:c.5107c>t enst00000696920.1:n.5370c>t enst00000696921.1:n.6213c>t enst00000696922.1:n.5516c>t enst00000696923.1:c.5107c>t enst00000696924.1:c.5107c>t enst00000696925.1:n.5516c>t enst00000343455.8:c.5107c>t enst00000393063.6:c.5107c>t enst00000526495.6:c.5107c>t enst00000556045.6:c.5107c>t enst00000675540.1:c.2852c>t enst00000675995.1:c.*3423c>t enst00000343455.7:c.5107c>t enst00000393063.5:c.5107c>t enst00000526495.5:c.5107c>t enst00000527414.5:c.5107c>t enst00000541352.5:c.5107c>t enst00000556045.5:c.1801c>t nm_001195573.1:c.5107c>t nm_001271282.2:c.5107c>t nm_001291628.1:c.5107c>t nm_030621.4:c.5107c>t lrg_492t1:c.5107c>t xm_011536599.1:c.5107c>t xm_011536600.1:c.5107c>t xm_011536601.1:c.5107c>t xm_011536602.1:c.5107c>t xm_011536603.1:c.5107c>t xm_011536604.1:c.4702c>t xm_011536605.1:c.3628c>t xm_011536599.2:c.5107c>t xm_011536600.3:c.5107c>t xm_011536601.3:c.5107c>t xm_011536602.3:c.5107c>t xm_011536604.2:c.4702c>t xm_011536605.2:c.3628c>t xm_017021120.2:c.5107c>t xm_017021121.2:c.5107c>t xm_017021122.2:c.4702c>t xm_017021123.2:c.4702c>t nm_001271282.3:c.5107c>t nm_001291628.2:c.5107c>t nm_177438.3:c.5107c>t nm_001395677.1:c.5107c>t nm_001395678.1:c.5107c>t nm_001395679.1:c.5107c>t nm_001395680.1:c.5107c>t nm_001395682.1:c.5107c>t nm_001395683.1:c.5107c>t nm_001395684.1:c.5107c>t nm_001395685.1:c.5107c>t nm_001395686.1:c.4825c>t nm_001395687.1:c.4702c>t nm_001395688.1:c.4702c>t nm_001395689.1:c.4702c>t nm_001395690.1:c.4702c>t nm_001395691.1:c.4540c>t nm_001395697.1:c.3424c>t nr_172715.1:n.5525c>t nr_172716.1:n.5709c>t nr_172717.1:n.5619c>t nr_172718.1:n.5542c>t nr_172719.1:n.5375c>t nr_172720.1:n.5452c>t nm_177438.2(dicer1):c.5107c>t (p.arg1703cys)",
      "metCodes": [
        "PM1_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm1_supporting pp3",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.2(DICER1):c.5107C>T (p.Arg1703Cys)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "NM_177438.2(DICER1):c.5107C>T variant in DICER1 is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 1703 (p.Arg1703Cys). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). The total allele frequency in gnomAD v4.1.0 is 0.000003098 (5/1614132 alleles) with a highest population minor allele frequency of 0.00002196 (2/91074 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met). This variant resides within the RNase IIIb mutational hotspot domain with critical functionality as defined by the ClinGen DICER1 VCEP (PM1_Supporting; PMID: 31342592). In silico tools predict damaging impact of the variant on protein function (REVEL: 0.916) (PP3). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PM1_Supporting, PP3. (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 2 which equates to a classification of variant of uncertain significance.",
      "unMetCodes": [
        "PM2",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PP1",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "PM5",
        "BP4",
        "BP2",
        "BA1"
      ],
      "unMetCodesSearch": "pm2 ps1 ps2 ps3 ps4 pp1 pp4 bs2 bs1 bs4 bs3 pm5 bp4 bp2 ba1",
      "uuid": "c327f58c-9a2c-4267-9b8b-346274bc72c7",
      "versionsList": [
        "2.1.0",
        "2.0.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000003985",
      "_id": "AlleleRecords/1573024445",
      "_key": "1573024445",
      "_rev": "_mbExfKO---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA10583232",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "242076",
      "docVersion": "2.1.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.2:c.2T>C",
        "NC_000014.9:g.95133457A>G",
        "CM000676.2:g.95133457A>G",
        "NC_000014.8:g.95599794A>G",
        "CM000676.1:g.95599794A>G",
        "NC_000014.7:g.94669547A>G",
        "NG_016311.1:g.28966T>C",
        "LRG_492:g.28966T>C",
        "ENST00000529720.2:c.2T>C",
        "ENST00000531162.7:c.2T>C",
        "ENST00000674628.2:c.2T>C",
        "ENST00000675540.2:c.2T>C",
        "ENST00000696733.1:c.2T>C",
        "ENST00000696734.1:c.2T>C",
        "ENST00000696736.1:c.2T>C",
        "ENST00000696737.1:c.2T>C",
        "ENST00000696739.1:n.450T>C",
        "ENST00000696740.1:c.2T>C",
        "ENST00000696921.1:n.233T>C",
        "ENST00000696922.1:n.411T>C",
        "ENST00000696923.1:c.2T>C",
        "ENST00000696924.1:c.2T>C",
        "ENST00000696925.1:n.411T>C",
        "ENST00000696928.1:n.199T>C",
        "ENST00000343455.8:c.2T>C",
        "ENST00000393063.6:c.2T>C",
        "ENST00000526495.6:c.2T>C",
        "ENST00000531162.6:c.2T>C",
        "ENST00000532939.3:c.2T>C",
        "ENST00000556045.6:c.2T>C",
        "ENST00000674628.1:c.2T>C",
        "ENST00000675995.1:c.2T>C",
        "ENST00000343455.7:c.2T>C",
        "ENST00000393063.5:c.2T>C",
        "ENST00000526495.5:c.2T>C",
        "ENST00000527414.5:c.2T>C",
        "ENST00000529206.1:n.143T>C",
        "ENST00000529720.1:c.2T>C",
        "ENST00000531162.5:c.2T>C",
        "ENST00000541352.5:c.2T>C",
        "NM_001195573.1:c.2T>C",
        "NM_001271282.2:c.2T>C",
        "NM_001291628.1:c.2T>C",
        "NM_030621.4:c.2T>C",
        "LRG_492t1:c.2T>C",
        "XM_011536599.1:c.2T>C",
        "XM_011536600.1:c.2T>C",
        "XM_011536601.1:c.2T>C",
        "XM_011536602.1:c.2T>C",
        "XM_011536603.1:c.2T>C",
        "XM_011536604.1:c.-273T>C",
        "XM_011536599.2:c.2T>C",
        "XM_011536600.3:c.2T>C",
        "XM_011536601.3:c.2T>C",
        "XM_011536602.3:c.2T>C",
        "XM_011536604.2:c.-273T>C",
        "XM_017021120.2:c.2T>C",
        "XM_017021121.2:c.2T>C",
        "XM_017021122.2:c.-273T>C",
        "XM_017021123.2:c.-273T>C",
        "NM_001271282.3:c.2T>C",
        "NM_001291628.2:c.2T>C",
        "NM_177438.3:c.2T>C",
        "NM_001395677.1:c.2T>C",
        "NM_001395678.1:c.2T>C",
        "NM_001395679.1:c.2T>C",
        "NM_001395680.1:c.2T>C",
        "NM_001395682.1:c.2T>C",
        "NM_001395683.1:c.2T>C",
        "NM_001395684.1:c.2T>C",
        "NM_001395685.1:c.2T>C",
        "NM_001395686.1:c.-273T>C",
        "NM_001395687.1:c.-130-780T>C",
        "NM_001395688.1:c.-273T>C",
        "NM_001395689.1:c.-273T>C",
        "NM_001395690.1:c.-273T>C",
        "NM_001395691.1:c.-457T>C",
        "NM_001395692.1:c.2T>C",
        "NM_001395693.1:c.2T>C",
        "NM_001395694.1:c.2T>C",
        "NM_001395695.1:c.2T>C",
        "NM_001395696.1:c.-273T>C",
        "NM_001395697.1:c.-1567T>C",
        "NM_001395698.1:c.-273T>C",
        "NM_001395699.1:c.2T>C",
        "NM_001395700.1:c.2T>C",
        "NR_172715.1:n.347T>C",
        "NR_172716.1:n.347T>C",
        "NR_172717.1:n.514T>C",
        "NR_172718.1:n.514T>C",
        "NR_172719.1:n.347T>C",
        "NR_172720.1:n.347T>C",
        "NM_177438.2(DICER1):c.2T>C (p.Met1Thr)"
      ],
      "hgvsSearch": "nm_177438.2:c.2t>c nc_000014.9:g.95133457a>g cm000676.2:g.95133457a>g nc_000014.8:g.95599794a>g cm000676.1:g.95599794a>g nc_000014.7:g.94669547a>g ng_016311.1:g.28966t>c lrg_492:g.28966t>c enst00000529720.2:c.2t>c enst00000531162.7:c.2t>c enst00000674628.2:c.2t>c enst00000675540.2:c.2t>c enst00000696733.1:c.2t>c enst00000696734.1:c.2t>c enst00000696736.1:c.2t>c enst00000696737.1:c.2t>c enst00000696739.1:n.450t>c enst00000696740.1:c.2t>c enst00000696921.1:n.233t>c enst00000696922.1:n.411t>c enst00000696923.1:c.2t>c enst00000696924.1:c.2t>c enst00000696925.1:n.411t>c enst00000696928.1:n.199t>c enst00000343455.8:c.2t>c enst00000393063.6:c.2t>c enst00000526495.6:c.2t>c enst00000531162.6:c.2t>c enst00000532939.3:c.2t>c enst00000556045.6:c.2t>c enst00000674628.1:c.2t>c enst00000675995.1:c.2t>c enst00000343455.7:c.2t>c enst00000393063.5:c.2t>c enst00000526495.5:c.2t>c enst00000527414.5:c.2t>c enst00000529206.1:n.143t>c enst00000529720.1:c.2t>c enst00000531162.5:c.2t>c enst00000541352.5:c.2t>c nm_001195573.1:c.2t>c nm_001271282.2:c.2t>c nm_001291628.1:c.2t>c nm_030621.4:c.2t>c lrg_492t1:c.2t>c xm_011536599.1:c.2t>c xm_011536600.1:c.2t>c xm_011536601.1:c.2t>c xm_011536602.1:c.2t>c xm_011536603.1:c.2t>c xm_011536604.1:c.-273t>c xm_011536599.2:c.2t>c xm_011536600.3:c.2t>c xm_011536601.3:c.2t>c xm_011536602.3:c.2t>c xm_011536604.2:c.-273t>c xm_017021120.2:c.2t>c xm_017021121.2:c.2t>c xm_017021122.2:c.-273t>c xm_017021123.2:c.-273t>c nm_001271282.3:c.2t>c nm_001291628.2:c.2t>c nm_177438.3:c.2t>c nm_001395677.1:c.2t>c nm_001395678.1:c.2t>c nm_001395679.1:c.2t>c nm_001395680.1:c.2t>c nm_001395682.1:c.2t>c nm_001395683.1:c.2t>c nm_001395684.1:c.2t>c nm_001395685.1:c.2t>c nm_001395686.1:c.-273t>c nm_001395687.1:c.-130-780t>c nm_001395688.1:c.-273t>c nm_001395689.1:c.-273t>c nm_001395690.1:c.-273t>c nm_001395691.1:c.-457t>c nm_001395692.1:c.2t>c nm_001395693.1:c.2t>c nm_001395694.1:c.2t>c nm_001395695.1:c.2t>c nm_001395696.1:c.-273t>c nm_001395697.1:c.-1567t>c nm_001395698.1:c.-273t>c nm_001395699.1:c.2t>c nm_001395700.1:c.2t>c nr_172715.1:n.347t>c nr_172716.1:n.347t>c nr_172717.1:n.514t>c nr_172718.1:n.514t>c nr_172719.1:n.347t>c nr_172720.1:n.347t>c nm_177438.2(dicer1):c.2t>c (p.met1thr)",
      "metCodes": [
        "BS2_Supporting"
      ],
      "metCodesSearch": "bs2_supporting",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.2(DICER1):c.2T>C (p.Met1Thr)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.2:c.2T>C (p.Met1Thr) variant in DICER1 is predicted to disrupt the translation start site (p.M1?),  but downstream start sites are known to exist (PVS1 not met). This variant has been seen in 10 or more unrelated females without tumors through age 50 in at least one testing laboratory (BS2_Supporting; Internal lab contributor). The total allele frequency in gnomAD v4.1.0 is 0.000004962 (8/1612216 alleles) with a highest population minor allele frequency of 0.000006785 (8/1179020 alleles) in European (non-Finnish) population (PM2_Supporting, BS1, and BA1 are not met). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BS2_Supporting (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = -1, which equates to a classification of VUS.",
      "unMetCodes": [
        "PM6",
        "PM2",
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PM1",
        "PP1",
        "PP2",
        "PP3",
        "PP4",
        "PM3",
        "BS1",
        "BS4",
        "BS3",
        "BP5",
        "BP7",
        "PM5",
        "BP4",
        "BP3",
        "BP1",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pm6 pm2 pvs1 ps1 ps2 ps3 ps4 pm1 pp1 pp2 pp3 pp4 pm3 bs1 bs4 bs3 bp5 bp7 pm5 bp4 bp3 bp1 bp2 ba1 pm4",
      "uuid": "58515022-c288-4fcb-b184-8cf685aea35f",
      "versionsList": [
        "2.1.0",
        "2.0.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004306",
      "_id": "AlleleRecords/1573025745",
      "_key": "1573025745",
      "_rev": "_mbE572e---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390864594",
      "classification": "Likely Pathogenic",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "429125",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.5465A>G",
        "NC_000014.9:g.95091265T>C",
        "CM000676.2:g.95091265T>C",
        "NC_000014.8:g.95557602T>C",
        "CM000676.1:g.95557602T>C",
        "NC_000014.7:g.94627355T>C",
        "NG_016311.1:g.71158A>G",
        "LRG_492:g.71158A>G",
        "ENST00000529720.2:c.5465A>G",
        "ENST00000531162.7:c.5465A>G",
        "ENST00000674628.2:c.5465A>G",
        "ENST00000675540.2:c.*2115A>G",
        "ENST00000696733.1:c.*87A>G",
        "ENST00000696734.1:c.*120A>G",
        "ENST00000696735.1:n.2452A>G",
        "ENST00000696736.1:c.5465A>G",
        "ENST00000696920.1:n.5728A>G",
        "ENST00000696921.1:n.6571A>G",
        "ENST00000696922.1:n.8396A>G",
        "ENST00000696923.1:c.*120A>G",
        "ENST00000696924.1:c.*87A>G",
        "ENST00000696925.1:n.8396A>G",
        "ENST00000343455.8:c.5465A>G",
        "ENST00000393063.6:c.5465A>G",
        "ENST00000526495.6:c.5465A>G",
        "ENST00000556045.6:c.*182A>G",
        "ENST00000675540.1:c.3210A>G",
        "ENST00000675995.1:c.*3781A>G",
        "ENST00000343455.7:c.5465A>G",
        "ENST00000393063.5:c.5465A>G",
        "ENST00000526495.5:c.5465A>G",
        "ENST00000527414.5:c.5465A>G",
        "ENST00000527416.2:n.58A>G",
        "ENST00000527554.2:n.158A>G",
        "ENST00000541352.5:c.5365-156A>G",
        "ENST00000556045.5:c.2159A>G",
        "NM_001195573.1:c.5365-156A>G",
        "NM_001271282.2:c.5465A>G",
        "NM_001291628.1:c.5465A>G",
        "NM_030621.4:c.5465A>G",
        "NM_177438.2:c.5465A>G",
        "LRG_492t1:c.5465A>G",
        "XM_011536599.1:c.5465A>G",
        "XM_011536600.1:c.5465A>G",
        "XM_011536601.1:c.5465A>G",
        "XM_011536602.1:c.5465A>G",
        "XM_011536603.1:c.5465A>G",
        "XM_011536604.1:c.5060A>G",
        "XM_011536605.1:c.3986A>G",
        "XM_011536599.2:c.5465A>G",
        "XM_011536600.3:c.5465A>G",
        "XM_011536601.3:c.5465A>G",
        "XM_011536602.3:c.5465A>G",
        "XM_011536604.2:c.5060A>G",
        "XM_011536605.2:c.3986A>G",
        "XM_017021120.2:c.5465A>G",
        "XM_017021121.2:c.5465A>G",
        "XM_017021122.2:c.5060A>G",
        "XM_017021123.2:c.5060A>G",
        "NM_001271282.3:c.5465A>G",
        "NM_001291628.2:c.5465A>G",
        "NM_001395677.1:c.5465A>G",
        "NM_001395678.1:c.5465A>G",
        "NM_001395679.1:c.5465A>G",
        "NM_001395680.1:c.5465A>G",
        "NM_001395682.1:c.5465A>G",
        "NM_001395683.1:c.5465A>G",
        "NM_001395684.1:c.5465A>G",
        "NM_001395685.1:c.5465A>G",
        "NM_001395686.1:c.5183A>G",
        "NM_001395687.1:c.5060A>G",
        "NM_001395688.1:c.5060A>G",
        "NM_001395689.1:c.5060A>G",
        "NM_001395690.1:c.5060A>G",
        "NM_001395691.1:c.4898A>G",
        "NM_001395697.1:c.3782A>G",
        "NR_172715.1:n.5883A>G",
        "NR_172716.1:n.6067A>G",
        "NR_172717.1:n.5977A>G",
        "NR_172718.1:n.5900A>G",
        "NR_172719.1:n.5733A>G",
        "NR_172720.1:n.5936A>G",
        "NM_177438.3(DICER1):c.5465A>G (p.Asp1822Gly)"
      ],
      "hgvsSearch": "nm_177438.3:c.5465a>g nc_000014.9:g.95091265t>c cm000676.2:g.95091265t>c nc_000014.8:g.95557602t>c cm000676.1:g.95557602t>c nc_000014.7:g.94627355t>c ng_016311.1:g.71158a>g lrg_492:g.71158a>g enst00000529720.2:c.5465a>g enst00000531162.7:c.5465a>g enst00000674628.2:c.5465a>g enst00000675540.2:c.*2115a>g enst00000696733.1:c.*87a>g enst00000696734.1:c.*120a>g enst00000696735.1:n.2452a>g enst00000696736.1:c.5465a>g enst00000696920.1:n.5728a>g enst00000696921.1:n.6571a>g enst00000696922.1:n.8396a>g enst00000696923.1:c.*120a>g enst00000696924.1:c.*87a>g enst00000696925.1:n.8396a>g enst00000343455.8:c.5465a>g enst00000393063.6:c.5465a>g enst00000526495.6:c.5465a>g enst00000556045.6:c.*182a>g enst00000675540.1:c.3210a>g enst00000675995.1:c.*3781a>g enst00000343455.7:c.5465a>g enst00000393063.5:c.5465a>g enst00000526495.5:c.5465a>g enst00000527414.5:c.5465a>g enst00000527416.2:n.58a>g enst00000527554.2:n.158a>g enst00000541352.5:c.5365-156a>g enst00000556045.5:c.2159a>g nm_001195573.1:c.5365-156a>g nm_001271282.2:c.5465a>g nm_001291628.1:c.5465a>g nm_030621.4:c.5465a>g nm_177438.2:c.5465a>g lrg_492t1:c.5465a>g xm_011536599.1:c.5465a>g xm_011536600.1:c.5465a>g xm_011536601.1:c.5465a>g xm_011536602.1:c.5465a>g xm_011536603.1:c.5465a>g xm_011536604.1:c.5060a>g xm_011536605.1:c.3986a>g xm_011536599.2:c.5465a>g xm_011536600.3:c.5465a>g xm_011536601.3:c.5465a>g xm_011536602.3:c.5465a>g xm_011536604.2:c.5060a>g xm_011536605.2:c.3986a>g xm_017021120.2:c.5465a>g xm_017021121.2:c.5465a>g xm_017021122.2:c.5060a>g xm_017021123.2:c.5060a>g nm_001271282.3:c.5465a>g nm_001291628.2:c.5465a>g nm_001395677.1:c.5465a>g nm_001395678.1:c.5465a>g nm_001395679.1:c.5465a>g nm_001395680.1:c.5465a>g nm_001395682.1:c.5465a>g nm_001395683.1:c.5465a>g nm_001395684.1:c.5465a>g nm_001395685.1:c.5465a>g nm_001395686.1:c.5183a>g nm_001395687.1:c.5060a>g nm_001395688.1:c.5060a>g nm_001395689.1:c.5060a>g nm_001395690.1:c.5060a>g nm_001395691.1:c.4898a>g nm_001395697.1:c.3782a>g nr_172715.1:n.5883a>g nr_172716.1:n.6067a>g nr_172717.1:n.5977a>g nr_172718.1:n.5900a>g nr_172719.1:n.5733a>g nr_172720.1:n.5936a>g nm_177438.3(dicer1):c.5465a>g (p.asp1822gly)",
      "metCodes": [
        "PM2_Supporting",
        "PM1_Supporting",
        "PS4_Moderate",
        "PP1",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pm1_supporting ps4_moderate pp1 pp3",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.5465A>G (p.Asp1822Gly)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.5465A>G variant in DICER1 is a missense variant predicted to cause substitution of aspartic acid by glycine at amino acid 1822 (p.Asp1822Gly). This variant received a total of 2 phenotype points across 2 unrelated probands meeting DICER1 VCEP phenotype specificity scoring criteria of 2-3.5 points (PS4_Moderate; Internal lab contributor). The variant has been reported to segregate with Sertoli Leydig cell tumors, PPB, and lung cysts in 4 meioses from 2 families (PP1; Internal lab contributor). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). In silico tools predict damaging impact of the variant on protein function (REVEL: 0.956) (PP3). This variant resides within the RNase IIIb mutational hotspot domain with critical functionality as defined by the ClinGen DICER1 VCEP (PM1_Supporting; PMID: 31342592). In summary, this variant meets the criteria to be classified as Likely Pathogenic for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PS4_Moderate, PP1, PM2_Supporting, PP3, PM1_Supporting (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330) and total points = 6, equating to a classification of Likely Pathogenic.",
      "unMetCodes": [
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "BP7",
        "PM5",
        "BP4",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pvs1 ps1 ps2 ps3 pp4 bs2 bs1 bs4 bs3 bp7 pm5 bp4 bp2 ba1 pm4",
      "uuid": "85a9bd30-cffd-49d0-bdc3-ddca494a51fc",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004309",
      "_id": "AlleleRecords/1573025757",
      "_key": "1573025757",
      "_rev": "_mbF1HF6---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390867511",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "1722522",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.4691A>G",
        "NC_000014.9:g.95096229T>C",
        "CM000676.2:g.95096229T>C",
        "NC_000014.8:g.95562566T>C",
        "CM000676.1:g.95562566T>C",
        "NC_000014.7:g.94632319T>C",
        "NG_016311.1:g.66194A>G",
        "LRG_492:g.66194A>G",
        "ENST00000529720.2:c.4691A>G",
        "ENST00000531162.7:c.4691A>G",
        "ENST00000674628.2:c.4691A>G",
        "ENST00000675540.2:c.*1341A>G",
        "ENST00000696733.1:c.4691A>G",
        "ENST00000696734.1:c.4691A>G",
        "ENST00000696735.1:n.1678A>G",
        "ENST00000696736.1:c.4691A>G",
        "ENST00000696737.1:c.4691A>G",
        "ENST00000696920.1:n.4954A>G",
        "ENST00000696921.1:n.5797A>G",
        "ENST00000696922.1:n.5100A>G",
        "ENST00000696923.1:c.4691A>G",
        "ENST00000696924.1:c.4691A>G",
        "ENST00000696925.1:n.5100A>G",
        "ENST00000343455.8:c.4691A>G",
        "ENST00000393063.6:c.4691A>G",
        "ENST00000526495.6:c.4691A>G",
        "ENST00000532939.3:c.4691A>G",
        "ENST00000556045.6:c.4691A>G",
        "ENST00000675540.1:c.2436A>G",
        "ENST00000675995.1:c.*3007A>G",
        "ENST00000343455.7:c.4691A>G",
        "ENST00000393063.5:c.4691A>G",
        "ENST00000526495.5:c.4691A>G",
        "ENST00000527414.5:c.4691A>G",
        "ENST00000532939.2:c.726A>G",
        "ENST00000541352.5:c.4691A>G",
        "ENST00000556045.5:c.1385A>G",
        "NM_001195573.1:c.4691A>G",
        "NM_001271282.2:c.4691A>G",
        "NM_001291628.1:c.4691A>G",
        "NM_030621.4:c.4691A>G",
        "NM_177438.2:c.4691A>G",
        "LRG_492t1:c.4691A>G",
        "XM_011536599.1:c.4691A>G",
        "XM_011536600.1:c.4691A>G",
        "XM_011536601.1:c.4691A>G",
        "XM_011536602.1:c.4691A>G",
        "XM_011536603.1:c.4691A>G",
        "XM_011536604.1:c.4286A>G",
        "XM_011536605.1:c.3212A>G",
        "XM_011536599.2:c.4691A>G",
        "XM_011536600.3:c.4691A>G",
        "XM_011536601.3:c.4691A>G",
        "XM_011536602.3:c.4691A>G",
        "XM_011536604.2:c.4286A>G",
        "XM_011536605.2:c.3212A>G",
        "XM_017021120.2:c.4691A>G",
        "XM_017021121.2:c.4691A>G",
        "XM_017021122.2:c.4286A>G",
        "XM_017021123.2:c.4286A>G",
        "NM_001271282.3:c.4691A>G",
        "NM_001291628.2:c.4691A>G",
        "NM_001395677.1:c.4691A>G",
        "NM_001395678.1:c.4691A>G",
        "NM_001395679.1:c.4691A>G",
        "NM_001395680.1:c.4691A>G",
        "NM_001395682.1:c.4691A>G",
        "NM_001395683.1:c.4691A>G",
        "NM_001395684.1:c.4691A>G",
        "NM_001395685.1:c.4691A>G",
        "NM_001395686.1:c.4409A>G",
        "NM_001395687.1:c.4286A>G",
        "NM_001395688.1:c.4286A>G",
        "NM_001395689.1:c.4286A>G",
        "NM_001395690.1:c.4286A>G",
        "NM_001395691.1:c.4124A>G",
        "NM_001395692.1:c.4691A>G",
        "NM_001395693.1:c.4691A>G",
        "NM_001395694.1:c.4691A>G",
        "NM_001395695.1:c.4691A>G",
        "NM_001395696.1:c.4286A>G",
        "NM_001395697.1:c.3008A>G",
        "NR_172715.1:n.5109A>G",
        "NR_172716.1:n.5293A>G",
        "NR_172717.1:n.5203A>G",
        "NR_172718.1:n.5126A>G",
        "NR_172719.1:n.4959A>G",
        "NR_172720.1:n.5036A>G",
        "NM_177438.3(DICER1):c.4691A>G (p.Glu1564Gly)"
      ],
      "hgvsSearch": "nm_177438.3:c.4691a>g nc_000014.9:g.95096229t>c cm000676.2:g.95096229t>c nc_000014.8:g.95562566t>c cm000676.1:g.95562566t>c nc_000014.7:g.94632319t>c ng_016311.1:g.66194a>g lrg_492:g.66194a>g enst00000529720.2:c.4691a>g enst00000531162.7:c.4691a>g enst00000674628.2:c.4691a>g enst00000675540.2:c.*1341a>g enst00000696733.1:c.4691a>g enst00000696734.1:c.4691a>g enst00000696735.1:n.1678a>g enst00000696736.1:c.4691a>g enst00000696737.1:c.4691a>g enst00000696920.1:n.4954a>g enst00000696921.1:n.5797a>g enst00000696922.1:n.5100a>g enst00000696923.1:c.4691a>g enst00000696924.1:c.4691a>g enst00000696925.1:n.5100a>g enst00000343455.8:c.4691a>g enst00000393063.6:c.4691a>g enst00000526495.6:c.4691a>g enst00000532939.3:c.4691a>g enst00000556045.6:c.4691a>g enst00000675540.1:c.2436a>g enst00000675995.1:c.*3007a>g enst00000343455.7:c.4691a>g enst00000393063.5:c.4691a>g enst00000526495.5:c.4691a>g enst00000527414.5:c.4691a>g enst00000532939.2:c.726a>g enst00000541352.5:c.4691a>g enst00000556045.5:c.1385a>g nm_001195573.1:c.4691a>g nm_001271282.2:c.4691a>g nm_001291628.1:c.4691a>g nm_030621.4:c.4691a>g nm_177438.2:c.4691a>g lrg_492t1:c.4691a>g xm_011536599.1:c.4691a>g xm_011536600.1:c.4691a>g xm_011536601.1:c.4691a>g xm_011536602.1:c.4691a>g xm_011536603.1:c.4691a>g xm_011536604.1:c.4286a>g xm_011536605.1:c.3212a>g xm_011536599.2:c.4691a>g xm_011536600.3:c.4691a>g xm_011536601.3:c.4691a>g xm_011536602.3:c.4691a>g xm_011536604.2:c.4286a>g xm_011536605.2:c.3212a>g xm_017021120.2:c.4691a>g xm_017021121.2:c.4691a>g xm_017021122.2:c.4286a>g xm_017021123.2:c.4286a>g nm_001271282.3:c.4691a>g nm_001291628.2:c.4691a>g nm_001395677.1:c.4691a>g nm_001395678.1:c.4691a>g nm_001395679.1:c.4691a>g nm_001395680.1:c.4691a>g nm_001395682.1:c.4691a>g nm_001395683.1:c.4691a>g nm_001395684.1:c.4691a>g nm_001395685.1:c.4691a>g nm_001395686.1:c.4409a>g nm_001395687.1:c.4286a>g nm_001395688.1:c.4286a>g nm_001395689.1:c.4286a>g nm_001395690.1:c.4286a>g nm_001395691.1:c.4124a>g nm_001395692.1:c.4691a>g nm_001395693.1:c.4691a>g nm_001395694.1:c.4691a>g nm_001395695.1:c.4691a>g nm_001395696.1:c.4286a>g nm_001395697.1:c.3008a>g nr_172715.1:n.5109a>g nr_172716.1:n.5293a>g nr_172717.1:n.5203a>g nr_172718.1:n.5126a>g nr_172719.1:n.4959a>g nr_172720.1:n.5036a>g nm_177438.3(dicer1):c.4691a>g (p.glu1564gly)",
      "metCodes": [
        "PM2_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pp3",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.4691A>G (p.Glu1564Gly)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.2:c.4691A>G variant in DICER1 is a missense variant predicted to cause substitution of Glutamic Acid by Glycine at amino acid 1564 (p.Glu1564Gly). Although this variant has been observed in at least one individual with neurodevelopmental phenotype, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In silico tools predict damaging impact of the variant on protein function (REVEL: 0.937) (PP3). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PP3, PM2_Supporting. (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 2, which equates to a classification of VUS.",
      "unMetCodes": [
        "PM6",
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PM1",
        "PP1",
        "PP2",
        "PP4",
        "BS2",
        "PM3",
        "BS1",
        "BS4",
        "BS3",
        "BP5",
        "BP7",
        "PM5",
        "BP4",
        "BP3",
        "BP1",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pm6 pvs1 ps1 ps2 ps3 ps4 pm1 pp1 pp2 pp4 bs2 pm3 bs1 bs4 bs3 bp5 bp7 pm5 bp4 bp3 bp1 bp2 ba1 pm4",
      "uuid": "4a63dee0-8e0e-409f-94e3-a2ede631daf8",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004310",
      "_id": "AlleleRecords/1573025761",
      "_key": "1573025761",
      "_rev": "_mbF9kT2---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390863032",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "825925",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.5729G>A",
        "NC_000014.9:g.95090538C>T",
        "CM000676.2:g.95090538C>T",
        "NC_000014.8:g.95556875C>T",
        "CM000676.1:g.95556875C>T",
        "NC_000014.7:g.94626628C>T",
        "NG_016311.1:g.71885G>A",
        "LRG_492:g.71885G>A",
        "ENST00000529720.2:c.5729G>A",
        "ENST00000531162.7:c.5729G>A",
        "ENST00000674628.2:c.5729G>A",
        "ENST00000675540.2:c.*2379G>A",
        "ENST00000696733.1:c.*351G>A",
        "ENST00000696734.1:c.*384G>A",
        "ENST00000696735.1:n.2716G>A",
        "ENST00000696736.1:c.*492G>A",
        "ENST00000696920.1:n.5992G>A",
        "ENST00000696921.1:n.6835G>A",
        "ENST00000696922.1:n.8660G>A",
        "ENST00000696923.1:c.*384G>A",
        "ENST00000696924.1:c.*351G>A",
        "ENST00000696925.1:n.9030G>A",
        "ENST00000343455.8:c.5729G>A",
        "ENST00000393063.6:c.5729G>A",
        "ENST00000526495.6:c.5729G>A",
        "ENST00000556045.6:c.*446G>A",
        "ENST00000675540.1:c.3474G>A",
        "ENST00000675995.1:c.*4045G>A",
        "ENST00000343455.7:c.5729G>A",
        "ENST00000393063.5:c.5729G>A",
        "ENST00000526495.5:c.5729G>A",
        "ENST00000527414.5:c.5729G>A",
        "ENST00000527416.2:n.322G>A",
        "ENST00000541352.5:c.*76G>A",
        "ENST00000556045.5:c.2423G>A",
        "NM_001195573.1:c.*76G>A",
        "NM_001271282.2:c.5729G>A",
        "NM_001291628.1:c.5729G>A",
        "NM_030621.4:c.5729G>A",
        "NM_177438.2:c.5729G>A",
        "LRG_492t1:c.5729G>A",
        "XM_011536599.1:c.5729G>A",
        "XM_011536600.1:c.5729G>A",
        "XM_011536601.1:c.5729G>A",
        "XM_011536602.1:c.5729G>A",
        "XM_011536603.1:c.5729G>A",
        "XM_011536604.1:c.5324G>A",
        "XM_011536605.1:c.4250G>A",
        "XM_011536599.2:c.5729G>A",
        "XM_011536600.3:c.5729G>A",
        "XM_011536601.3:c.5729G>A",
        "XM_011536602.3:c.5729G>A",
        "XM_011536604.2:c.5324G>A",
        "XM_011536605.2:c.4250G>A",
        "XM_017021120.2:c.5729G>A",
        "XM_017021121.2:c.5729G>A",
        "XM_017021122.2:c.5324G>A",
        "XM_017021123.2:c.5324G>A",
        "NM_001271282.3:c.5729G>A",
        "NM_001291628.2:c.5729G>A",
        "NM_001395677.1:c.5729G>A",
        "NM_001395678.1:c.5729G>A",
        "NM_001395679.1:c.5729G>A",
        "NM_001395680.1:c.5729G>A",
        "NM_001395682.1:c.5729G>A",
        "NM_001395683.1:c.5729G>A",
        "NM_001395684.1:c.5729G>A",
        "NM_001395685.1:c.*275G>A",
        "NM_001395686.1:c.5447G>A",
        "NM_001395687.1:c.5324G>A",
        "NM_001395688.1:c.5324G>A",
        "NM_001395689.1:c.5324G>A",
        "NM_001395690.1:c.5324G>A",
        "NM_001395691.1:c.5162G>A",
        "NM_001395697.1:c.4046G>A",
        "NR_172715.1:n.6147G>A",
        "NR_172716.1:n.6331G>A",
        "NR_172717.1:n.6241G>A",
        "NR_172718.1:n.6164G>A",
        "NR_172719.1:n.5997G>A",
        "NR_172720.1:n.6200G>A",
        "NM_177438.3(DICER1):c.5729G>A (p.Arg1910Gln)"
      ],
      "hgvsSearch": "nm_177438.3:c.5729g>a nc_000014.9:g.95090538c>t cm000676.2:g.95090538c>t nc_000014.8:g.95556875c>t cm000676.1:g.95556875c>t nc_000014.7:g.94626628c>t ng_016311.1:g.71885g>a lrg_492:g.71885g>a enst00000529720.2:c.5729g>a enst00000531162.7:c.5729g>a enst00000674628.2:c.5729g>a enst00000675540.2:c.*2379g>a enst00000696733.1:c.*351g>a enst00000696734.1:c.*384g>a enst00000696735.1:n.2716g>a enst00000696736.1:c.*492g>a enst00000696920.1:n.5992g>a enst00000696921.1:n.6835g>a enst00000696922.1:n.8660g>a enst00000696923.1:c.*384g>a enst00000696924.1:c.*351g>a enst00000696925.1:n.9030g>a enst00000343455.8:c.5729g>a enst00000393063.6:c.5729g>a enst00000526495.6:c.5729g>a enst00000556045.6:c.*446g>a enst00000675540.1:c.3474g>a enst00000675995.1:c.*4045g>a enst00000343455.7:c.5729g>a enst00000393063.5:c.5729g>a enst00000526495.5:c.5729g>a enst00000527414.5:c.5729g>a enst00000527416.2:n.322g>a enst00000541352.5:c.*76g>a enst00000556045.5:c.2423g>a nm_001195573.1:c.*76g>a nm_001271282.2:c.5729g>a nm_001291628.1:c.5729g>a nm_030621.4:c.5729g>a nm_177438.2:c.5729g>a lrg_492t1:c.5729g>a xm_011536599.1:c.5729g>a xm_011536600.1:c.5729g>a xm_011536601.1:c.5729g>a xm_011536602.1:c.5729g>a xm_011536603.1:c.5729g>a xm_011536604.1:c.5324g>a xm_011536605.1:c.4250g>a xm_011536599.2:c.5729g>a xm_011536600.3:c.5729g>a xm_011536601.3:c.5729g>a xm_011536602.3:c.5729g>a xm_011536604.2:c.5324g>a xm_011536605.2:c.4250g>a xm_017021120.2:c.5729g>a xm_017021121.2:c.5729g>a xm_017021122.2:c.5324g>a xm_017021123.2:c.5324g>a nm_001271282.3:c.5729g>a nm_001291628.2:c.5729g>a nm_001395677.1:c.5729g>a nm_001395678.1:c.5729g>a nm_001395679.1:c.5729g>a nm_001395680.1:c.5729g>a nm_001395682.1:c.5729g>a nm_001395683.1:c.5729g>a nm_001395684.1:c.5729g>a nm_001395685.1:c.*275g>a nm_001395686.1:c.5447g>a nm_001395687.1:c.5324g>a nm_001395688.1:c.5324g>a nm_001395689.1:c.5324g>a nm_001395690.1:c.5324g>a nm_001395691.1:c.5162g>a nm_001395697.1:c.4046g>a nr_172715.1:n.6147g>a nr_172716.1:n.6331g>a nr_172717.1:n.6241g>a nr_172718.1:n.6164g>a nr_172719.1:n.5997g>a nr_172720.1:n.6200g>a nm_177438.3(dicer1):c.5729g>a (p.arg1910gln)",
      "metCodes": [
        "PM2_Supporting",
        "BP4"
      ],
      "metCodesSearch": "pm2_supporting bp4",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.5729G>A (p.Arg1910Gln)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.5729G>A variant in DICER1 is a missense variant predicted to replace arginine with glutamine at codon 1910 (p.Arg1910Gln). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). This variant has an allele frequency of 6.196e-7 (1/1614038 alleles) across gnomAD v4.1.1 with no more than one allele in any subpopulation, which is lower than the ClinGen DICER1 VCEP threshold (<0.000005) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.29, which is below the threshold of 0.500, and the splice site predictors SpliceAI and MaxEntScan indicated that the variant has no impact on splicing, evidence that does not predict a damaging effect on DICER1 function (BP4). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PM2_Supporting, BP4. (VCEP specifications version 1.4.0) Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 0, which equates to a classification of Uncertain Significance.",
      "unMetCodes": [
        "PM6",
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PM1",
        "PP1",
        "PP3",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "BP7",
        "PM5",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pm6 pvs1 ps1 ps2 ps3 ps4 pm1 pp1 pp3 pp4 bs2 bs1 bs4 bs3 bp7 pm5 bp2 ba1 pm4",
      "uuid": "b499c2a0-98c0-4af5-ac6f-f993a7c3d9cc",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004311",
      "_id": "AlleleRecords/1573025765",
      "_key": "1573025765",
      "_rev": "_mbGGCJS---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390863446",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "653922",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.5656G>A",
        "NC_000014.9:g.95090611C>T",
        "CM000676.2:g.95090611C>T",
        "NC_000014.8:g.95556948C>T",
        "CM000676.1:g.95556948C>T",
        "NC_000014.7:g.94626701C>T",
        "NG_016311.1:g.71812G>A",
        "LRG_492:g.71812G>A",
        "ENST00000529720.2:c.5656G>A",
        "ENST00000531162.7:c.5656G>A",
        "ENST00000674628.2:c.5656G>A",
        "ENST00000675540.2:c.*2306G>A",
        "ENST00000696733.1:c.*278G>A",
        "ENST00000696734.1:c.*311G>A",
        "ENST00000696735.1:n.2643G>A",
        "ENST00000696736.1:c.*419G>A",
        "ENST00000696920.1:n.5919G>A",
        "ENST00000696921.1:n.6762G>A",
        "ENST00000696922.1:n.8587G>A",
        "ENST00000696923.1:c.*311G>A",
        "ENST00000696924.1:c.*278G>A",
        "ENST00000696925.1:n.8957G>A",
        "ENST00000343455.8:c.5656G>A",
        "ENST00000393063.6:c.5656G>A",
        "ENST00000526495.6:c.5656G>A",
        "ENST00000556045.6:c.*373G>A",
        "ENST00000675540.1:c.3401G>A",
        "ENST00000675995.1:c.*3972G>A",
        "ENST00000343455.7:c.5656G>A",
        "ENST00000393063.5:c.5656G>A",
        "ENST00000526495.5:c.5656G>A",
        "ENST00000527414.5:c.5656G>A",
        "ENST00000527416.2:n.249G>A",
        "ENST00000541352.5:c.*3G>A",
        "ENST00000556045.5:c.2350G>A",
        "NM_001195573.1:c.*3G>A",
        "NM_001271282.2:c.5656G>A",
        "NM_001291628.1:c.5656G>A",
        "NM_030621.4:c.5656G>A",
        "NM_177438.2:c.5656G>A",
        "LRG_492t1:c.5656G>A",
        "XM_011536599.1:c.5656G>A",
        "XM_011536600.1:c.5656G>A",
        "XM_011536601.1:c.5656G>A",
        "XM_011536602.1:c.5656G>A",
        "XM_011536603.1:c.5656G>A",
        "XM_011536604.1:c.5251G>A",
        "XM_011536605.1:c.4177G>A",
        "XM_011536599.2:c.5656G>A",
        "XM_011536600.3:c.5656G>A",
        "XM_011536601.3:c.5656G>A",
        "XM_011536602.3:c.5656G>A",
        "XM_011536604.2:c.5251G>A",
        "XM_011536605.2:c.4177G>A",
        "XM_017021120.2:c.5656G>A",
        "XM_017021121.2:c.5656G>A",
        "XM_017021122.2:c.5251G>A",
        "XM_017021123.2:c.5251G>A",
        "NM_001271282.3:c.5656G>A",
        "NM_001291628.2:c.5656G>A",
        "NM_001395677.1:c.5656G>A",
        "NM_001395678.1:c.5656G>A",
        "NM_001395679.1:c.5656G>A",
        "NM_001395680.1:c.5656G>A",
        "NM_001395682.1:c.5656G>A",
        "NM_001395683.1:c.5656G>A",
        "NM_001395684.1:c.5656G>A",
        "NM_001395685.1:c.*202G>A",
        "NM_001395686.1:c.5374G>A",
        "NM_001395687.1:c.5251G>A",
        "NM_001395688.1:c.5251G>A",
        "NM_001395689.1:c.5251G>A",
        "NM_001395690.1:c.5251G>A",
        "NM_001395691.1:c.5089G>A",
        "NM_001395697.1:c.3973G>A",
        "NR_172715.1:n.6074G>A",
        "NR_172716.1:n.6258G>A",
        "NR_172717.1:n.6168G>A",
        "NR_172718.1:n.6091G>A",
        "NR_172719.1:n.5924G>A",
        "NR_172720.1:n.6127G>A",
        "NM_177438.3(DICER1):c.5656G>A (p.Gly1886Arg)"
      ],
      "hgvsSearch": "nm_177438.3:c.5656g>a nc_000014.9:g.95090611c>t cm000676.2:g.95090611c>t nc_000014.8:g.95556948c>t cm000676.1:g.95556948c>t nc_000014.7:g.94626701c>t ng_016311.1:g.71812g>a lrg_492:g.71812g>a enst00000529720.2:c.5656g>a enst00000531162.7:c.5656g>a enst00000674628.2:c.5656g>a enst00000675540.2:c.*2306g>a enst00000696733.1:c.*278g>a enst00000696734.1:c.*311g>a enst00000696735.1:n.2643g>a enst00000696736.1:c.*419g>a enst00000696920.1:n.5919g>a enst00000696921.1:n.6762g>a enst00000696922.1:n.8587g>a enst00000696923.1:c.*311g>a enst00000696924.1:c.*278g>a enst00000696925.1:n.8957g>a enst00000343455.8:c.5656g>a enst00000393063.6:c.5656g>a enst00000526495.6:c.5656g>a enst00000556045.6:c.*373g>a enst00000675540.1:c.3401g>a enst00000675995.1:c.*3972g>a enst00000343455.7:c.5656g>a enst00000393063.5:c.5656g>a enst00000526495.5:c.5656g>a enst00000527414.5:c.5656g>a enst00000527416.2:n.249g>a enst00000541352.5:c.*3g>a enst00000556045.5:c.2350g>a nm_001195573.1:c.*3g>a nm_001271282.2:c.5656g>a nm_001291628.1:c.5656g>a nm_030621.4:c.5656g>a nm_177438.2:c.5656g>a lrg_492t1:c.5656g>a xm_011536599.1:c.5656g>a xm_011536600.1:c.5656g>a xm_011536601.1:c.5656g>a xm_011536602.1:c.5656g>a xm_011536603.1:c.5656g>a xm_011536604.1:c.5251g>a xm_011536605.1:c.4177g>a xm_011536599.2:c.5656g>a xm_011536600.3:c.5656g>a xm_011536601.3:c.5656g>a xm_011536602.3:c.5656g>a xm_011536604.2:c.5251g>a xm_011536605.2:c.4177g>a xm_017021120.2:c.5656g>a xm_017021121.2:c.5656g>a xm_017021122.2:c.5251g>a xm_017021123.2:c.5251g>a nm_001271282.3:c.5656g>a nm_001291628.2:c.5656g>a nm_001395677.1:c.5656g>a nm_001395678.1:c.5656g>a nm_001395679.1:c.5656g>a nm_001395680.1:c.5656g>a nm_001395682.1:c.5656g>a nm_001395683.1:c.5656g>a nm_001395684.1:c.5656g>a nm_001395685.1:c.*202g>a nm_001395686.1:c.5374g>a nm_001395687.1:c.5251g>a nm_001395688.1:c.5251g>a nm_001395689.1:c.5251g>a nm_001395690.1:c.5251g>a nm_001395691.1:c.5089g>a nm_001395697.1:c.3973g>a nr_172715.1:n.6074g>a nr_172716.1:n.6258g>a nr_172717.1:n.6168g>a nr_172718.1:n.6091g>a nr_172719.1:n.5924g>a nr_172720.1:n.6127g>a nm_177438.3(dicer1):c.5656g>a (p.gly1886arg)",
      "metCodes": [
        "PM2_Supporting"
      ],
      "metCodesSearch": "pm2_supporting",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.5656G>A (p.Gly1886Arg)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.5656G>A variant in DICER1 is a missense variant predicted to cause substitution of glycine by arginine at amino acid 1886. This variant has an allele frequency of 0.000000847 (1/1180038 alleles) across gnomAD v4.1.1 with no more than one allele in any subpopulation, which is lower than the ClinGen DICER1 VCEP threshold (<0.000005) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.572 which is neither above nor below the thresholds predicting a damaging or benign impact on DICER1 function (PP3 and BP4 not met). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; PMIDs, ClinVar GTRs, Internal lab contributors). In summary, this variant meets the criteria to be classified as a Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 and miRNA-Processing Gene VCEP: PM2_Supporting (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 1, which equates to a classification of Uncertain Significance.",
      "unMetCodes": [
        "PS2",
        "PS4",
        "PP1",
        "PP3",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BP4",
        "BP2",
        "BA1"
      ],
      "unMetCodesSearch": "ps2 ps4 pp1 pp3 pp4 bs2 bs1 bs4 bp4 bp2 ba1",
      "uuid": "fe8baa9d-249f-4ec0-958d-94b6ad175905",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004312",
      "_id": "AlleleRecords/1573025769",
      "_key": "1573025769",
      "_rev": "_mbGW8zm---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390864624",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "933126",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.5452G>A",
        "NC_000014.9:g.95091278C>T",
        "CM000676.2:g.95091278C>T",
        "NC_000014.8:g.95557615C>T",
        "CM000676.1:g.95557615C>T",
        "NC_000014.7:g.94627368C>T",
        "NG_016311.1:g.71145G>A",
        "LRG_492:g.71145G>A",
        "ENST00000529720.2:c.5452G>A",
        "ENST00000531162.7:c.5452G>A",
        "ENST00000674628.2:c.5452G>A",
        "ENST00000675540.2:c.*2102G>A",
        "ENST00000696733.1:c.*74G>A",
        "ENST00000696734.1:c.*107G>A",
        "ENST00000696735.1:n.2439G>A",
        "ENST00000696736.1:c.5452G>A",
        "ENST00000696920.1:n.5715G>A",
        "ENST00000696921.1:n.6558G>A",
        "ENST00000696922.1:n.8383G>A",
        "ENST00000696923.1:c.*107G>A",
        "ENST00000696924.1:c.*74G>A",
        "ENST00000696925.1:n.8383G>A",
        "ENST00000343455.8:c.5452G>A",
        "ENST00000393063.6:c.5452G>A",
        "ENST00000526495.6:c.5452G>A",
        "ENST00000556045.6:c.*169G>A",
        "ENST00000675540.1:c.3197G>A",
        "ENST00000675995.1:c.*3768G>A",
        "ENST00000343455.7:c.5452G>A",
        "ENST00000393063.5:c.5452G>A",
        "ENST00000526495.5:c.5452G>A",
        "ENST00000527414.5:c.5452G>A",
        "ENST00000527416.2:n.45G>A",
        "ENST00000527554.2:n.145G>A",
        "ENST00000541352.5:c.5365-169G>A",
        "ENST00000556045.5:c.2146G>A",
        "NM_001195573.1:c.5365-169G>A",
        "NM_001271282.2:c.5452G>A",
        "NM_001291628.1:c.5452G>A",
        "NM_030621.4:c.5452G>A",
        "NM_177438.2:c.5452G>A",
        "LRG_492t1:c.5452G>A",
        "XM_011536599.1:c.5452G>A",
        "XM_011536600.1:c.5452G>A",
        "XM_011536601.1:c.5452G>A",
        "XM_011536602.1:c.5452G>A",
        "XM_011536603.1:c.5452G>A",
        "XM_011536604.1:c.5047G>A",
        "XM_011536605.1:c.3973G>A",
        "XM_011536599.2:c.5452G>A",
        "XM_011536600.3:c.5452G>A",
        "XM_011536601.3:c.5452G>A",
        "XM_011536602.3:c.5452G>A",
        "XM_011536604.2:c.5047G>A",
        "XM_011536605.2:c.3973G>A",
        "XM_017021120.2:c.5452G>A",
        "XM_017021121.2:c.5452G>A",
        "XM_017021122.2:c.5047G>A",
        "XM_017021123.2:c.5047G>A",
        "NM_001271282.3:c.5452G>A",
        "NM_001291628.2:c.5452G>A",
        "NM_001395677.1:c.5452G>A",
        "NM_001395678.1:c.5452G>A",
        "NM_001395679.1:c.5452G>A",
        "NM_001395680.1:c.5452G>A",
        "NM_001395682.1:c.5452G>A",
        "NM_001395683.1:c.5452G>A",
        "NM_001395684.1:c.5452G>A",
        "NM_001395685.1:c.5452G>A",
        "NM_001395686.1:c.5170G>A",
        "NM_001395687.1:c.5047G>A",
        "NM_001395688.1:c.5047G>A",
        "NM_001395689.1:c.5047G>A",
        "NM_001395690.1:c.5047G>A",
        "NM_001395691.1:c.4885G>A",
        "NM_001395697.1:c.3769G>A",
        "NR_172715.1:n.5870G>A",
        "NR_172716.1:n.6054G>A",
        "NR_172717.1:n.5964G>A",
        "NR_172718.1:n.5887G>A",
        "NR_172719.1:n.5720G>A",
        "NR_172720.1:n.5923G>A",
        "NM_177438.3(DICER1):c.5452G>A (p.Ala1818Thr)"
      ],
      "hgvsSearch": "nm_177438.3:c.5452g>a nc_000014.9:g.95091278c>t cm000676.2:g.95091278c>t nc_000014.8:g.95557615c>t cm000676.1:g.95557615c>t nc_000014.7:g.94627368c>t ng_016311.1:g.71145g>a lrg_492:g.71145g>a enst00000529720.2:c.5452g>a enst00000531162.7:c.5452g>a enst00000674628.2:c.5452g>a enst00000675540.2:c.*2102g>a enst00000696733.1:c.*74g>a enst00000696734.1:c.*107g>a enst00000696735.1:n.2439g>a enst00000696736.1:c.5452g>a enst00000696920.1:n.5715g>a enst00000696921.1:n.6558g>a enst00000696922.1:n.8383g>a enst00000696923.1:c.*107g>a enst00000696924.1:c.*74g>a enst00000696925.1:n.8383g>a enst00000343455.8:c.5452g>a enst00000393063.6:c.5452g>a enst00000526495.6:c.5452g>a enst00000556045.6:c.*169g>a enst00000675540.1:c.3197g>a enst00000675995.1:c.*3768g>a enst00000343455.7:c.5452g>a enst00000393063.5:c.5452g>a enst00000526495.5:c.5452g>a enst00000527414.5:c.5452g>a enst00000527416.2:n.45g>a enst00000527554.2:n.145g>a enst00000541352.5:c.5365-169g>a enst00000556045.5:c.2146g>a nm_001195573.1:c.5365-169g>a nm_001271282.2:c.5452g>a nm_001291628.1:c.5452g>a nm_030621.4:c.5452g>a nm_177438.2:c.5452g>a lrg_492t1:c.5452g>a xm_011536599.1:c.5452g>a xm_011536600.1:c.5452g>a xm_011536601.1:c.5452g>a xm_011536602.1:c.5452g>a xm_011536603.1:c.5452g>a xm_011536604.1:c.5047g>a xm_011536605.1:c.3973g>a xm_011536599.2:c.5452g>a xm_011536600.3:c.5452g>a xm_011536601.3:c.5452g>a xm_011536602.3:c.5452g>a xm_011536604.2:c.5047g>a xm_011536605.2:c.3973g>a xm_017021120.2:c.5452g>a xm_017021121.2:c.5452g>a xm_017021122.2:c.5047g>a xm_017021123.2:c.5047g>a nm_001271282.3:c.5452g>a nm_001291628.2:c.5452g>a nm_001395677.1:c.5452g>a nm_001395678.1:c.5452g>a nm_001395679.1:c.5452g>a nm_001395680.1:c.5452g>a nm_001395682.1:c.5452g>a nm_001395683.1:c.5452g>a nm_001395684.1:c.5452g>a nm_001395685.1:c.5452g>a nm_001395686.1:c.5170g>a nm_001395687.1:c.5047g>a nm_001395688.1:c.5047g>a nm_001395689.1:c.5047g>a nm_001395690.1:c.5047g>a nm_001395691.1:c.4885g>a nm_001395697.1:c.3769g>a nr_172715.1:n.5870g>a nr_172716.1:n.6054g>a nr_172717.1:n.5964g>a nr_172718.1:n.5887g>a nr_172719.1:n.5720g>a nr_172720.1:n.5923g>a nm_177438.3(dicer1):c.5452g>a (p.ala1818thr)",
      "metCodes": [
        "PM2_Supporting",
        "PS3_Supporting",
        "PM1_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting ps3_supporting pm1_supporting pp3",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.5452G>A (p.Ala1818Thr)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.5452G>A variant in DICER1 is a missense variant predicted to cause substitution of alanine by threonine at amino acid 1818 (p.Ala1818Thr). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). An in vitro cleavage assay carried out using immunopurified DICER1 variant p.Ala1818Thr showed that this variant reduces the capacity of the protein to produce 5p/3p microRNAs from a pre-miRNA, indicating that it impacts protein function (PS3_Supporting; Wu 2018, McGill University). The computational predictor REVEL gives a score of 0.925,  which is above the threshold of 0.750, evidence that correlates with impact to DICER1 function (PP3). This variant resides within the RNase IIIb domain (PM1_Supporting; PMID: 31342592). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PM2_supporting, PS3_Supporting, PP3, PM1_Supporting. (VCEP specifications version 1.4.0) Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 4, which equates to a classification of VUS.",
      "unMetCodes": [
        "PVS1",
        "PS1",
        "PS2",
        "PS4",
        "PP1",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "BP7",
        "PM5",
        "BP4",
        "BP3",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pvs1 ps1 ps2 ps4 pp1 pp4 bs2 bs1 bs4 bs3 bp7 pm5 bp4 bp3 bp2 ba1 pm4",
      "uuid": "015b6ae7-3db6-44f2-882b-3d3b5b3aa66c",
      "versionsList": [
        "2.0.0",
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004313",
      "_id": "AlleleRecords/1573025773",
      "_key": "1573025773",
      "_rev": "_mbGOfb2---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA390862947",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "825934",
      "docVersion": "2.0.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.5744A>G",
        "NC_000014.9:g.95090523T>C",
        "CM000676.2:g.95090523T>C",
        "NC_000014.8:g.95556860T>C",
        "CM000676.1:g.95556860T>C",
        "NC_000014.7:g.94626613T>C",
        "NG_016311.1:g.71900A>G",
        "LRG_492:g.71900A>G",
        "ENST00000529720.2:c.5744A>G",
        "ENST00000531162.7:c.5744A>G",
        "ENST00000674628.2:c.5744A>G",
        "ENST00000675540.2:c.*2394A>G",
        "ENST00000696733.1:c.*366A>G",
        "ENST00000696734.1:c.*399A>G",
        "ENST00000696735.1:n.2731A>G",
        "ENST00000696920.1:n.6007A>G",
        "ENST00000696921.1:n.6850A>G",
        "ENST00000696922.1:n.8675A>G",
        "ENST00000696923.1:c.*399A>G",
        "ENST00000696924.1:c.*366A>G",
        "ENST00000696925.1:n.9045A>G",
        "ENST00000343455.8:c.5744A>G",
        "ENST00000393063.6:c.5744A>G",
        "ENST00000526495.6:c.5744A>G",
        "ENST00000556045.6:c.*461A>G",
        "ENST00000675540.1:c.3489A>G",
        "ENST00000675995.1:c.*4060A>G",
        "ENST00000343455.7:c.5744A>G",
        "ENST00000393063.5:c.5744A>G",
        "ENST00000526495.5:c.5744A>G",
        "ENST00000527414.5:c.5744A>G",
        "ENST00000527416.2:n.337A>G",
        "ENST00000541352.5:c.*91A>G",
        "ENST00000556045.5:c.2438A>G",
        "NM_001195573.1:c.*91A>G",
        "NM_001271282.2:c.5744A>G",
        "NM_001291628.1:c.5744A>G",
        "NM_030621.4:c.5744A>G",
        "NM_177438.2:c.5744A>G",
        "LRG_492t1:c.5744A>G",
        "XM_011536599.1:c.5744A>G",
        "XM_011536600.1:c.5744A>G",
        "XM_011536601.1:c.5744A>G",
        "XM_011536602.1:c.5744A>G",
        "XM_011536603.1:c.5744A>G",
        "XM_011536604.1:c.5339A>G",
        "XM_011536605.1:c.4265A>G",
        "XM_011536599.2:c.5744A>G",
        "XM_011536600.3:c.5744A>G",
        "XM_011536601.3:c.5744A>G",
        "XM_011536602.3:c.5744A>G",
        "XM_011536604.2:c.5339A>G",
        "XM_011536605.2:c.4265A>G",
        "XM_017021120.2:c.5744A>G",
        "XM_017021121.2:c.5744A>G",
        "XM_017021122.2:c.5339A>G",
        "XM_017021123.2:c.5339A>G",
        "NM_001271282.3:c.5744A>G",
        "NM_001291628.2:c.5744A>G",
        "NM_001395677.1:c.5744A>G",
        "NM_001395678.1:c.5744A>G",
        "NM_001395679.1:c.5744A>G",
        "NM_001395680.1:c.5744A>G",
        "NM_001395682.1:c.5744A>G",
        "NM_001395683.1:c.5744A>G",
        "NM_001395684.1:c.5744A>G",
        "NM_001395685.1:c.*290A>G",
        "NM_001395686.1:c.5462A>G",
        "NM_001395687.1:c.5339A>G",
        "NM_001395688.1:c.5339A>G",
        "NM_001395689.1:c.5339A>G",
        "NM_001395690.1:c.5339A>G",
        "NM_001395691.1:c.5177A>G",
        "NM_001395697.1:c.4061A>G",
        "NR_172715.1:n.6162A>G",
        "NR_172716.1:n.6346A>G",
        "NR_172717.1:n.6256A>G",
        "NR_172718.1:n.6179A>G",
        "NR_172719.1:n.6012A>G",
        "NR_172720.1:n.6215A>G",
        "NM_177438.3(DICER1):c.5744A>G (p.Asn1915Ser)"
      ],
      "hgvsSearch": "nm_177438.3:c.5744a>g nc_000014.9:g.95090523t>c cm000676.2:g.95090523t>c nc_000014.8:g.95556860t>c cm000676.1:g.95556860t>c nc_000014.7:g.94626613t>c ng_016311.1:g.71900a>g lrg_492:g.71900a>g enst00000529720.2:c.5744a>g enst00000531162.7:c.5744a>g enst00000674628.2:c.5744a>g enst00000675540.2:c.*2394a>g enst00000696733.1:c.*366a>g enst00000696734.1:c.*399a>g enst00000696735.1:n.2731a>g enst00000696920.1:n.6007a>g enst00000696921.1:n.6850a>g enst00000696922.1:n.8675a>g enst00000696923.1:c.*399a>g enst00000696924.1:c.*366a>g enst00000696925.1:n.9045a>g enst00000343455.8:c.5744a>g enst00000393063.6:c.5744a>g enst00000526495.6:c.5744a>g enst00000556045.6:c.*461a>g enst00000675540.1:c.3489a>g enst00000675995.1:c.*4060a>g enst00000343455.7:c.5744a>g enst00000393063.5:c.5744a>g enst00000526495.5:c.5744a>g enst00000527414.5:c.5744a>g enst00000527416.2:n.337a>g enst00000541352.5:c.*91a>g enst00000556045.5:c.2438a>g nm_001195573.1:c.*91a>g nm_001271282.2:c.5744a>g nm_001291628.1:c.5744a>g nm_030621.4:c.5744a>g nm_177438.2:c.5744a>g lrg_492t1:c.5744a>g xm_011536599.1:c.5744a>g xm_011536600.1:c.5744a>g xm_011536601.1:c.5744a>g xm_011536602.1:c.5744a>g xm_011536603.1:c.5744a>g xm_011536604.1:c.5339a>g xm_011536605.1:c.4265a>g xm_011536599.2:c.5744a>g xm_011536600.3:c.5744a>g xm_011536601.3:c.5744a>g xm_011536602.3:c.5744a>g xm_011536604.2:c.5339a>g xm_011536605.2:c.4265a>g xm_017021120.2:c.5744a>g xm_017021121.2:c.5744a>g xm_017021122.2:c.5339a>g xm_017021123.2:c.5339a>g nm_001271282.3:c.5744a>g nm_001291628.2:c.5744a>g nm_001395677.1:c.5744a>g nm_001395678.1:c.5744a>g nm_001395679.1:c.5744a>g nm_001395680.1:c.5744a>g nm_001395682.1:c.5744a>g nm_001395683.1:c.5744a>g nm_001395684.1:c.5744a>g nm_001395685.1:c.*290a>g nm_001395686.1:c.5462a>g nm_001395687.1:c.5339a>g nm_001395688.1:c.5339a>g nm_001395689.1:c.5339a>g nm_001395690.1:c.5339a>g nm_001395691.1:c.5177a>g nm_001395697.1:c.4061a>g nr_172715.1:n.6162a>g nr_172716.1:n.6346a>g nr_172717.1:n.6256a>g nr_172718.1:n.6179a>g nr_172719.1:n.6012a>g nr_172720.1:n.6215a>g nm_177438.3(dicer1):c.5744a>g (p.asn1915ser)",
      "metCodes": [
        "BP4"
      ],
      "metCodesSearch": "bp4",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.5744A>G (p.Asn1915Ser)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.5744A>G variant in DICER1 is a missense variant predicted to cause substitution of Asparagine by Serine at amino acid 1915 (p.Asn1915Ser). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; Internal lab contributors). The highest population minor allele frequency in gnomAD v.4.1.1 is 0.00006672 (5/74942 alleles) in the African/African American population (PM2_Supporting, BS1, and BA1 are not met). The computational predictor REVEL gives a score of 0.184, which is below the threshold of 0.5, and the splice site predictors MaxEntScan and SpliceAI indicate that the variant has no impact on splicing, evidence that does not predict a damaging effect on DICER1 function (BP4). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1 syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BP4. (VCEP specifications version 1.4.0; 8/12/2026). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = -1, which equates to a classification of Uncertain Significance.",
      "unMetCodes": [
        "PM6",
        "PM2",
        "PVS1",
        "PS1",
        "PS2",
        "PS3",
        "PS4",
        "PM1",
        "PP1",
        "PP3",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "BP7",
        "PM5",
        "BP2",
        "BA1",
        "PM4"
      ],
      "unMetCodesSearch": "pm6 pm2 pvs1 ps1 ps2 ps3 ps4 pm1 pp1 pp3 pp4 bs2 bs1 bs4 bs3 bp7 pm5 bp2 ba1 pm4",
      "uuid": "141155a2-7fdc-4e4d-84c9-91cfd9256f73",
      "versionsList": [
        "2.0.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013753",
      "_id": "AlleleRecords/1687390102",
      "_key": "1687390102",
      "_rev": "_mbCN40y---",
      "affiliationId": "50118",
      "approvedDate": "2026-11-11",
      "caId": "CA4262225",
      "classification": "Likely Benign",
      "condition": "aromatic L-amino acid decarboxylase deficiency",
      "cvId": "753732",
      "docVersion": "1.0.0",
      "ep": "Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) VCEP",
      "gene": "DDC",
      "geneNcbiId": "1644",
      "hgvs": [
        "NM_001082971.2:c.816A>C",
        "NC_000007.14:g.50499208T>G",
        "CM000669.2:g.50499208T>G",
        "NC_000007.13:g.50566906T>G",
        "CM000669.1:g.50566906T>G",
        "NC_000007.12:g.50534400T>G",
        "NG_008742.1:g.71249A>C",
        "ENST00000444124.7:c.816A>C",
        "ENST00000357936.9:c.816A>C",
        "ENST00000380984.4:c.816A>C",
        "ENST00000426377.5:c.582A>C",
        "ENST00000430300.5:c.458A>C",
        "ENST00000431062.5:c.537A>C",
        "ENST00000444124.6:c.816A>C",
        "ENST00000444733.5:c.668-3791A>C",
        "ENST00000613602.3:c.-11+43310A>C",
        "ENST00000615193.4:c.537A>C",
        "ENST00000617822.4:c.672A>C",
        "ENST00000622873.4:c.702A>C",
        "NM_000790.3:c.816A>C",
        "NM_001082971.1:c.816A>C",
        "NM_001242886.1:c.702A>C",
        "NM_001242887.1:c.672A>C",
        "NM_001242888.1:c.582A>C",
        "NM_001242889.1:c.537A>C",
        "NM_001242890.1:c.816A>C",
        "XM_005271745.3:c.702A>C",
        "XM_011515161.1:c.465A>C",
        "XM_005271745.4:c.702A>C",
        "XM_011515161.2:c.759A>C",
        "NM_000790.4:c.816A>C",
        "NM_001242888.2:c.582A>C",
        "NM_001242890.2:c.816A>C",
        "NM_001242886.2:c.702A>C",
        "NM_001242887.2:c.672A>C",
        "NM_001242889.2:c.537A>C",
        "NM_001082971.2(DDC):c.816A>C (p.Ala272=)"
      ],
      "hgvsSearch": "nm_001082971.2:c.816a>c nc_000007.14:g.50499208t>g cm000669.2:g.50499208t>g nc_000007.13:g.50566906t>g cm000669.1:g.50566906t>g nc_000007.12:g.50534400t>g ng_008742.1:g.71249a>c enst00000444124.7:c.816a>c enst00000357936.9:c.816a>c enst00000380984.4:c.816a>c enst00000426377.5:c.582a>c enst00000430300.5:c.458a>c enst00000431062.5:c.537a>c enst00000444124.6:c.816a>c enst00000444733.5:c.668-3791a>c enst00000613602.3:c.-11+43310a>c enst00000615193.4:c.537a>c enst00000617822.4:c.672a>c enst00000622873.4:c.702a>c nm_000790.3:c.816a>c nm_001082971.1:c.816a>c nm_001242886.1:c.702a>c nm_001242887.1:c.672a>c nm_001242888.1:c.582a>c nm_001242889.1:c.537a>c nm_001242890.1:c.816a>c xm_005271745.3:c.702a>c xm_011515161.1:c.465a>c xm_005271745.4:c.702a>c xm_011515161.2:c.759a>c nm_000790.4:c.816a>c nm_001242888.2:c.582a>c nm_001242890.2:c.816a>c nm_001242886.2:c.702a>c nm_001242887.2:c.672a>c nm_001242889.2:c.537a>c nm_001082971.2(ddc):c.816a>c (p.ala272=)",
      "metCodes": [
        "BS2",
        "BP7",
        "BP4"
      ],
      "metCodesSearch": "bs2 bp7 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012084",
      "preferredVarTitle": "NM_001082971.2(DDC):c.816A>C (p.Ala272=)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_001082971.2:c.816A>C variant in DDC is a synonymous variant and is not predicted by SpliceAI to impact the splice consensus sequence or to create a new splice site (Δ score = 0.08) (BP4, BP7). The variant has not been reported in the literature. The highest subpopulation allele frequency is 0.0004948 (3/6062) in Middle Eastern population in gnomAD v4.1.2, which is higher than the cutoff for PM2_Supporting (<0.0002) but lower than the cutoff for BS1 (>0.002) determined by the DDC VCEP (PM2_Supporting not met, BS1 not met). However, the variant has been observed in 1 homozygous individual in gnomAD v4.1.2 (BS2). In summary, this variant is classified as a likely benign variant for aromatic L-amino acid decarboxylase deficiency. ACMG/AMP criteria applied, as specified by the ClinGen DDC-VCEP: BS2, BP4, BP7. (VCEP specifications version v1.0)",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "d19c620a-f94e-4ab6-b379-15d6b5bace40",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013754",
      "_id": "AlleleRecords/1687391741",
      "_key": "1687391741",
      "_rev": "_mbCWUze---",
      "affiliationId": "50118",
      "approvedDate": "2026-11-11",
      "caId": "CA4262392",
      "classification": "Likely Benign",
      "condition": "aromatic L-amino acid decarboxylase deficiency",
      "cvId": "360439",
      "docVersion": "1.0.0",
      "ep": "Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) VCEP",
      "gene": "DDC",
      "geneNcbiId": "1644",
      "hgvs": [
        "NM_001082971.2:c.366C>T",
        "NC_000007.14:g.50537929G>A",
        "CM000669.2:g.50537929G>A",
        "NC_000007.13:g.50605627G>A",
        "CM000669.1:g.50605627G>A",
        "NC_000007.12:g.50573121G>A",
        "NG_008742.1:g.32528C>T",
        "ENST00000444124.7:c.366C>T",
        "ENST00000357936.9:c.366C>T",
        "ENST00000380984.4:c.366C>T",
        "ENST00000426377.5:c.201+5956C>T",
        "ENST00000430300.5:c.212+1986C>T",
        "ENST00000431062.5:c.366C>T",
        "ENST00000444124.6:c.366C>T",
        "ENST00000444733.5:c.252C>T",
        "ENST00000489162.1:n.165C>T",
        "ENST00000613602.3:c.-11+4589C>T",
        "ENST00000615193.4:c.366C>T",
        "ENST00000617822.4:c.366C>T",
        "ENST00000622873.4:c.252C>T",
        "NM_000790.3:c.366C>T",
        "NM_001082971.1:c.366C>T",
        "NM_001242886.1:c.252C>T",
        "NM_001242887.1:c.366C>T",
        "NM_001242888.1:c.201+5956C>T",
        "NM_001242889.1:c.366C>T",
        "NM_001242890.1:c.366C>T",
        "NR_033845.1:n.125-1185G>A",
        "XM_005271745.3:c.252C>T",
        "XM_011515161.1:c.15C>T",
        "XM_005271745.4:c.252C>T",
        "XM_011515161.2:c.309C>T",
        "NM_000790.4:c.366C>T",
        "NM_001242888.2:c.201+5956C>T",
        "NM_001242890.2:c.366C>T",
        "NM_001242886.2:c.252C>T",
        "NM_001242887.2:c.366C>T",
        "NM_001242889.2:c.366C>T",
        "NM_001082971.2(DDC):c.366C>T (p.Leu122=)"
      ],
      "hgvsSearch": "nm_001082971.2:c.366c>t nc_000007.14:g.50537929g>a cm000669.2:g.50537929g>a nc_000007.13:g.50605627g>a cm000669.1:g.50605627g>a nc_000007.12:g.50573121g>a ng_008742.1:g.32528c>t enst00000444124.7:c.366c>t enst00000357936.9:c.366c>t enst00000380984.4:c.366c>t enst00000426377.5:c.201+5956c>t enst00000430300.5:c.212+1986c>t enst00000431062.5:c.366c>t enst00000444124.6:c.366c>t enst00000444733.5:c.252c>t enst00000489162.1:n.165c>t enst00000613602.3:c.-11+4589c>t enst00000615193.4:c.366c>t enst00000617822.4:c.366c>t enst00000622873.4:c.252c>t nm_000790.3:c.366c>t nm_001082971.1:c.366c>t nm_001242886.1:c.252c>t nm_001242887.1:c.366c>t nm_001242888.1:c.201+5956c>t nm_001242889.1:c.366c>t nm_001242890.1:c.366c>t nr_033845.1:n.125-1185g>a xm_005271745.3:c.252c>t xm_011515161.1:c.15c>t xm_005271745.4:c.252c>t xm_011515161.2:c.309c>t nm_000790.4:c.366c>t nm_001242888.2:c.201+5956c>t nm_001242890.2:c.366c>t nm_001242886.2:c.252c>t nm_001242887.2:c.366c>t nm_001242889.2:c.366c>t nm_001082971.2(ddc):c.366c>t (p.leu122=)",
      "metCodes": [
        "BP7",
        "BP4"
      ],
      "metCodesSearch": "bp7 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012084",
      "preferredVarTitle": "NM_001082971.2(DDC):c.366C>T (p.Leu122=)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_001082971.2:c.366C>T variant in DDC is a synonymous variant and is not predicted by SpliceAI to impact the splice consensus sequence or to create a new splice site (Δ score = 0.01) (BP4, BP7). The variant has not been reported in the literature. The highest subpopulation allele frequency of this variant is 0.0004167 (25/59986) in Admixed American population in gnomAD v4.1.2, which is higher than the cutoff for PM2_Supporting (<0.0002) determined by the DDC VCEP (PM2_Supporting not met). In summary, this variant is classified as a likely benign variant for aromatic L-amino acid decarboxylase deficiency. ACMG/AMP criteria applied, as specified by the ClinGen DDC-VCEP: BP4, BP7. (VCEP specifications version v1.0)",
      "unMetCodes": [
        "PM2"
      ],
      "unMetCodesSearch": "pm2",
      "uuid": "df9bafce-a933-4685-81c1-6a44ef886fe7",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013755",
      "_id": "AlleleRecords/1687393468",
      "_key": "1687393468",
      "_rev": "_mbCexC6---",
      "affiliationId": "50118",
      "approvedDate": "2026-11-11",
      "caId": "CA4262524",
      "classification": "Likely Benign",
      "condition": "aromatic L-amino acid decarboxylase deficiency",
      "cvId": "360444",
      "docVersion": "1.0.0",
      "ep": "Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) VCEP",
      "gene": "DDC",
      "geneNcbiId": "1644",
      "hgvs": [
        "NM_001082971.2:c.6C>T",
        "NC_000007.14:g.50544080G>A",
        "CM000669.2:g.50544080G>A",
        "NC_000007.13:g.50611778G>A",
        "CM000669.1:g.50611778G>A",
        "NC_000007.12:g.50579272G>A",
        "NG_008742.1:g.26377C>T",
        "ENST00000444124.7:c.6C>T",
        "ENST00000357936.9:c.6C>T",
        "ENST00000380984.4:c.6C>T",
        "ENST00000420203.1:c.6C>T",
        "ENST00000426377.5:c.6C>T",
        "ENST00000431062.5:c.6C>T",
        "ENST00000444124.6:c.6C>T",
        "ENST00000444733.5:c.6C>T",
        "ENST00000615193.4:c.6C>T",
        "ENST00000617822.4:c.6C>T",
        "ENST00000622873.4:c.6C>T",
        "NM_000790.3:c.6C>T",
        "NM_001082971.1:c.6C>T",
        "NM_001242886.1:c.6C>T",
        "NM_001242887.1:c.6C>T",
        "NM_001242888.1:c.6C>T",
        "NM_001242889.1:c.6C>T",
        "NM_001242890.1:c.6C>T",
        "XM_005271745.3:c.6C>T",
        "XM_005271745.4:c.6C>T",
        "NM_000790.4:c.6C>T",
        "NM_001242888.2:c.6C>T",
        "NM_001242890.2:c.6C>T",
        "NM_001242886.2:c.6C>T",
        "NM_001242887.2:c.6C>T",
        "NM_001242889.2:c.6C>T",
        "NM_001082971.2(DDC):c.6C>T (p.Asn2=)"
      ],
      "hgvsSearch": "nm_001082971.2:c.6c>t nc_000007.14:g.50544080g>a cm000669.2:g.50544080g>a nc_000007.13:g.50611778g>a cm000669.1:g.50611778g>a nc_000007.12:g.50579272g>a ng_008742.1:g.26377c>t enst00000444124.7:c.6c>t enst00000357936.9:c.6c>t enst00000380984.4:c.6c>t enst00000420203.1:c.6c>t enst00000426377.5:c.6c>t enst00000431062.5:c.6c>t enst00000444124.6:c.6c>t enst00000444733.5:c.6c>t enst00000615193.4:c.6c>t enst00000617822.4:c.6c>t enst00000622873.4:c.6c>t nm_000790.3:c.6c>t nm_001082971.1:c.6c>t nm_001242886.1:c.6c>t nm_001242887.1:c.6c>t nm_001242888.1:c.6c>t nm_001242889.1:c.6c>t nm_001242890.1:c.6c>t xm_005271745.3:c.6c>t xm_005271745.4:c.6c>t nm_000790.4:c.6c>t nm_001242888.2:c.6c>t nm_001242890.2:c.6c>t nm_001242886.2:c.6c>t nm_001242887.2:c.6c>t nm_001242889.2:c.6c>t nm_001082971.2(ddc):c.6c>t (p.asn2=)",
      "metCodes": [
        "BP7",
        "BP4"
      ],
      "metCodesSearch": "bp7 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012084",
      "preferredVarTitle": "NM_001082971.2(DDC):c.6C>T (p.Asn2=)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_001082971.2:c.6C>T variant in DDC is a synonymous variant and is not predicted by SpliceAI to impact the splice consensus sequence or to create a new splice site (Δ score = 0.00) (BP4, BP7). The variant has not been reported in the literature. The highest subpopulation allele frequency of this variant is 0.0002525 (23/91072) in South Asia population in gnomAD v4.1.2, which is higher than the cutoff for PM2_Supporting (<0.0002) determined by the DDC VCEP (PM2_Supporting not met). In summary, this variant is classified as a likely benign variant for aromatic L-amino acid decarboxylase deficiency. ACMG/AMP criteria applied, as specified by the ClinGen DDC-VCEP: BP4, BP7. (VCEP specifications version v1.0)",
      "unMetCodes": [
        "PM2"
      ],
      "unMetCodesSearch": "pm2",
      "uuid": "a6cdbb33-870b-443b-b3ff-332c23dadced",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013756",
      "_id": "AlleleRecords/1687395049",
      "_key": "1687395049",
      "_rev": "_mbCnNJS---",
      "affiliationId": "50118",
      "approvedDate": "2026-11-11",
      "caId": "CA4262489",
      "classification": "Likely Benign",
      "condition": "aromatic L-amino acid decarboxylase deficiency",
      "cvId": "911253",
      "docVersion": "1.0.0",
      "ep": "Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) VCEP",
      "gene": "DDC",
      "geneNcbiId": "1644",
      "hgvs": [
        "NM_001082971.2:c.135T>C",
        "NC_000007.14:g.50543951A>G",
        "CM000669.2:g.50543951A>G",
        "NC_000007.13:g.50611649A>G",
        "CM000669.1:g.50611649A>G",
        "NC_000007.12:g.50579143A>G",
        "NG_008742.1:g.26506T>C",
        "ENST00000444124.7:c.135T>C",
        "ENST00000357936.9:c.135T>C",
        "ENST00000380984.4:c.135T>C",
        "ENST00000426377.5:c.135T>C",
        "ENST00000430300.5:c.32T>C",
        "ENST00000431062.5:c.135T>C",
        "ENST00000444124.6:c.135T>C",
        "ENST00000444733.5:c.135T>C",
        "ENST00000615193.4:c.135T>C",
        "ENST00000617822.4:c.135T>C",
        "ENST00000622873.4:c.135T>C",
        "NM_000790.3:c.135T>C",
        "NM_001082971.1:c.135T>C",
        "NM_001242886.1:c.135T>C",
        "NM_001242887.1:c.135T>C",
        "NM_001242888.1:c.135T>C",
        "NM_001242889.1:c.135T>C",
        "NM_001242890.1:c.135T>C",
        "XM_005271745.3:c.135T>C",
        "XM_005271745.4:c.135T>C",
        "NM_000790.4:c.135T>C",
        "NM_001242888.2:c.135T>C",
        "NM_001242890.2:c.135T>C",
        "NM_001242886.2:c.135T>C",
        "NM_001242887.2:c.135T>C",
        "NM_001242889.2:c.135T>C",
        "NM_001082971.2(DDC):c.135T>C (p.Ala45=)"
      ],
      "hgvsSearch": "nm_001082971.2:c.135t>c nc_000007.14:g.50543951a>g cm000669.2:g.50543951a>g nc_000007.13:g.50611649a>g cm000669.1:g.50611649a>g nc_000007.12:g.50579143a>g ng_008742.1:g.26506t>c enst00000444124.7:c.135t>c enst00000357936.9:c.135t>c enst00000380984.4:c.135t>c enst00000426377.5:c.135t>c enst00000430300.5:c.32t>c enst00000431062.5:c.135t>c enst00000444124.6:c.135t>c enst00000444733.5:c.135t>c enst00000615193.4:c.135t>c enst00000617822.4:c.135t>c enst00000622873.4:c.135t>c nm_000790.3:c.135t>c nm_001082971.1:c.135t>c nm_001242886.1:c.135t>c nm_001242887.1:c.135t>c nm_001242888.1:c.135t>c nm_001242889.1:c.135t>c nm_001242890.1:c.135t>c xm_005271745.3:c.135t>c xm_005271745.4:c.135t>c nm_000790.4:c.135t>c nm_001242888.2:c.135t>c nm_001242890.2:c.135t>c nm_001242886.2:c.135t>c nm_001242887.2:c.135t>c nm_001242889.2:c.135t>c nm_001082971.2(ddc):c.135t>c (p.ala45=)",
      "metCodes": [
        "BP7",
        "BP4"
      ],
      "metCodesSearch": "bp7 bp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012084",
      "preferredVarTitle": "NM_001082971.2(DDC):c.135T>C (p.Ala45=)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_001082971.2:c.135T>C variant in DDC is a synonymous variant and is not predicted by SpliceAI to impact the splice consensus sequence or to create a new splice site (Δ score = 0.00) (BP4, BP7). The variant has not been reported in the literature. The highest subpopulation allele frequency is 0.001716 (103/60022) in Admixed American population in gnomAD v4.1.2, which is higher than the cutoff for PM2_Supporting (<0.0002) but lower than the cutoff for BS1 (>0.002) determined by the DDC VCEP (PM2_supporting not met, BS1 not met). In summary, this variant is classified as a likely benign variant for aromatic L-amino acid decarboxylase deficiency. ACMG/AMP criteria applied, as specified by the ClinGen DDC-VCEP: BP4, BP7. (VCEP specifications version v1.0)",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "49e61383-4b9e-427e-a83e-e6c29e15c17e",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000008746",
      "_id": "AlleleRecords/60593384",
      "_key": "60593384",
      "_rev": "_mbFbvsS---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA265917282",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "477043",
      "docVersion": "1.1.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.1453G>A",
        "NC_000014.9:g.95117678C>T",
        "CM000676.2:g.95117678C>T",
        "NC_000014.8:g.95584015C>T",
        "CM000676.1:g.95584015C>T",
        "NC_000014.7:g.94653768C>T",
        "NG_016311.1:g.44745G>A",
        "LRG_492:g.44745G>A",
        "ENST00000529720.2:c.1453G>A",
        "ENST00000531162.7:c.1453G>A",
        "ENST00000674628.2:c.1453G>A",
        "ENST00000675540.2:c.1453G>A",
        "ENST00000696733.1:c.1453G>A",
        "ENST00000696734.1:c.1453G>A",
        "ENST00000696736.1:c.1453G>A",
        "ENST00000696737.1:c.1453G>A",
        "ENST00000696920.1:n.1716G>A",
        "ENST00000696921.1:n.2559G>A",
        "ENST00000696922.1:n.1862G>A",
        "ENST00000696923.1:c.1453G>A",
        "ENST00000696924.1:c.1453G>A",
        "ENST00000696925.1:n.1862G>A",
        "ENST00000696927.1:n.1056G>A",
        "ENST00000696928.1:n.1650G>A",
        "ENST00000343455.8:c.1453G>A",
        "ENST00000393063.6:c.1453G>A",
        "ENST00000526495.6:c.1453G>A",
        "ENST00000532939.3:c.1453G>A",
        "ENST00000556045.6:c.1453G>A",
        "ENST00000674628.1:c.1453G>A",
        "ENST00000675995.1:c.1453G>A",
        "ENST00000343455.7:c.1453G>A",
        "ENST00000393063.5:c.1453G>A",
        "ENST00000526495.5:c.1453G>A",
        "ENST00000527414.5:c.1453G>A",
        "ENST00000532458.1:n.157G>A",
        "ENST00000541352.5:c.1453G>A",
        "NM_001195573.1:c.1453G>A",
        "NM_001271282.2:c.1453G>A",
        "NM_001291628.1:c.1453G>A",
        "NM_030621.4:c.1453G>A",
        "NM_177438.2:c.1453G>A",
        "LRG_492t1:c.1453G>A",
        "XM_011536599.1:c.1453G>A",
        "XM_011536600.1:c.1453G>A",
        "XM_011536601.1:c.1453G>A",
        "XM_011536602.1:c.1453G>A",
        "XM_011536603.1:c.1453G>A",
        "XM_011536604.1:c.1048G>A",
        "XM_011536605.1:c.-27G>A",
        "XM_011536599.2:c.1453G>A",
        "XM_011536600.3:c.1453G>A",
        "XM_011536601.3:c.1453G>A",
        "XM_011536602.3:c.1453G>A",
        "XM_011536604.2:c.1048G>A",
        "XM_011536605.2:c.-27G>A",
        "XM_017021120.2:c.1453G>A",
        "XM_017021121.2:c.1453G>A",
        "XM_017021122.2:c.1048G>A",
        "XM_017021123.2:c.1048G>A",
        "NM_001271282.3:c.1453G>A",
        "NM_001291628.2:c.1453G>A",
        "NM_001395677.1:c.1453G>A",
        "NM_001395678.1:c.1453G>A",
        "NM_001395679.1:c.1453G>A",
        "NM_001395680.1:c.1453G>A",
        "NM_001395682.1:c.1453G>A",
        "NM_001395683.1:c.1453G>A",
        "NM_001395684.1:c.1453G>A",
        "NM_001395685.1:c.1453G>A",
        "NM_001395686.1:c.1171G>A",
        "NM_001395687.1:c.1048G>A",
        "NM_001395688.1:c.1048G>A",
        "NM_001395689.1:c.1048G>A",
        "NM_001395690.1:c.1048G>A",
        "NM_001395691.1:c.886G>A",
        "NM_001395692.1:c.1453G>A",
        "NM_001395693.1:c.1453G>A",
        "NM_001395694.1:c.1453G>A",
        "NM_001395695.1:c.1453G>A",
        "NM_001395696.1:c.1048G>A",
        "NM_001395697.1:c.-116G>A",
        "NM_001395698.1:c.1048G>A",
        "NR_172715.1:n.1871G>A",
        "NR_172716.1:n.1798G>A",
        "NR_172717.1:n.1965G>A",
        "NR_172718.1:n.1965G>A",
        "NR_172719.1:n.1798G>A",
        "NR_172720.1:n.1798G>A",
        "NM_177438.3(DICER1):c.1453G>A (p.Gly485Arg)"
      ],
      "hgvsSearch": "nm_177438.3:c.1453g>a nc_000014.9:g.95117678c>t cm000676.2:g.95117678c>t nc_000014.8:g.95584015c>t cm000676.1:g.95584015c>t nc_000014.7:g.94653768c>t ng_016311.1:g.44745g>a lrg_492:g.44745g>a enst00000529720.2:c.1453g>a enst00000531162.7:c.1453g>a enst00000674628.2:c.1453g>a enst00000675540.2:c.1453g>a enst00000696733.1:c.1453g>a enst00000696734.1:c.1453g>a enst00000696736.1:c.1453g>a enst00000696737.1:c.1453g>a enst00000696920.1:n.1716g>a enst00000696921.1:n.2559g>a enst00000696922.1:n.1862g>a enst00000696923.1:c.1453g>a enst00000696924.1:c.1453g>a enst00000696925.1:n.1862g>a enst00000696927.1:n.1056g>a enst00000696928.1:n.1650g>a enst00000343455.8:c.1453g>a enst00000393063.6:c.1453g>a enst00000526495.6:c.1453g>a enst00000532939.3:c.1453g>a enst00000556045.6:c.1453g>a enst00000674628.1:c.1453g>a enst00000675995.1:c.1453g>a enst00000343455.7:c.1453g>a enst00000393063.5:c.1453g>a enst00000526495.5:c.1453g>a enst00000527414.5:c.1453g>a enst00000532458.1:n.157g>a enst00000541352.5:c.1453g>a nm_001195573.1:c.1453g>a nm_001271282.2:c.1453g>a nm_001291628.1:c.1453g>a nm_030621.4:c.1453g>a nm_177438.2:c.1453g>a lrg_492t1:c.1453g>a xm_011536599.1:c.1453g>a xm_011536600.1:c.1453g>a xm_011536601.1:c.1453g>a xm_011536602.1:c.1453g>a xm_011536603.1:c.1453g>a xm_011536604.1:c.1048g>a xm_011536605.1:c.-27g>a xm_011536599.2:c.1453g>a xm_011536600.3:c.1453g>a xm_011536601.3:c.1453g>a xm_011536602.3:c.1453g>a xm_011536604.2:c.1048g>a xm_011536605.2:c.-27g>a xm_017021120.2:c.1453g>a xm_017021121.2:c.1453g>a xm_017021122.2:c.1048g>a xm_017021123.2:c.1048g>a nm_001271282.3:c.1453g>a nm_001291628.2:c.1453g>a nm_001395677.1:c.1453g>a nm_001395678.1:c.1453g>a nm_001395679.1:c.1453g>a nm_001395680.1:c.1453g>a nm_001395682.1:c.1453g>a nm_001395683.1:c.1453g>a nm_001395684.1:c.1453g>a nm_001395685.1:c.1453g>a nm_001395686.1:c.1171g>a nm_001395687.1:c.1048g>a nm_001395688.1:c.1048g>a nm_001395689.1:c.1048g>a nm_001395690.1:c.1048g>a nm_001395691.1:c.886g>a nm_001395692.1:c.1453g>a nm_001395693.1:c.1453g>a nm_001395694.1:c.1453g>a nm_001395695.1:c.1453g>a nm_001395696.1:c.1048g>a nm_001395697.1:c.-116g>a nm_001395698.1:c.1048g>a nr_172715.1:n.1871g>a nr_172716.1:n.1798g>a nr_172717.1:n.1965g>a nr_172718.1:n.1965g>a nr_172719.1:n.1798g>a nr_172720.1:n.1798g>a nm_177438.3(dicer1):c.1453g>a (p.gly485arg)",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.1453G>A (p.Gly485Arg)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.1453G>A variant in DICER1 is a missense variant predicted to cause substitution of glycine by arginine at amino acid 485 (p.Gly485Arg). To our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition. The total allele frequency in gnomAD v4.1.1 is 0.000007435 (12/1613916 alleles) with a highest population minor allele frequency of 0.00001017 (12/1179952 alleles) in the European (non-Finnish) population (PM2_Supporting, BS1, and BA1 are not met).  The computational predictor REVEL gives a score of 0.681, which is neither above nor below the thresholds predicting a damaging or benign impact on DICER1 function (PP3 and BP4 not met). A different missense variant, c.1454G>A (p.Gly485Glu), in the same codon has been reported (ClinVar Variation ID: 2738880). However, this variant has not yet met the criteria to be classified as pathogenic by the ClinGen DICER VCEP (PM5 not met). Although this variant has been observed in individuals undergoing genetic sequencing, to our knowledge, this variant has not been reported in individuals with DICER1-related tumor predisposition (PS4 not met; PMIDs, ClinVar GTRs, Internal lab contributors). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: no criteria met (VCEP specifications version 1.4.0). Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 0, which equates to a classification of Uncertain Significance.",
      "unMetCodes": [
        "PM2",
        "PM1",
        "PP3",
        "BS2",
        "BS1",
        "PM5",
        "BP4",
        "BA1"
      ],
      "unMetCodesSearch": "pm2 pm1 pp3 bs2 bs1 pm5 bp4 ba1",
      "uuid": "46c10a91-4249-41d8-be22-bb5f2aab0046",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000008747",
      "_id": "AlleleRecords/60595612",
      "_key": "60595612",
      "_rev": "_mbFkMpa---",
      "affiliationId": "50050",
      "approvedDate": "2026-11-03",
      "caId": "CA7331435",
      "classification": "Uncertain Significance",
      "condition": "DICER1-related tumor predisposition",
      "cvId": "254293",
      "docVersion": "1.1.0",
      "ep": "DICER1 and miRNA-Processing Gene VCEP",
      "gene": "DICER1",
      "geneNcbiId": "23405",
      "hgvs": [
        "NM_177438.3:c.1745T>C",
        "NC_000014.9:g.95116460A>G",
        "CM000676.2:g.95116460A>G",
        "NC_000014.8:g.95582797A>G",
        "CM000676.1:g.95582797A>G",
        "NC_000014.7:g.94652550A>G",
        "NG_016311.1:g.45963T>C",
        "LRG_492:g.45963T>C",
        "ENST00000529720.2:c.1745T>C",
        "ENST00000531162.7:c.1745T>C",
        "ENST00000674628.2:c.1745T>C",
        "ENST00000675540.2:c.1745T>C",
        "ENST00000696733.1:c.1745T>C",
        "ENST00000696734.1:c.1745T>C",
        "ENST00000696736.1:c.1745T>C",
        "ENST00000696737.1:c.1745T>C",
        "ENST00000696920.1:n.2008T>C",
        "ENST00000696921.1:n.2851T>C",
        "ENST00000696922.1:n.2154T>C",
        "ENST00000696923.1:c.1745T>C",
        "ENST00000696924.1:c.1745T>C",
        "ENST00000696925.1:n.2154T>C",
        "ENST00000696927.1:n.1340T>C",
        "ENST00000696928.1:n.1942T>C",
        "ENST00000343455.8:c.1745T>C",
        "ENST00000393063.6:c.1745T>C",
        "ENST00000526495.6:c.1745T>C",
        "ENST00000532939.3:c.1745T>C",
        "ENST00000556045.6:c.1745T>C",
        "ENST00000675995.1:c.*61T>C",
        "ENST00000343455.7:c.1745T>C",
        "ENST00000393063.5:c.1745T>C",
        "ENST00000526495.5:c.1745T>C",
        "ENST00000527414.5:c.1745T>C",
        "ENST00000532458.1:n.334T>C",
        "ENST00000541352.5:c.1745T>C",
        "NM_001195573.1:c.1745T>C",
        "NM_001271282.2:c.1745T>C",
        "NM_001291628.1:c.1745T>C",
        "NM_030621.4:c.1745T>C",
        "NM_177438.2:c.1745T>C",
        "LRG_492t1:c.1745T>C",
        "XM_011536599.1:c.1745T>C",
        "XM_011536600.1:c.1745T>C",
        "XM_011536601.1:c.1745T>C",
        "XM_011536602.1:c.1745T>C",
        "XM_011536603.1:c.1745T>C",
        "XM_011536604.1:c.1340T>C",
        "XM_011536605.1:c.266T>C",
        "XM_011536599.2:c.1745T>C",
        "XM_011536600.3:c.1745T>C",
        "XM_011536601.3:c.1745T>C",
        "XM_011536602.3:c.1745T>C",
        "XM_011536604.2:c.1340T>C",
        "XM_011536605.2:c.266T>C",
        "XM_017021120.2:c.1745T>C",
        "XM_017021121.2:c.1745T>C",
        "XM_017021122.2:c.1340T>C",
        "XM_017021123.2:c.1340T>C",
        "NM_001271282.3:c.1745T>C",
        "NM_001291628.2:c.1745T>C",
        "NM_001395677.1:c.1745T>C",
        "NM_001395678.1:c.1745T>C",
        "NM_001395679.1:c.1745T>C",
        "NM_001395680.1:c.1745T>C",
        "NM_001395682.1:c.1745T>C",
        "NM_001395683.1:c.1745T>C",
        "NM_001395684.1:c.1745T>C",
        "NM_001395685.1:c.1745T>C",
        "NM_001395686.1:c.1463T>C",
        "NM_001395687.1:c.1340T>C",
        "NM_001395688.1:c.1340T>C",
        "NM_001395689.1:c.1340T>C",
        "NM_001395690.1:c.1340T>C",
        "NM_001395691.1:c.1178T>C",
        "NM_001395692.1:c.1745T>C",
        "NM_001395693.1:c.1745T>C",
        "NM_001395694.1:c.1745T>C",
        "NM_001395695.1:c.1745T>C",
        "NM_001395696.1:c.1340T>C",
        "NM_001395697.1:c.62T>C",
        "NM_001395698.1:c.1340T>C",
        "NR_172715.1:n.2163T>C",
        "NR_172716.1:n.2090T>C",
        "NR_172717.1:n.2257T>C",
        "NR_172718.1:n.2257T>C",
        "NR_172719.1:n.2090T>C",
        "NR_172720.1:n.2090T>C",
        "NM_177438.3(DICER1):c.1745T>C (p.Ile582Thr)"
      ],
      "hgvsSearch": "nm_177438.3:c.1745t>c nc_000014.9:g.95116460a>g cm000676.2:g.95116460a>g nc_000014.8:g.95582797a>g cm000676.1:g.95582797a>g nc_000014.7:g.94652550a>g ng_016311.1:g.45963t>c lrg_492:g.45963t>c enst00000529720.2:c.1745t>c enst00000531162.7:c.1745t>c enst00000674628.2:c.1745t>c enst00000675540.2:c.1745t>c enst00000696733.1:c.1745t>c enst00000696734.1:c.1745t>c enst00000696736.1:c.1745t>c enst00000696737.1:c.1745t>c enst00000696920.1:n.2008t>c enst00000696921.1:n.2851t>c enst00000696922.1:n.2154t>c enst00000696923.1:c.1745t>c enst00000696924.1:c.1745t>c enst00000696925.1:n.2154t>c enst00000696927.1:n.1340t>c enst00000696928.1:n.1942t>c enst00000343455.8:c.1745t>c enst00000393063.6:c.1745t>c enst00000526495.6:c.1745t>c enst00000532939.3:c.1745t>c enst00000556045.6:c.1745t>c enst00000675995.1:c.*61t>c enst00000343455.7:c.1745t>c enst00000393063.5:c.1745t>c enst00000526495.5:c.1745t>c enst00000527414.5:c.1745t>c enst00000532458.1:n.334t>c enst00000541352.5:c.1745t>c nm_001195573.1:c.1745t>c nm_001271282.2:c.1745t>c nm_001291628.1:c.1745t>c nm_030621.4:c.1745t>c nm_177438.2:c.1745t>c lrg_492t1:c.1745t>c xm_011536599.1:c.1745t>c xm_011536600.1:c.1745t>c xm_011536601.1:c.1745t>c xm_011536602.1:c.1745t>c xm_011536603.1:c.1745t>c xm_011536604.1:c.1340t>c xm_011536605.1:c.266t>c xm_011536599.2:c.1745t>c xm_011536600.3:c.1745t>c xm_011536601.3:c.1745t>c xm_011536602.3:c.1745t>c xm_011536604.2:c.1340t>c xm_011536605.2:c.266t>c xm_017021120.2:c.1745t>c xm_017021121.2:c.1745t>c xm_017021122.2:c.1340t>c xm_017021123.2:c.1340t>c nm_001271282.3:c.1745t>c nm_001291628.2:c.1745t>c nm_001395677.1:c.1745t>c nm_001395678.1:c.1745t>c nm_001395679.1:c.1745t>c nm_001395680.1:c.1745t>c nm_001395682.1:c.1745t>c nm_001395683.1:c.1745t>c nm_001395684.1:c.1745t>c nm_001395685.1:c.1745t>c nm_001395686.1:c.1463t>c nm_001395687.1:c.1340t>c nm_001395688.1:c.1340t>c nm_001395689.1:c.1340t>c nm_001395690.1:c.1340t>c nm_001395691.1:c.1178t>c nm_001395692.1:c.1745t>c nm_001395693.1:c.1745t>c nm_001395694.1:c.1745t>c nm_001395695.1:c.1745t>c nm_001395696.1:c.1340t>c nm_001395697.1:c.62t>c nm_001395698.1:c.1340t>c nr_172715.1:n.2163t>c nr_172716.1:n.2090t>c nr_172717.1:n.2257t>c nr_172718.1:n.2257t>c nr_172719.1:n.2090t>c nr_172720.1:n.2090t>c nm_177438.3(dicer1):c.1745t>c (p.ile582thr)",
      "metCodes": [
        "PS4_Supporting",
        "BP4"
      ],
      "metCodesSearch": "ps4_supporting bp4",
      "moi": "Autosomal dominant inheritance",
      "mondoId": "MONDO:0100216",
      "preferredVarTitle": "NM_177438.3(DICER1):c.1745T>C (p.Ile582Thr)",
      "publishedDate": "2026-11-12",
      "retracted": false,
      "summaryDesc": "The NM_177438.3:c.1745T>C variant in DICER1 is a missense variant predicted to cause substitution of isoleucine by threonine at amino acid 582 (p.Ile582Thr). This variant received a total of 1 phenotype point(s) across 1 unrelated proband meeting DICER1 VCEP phenotype specificity scoring criteria of 1-1.5 points (PS4_Supporting; PMID 26925222). The total allele frequency in gnomAD v4.1.1 is 0.000001861 (3/1611810 alleles) with a highest population minor allele frequency of 0.00003201 (2/62476 alleles) in \"remaining\" population (PM2_Supporting, BS1, and BA1 are not met). The computational predictor REVEL gives a score of 0.493,  which is below the threshold of 0.500, and the splice site predictors SpliceAI and MaxEntScan indicated that the variant has no impact on splicing, evidence that does not predict a damaging effect on DICER1 function (BP4). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: PS4_Supporting, BP4. (VCEP specifications version 1.4.0) Based on Tavtigian et al 2020 (PMID:32720330), the total points applied = 0, which equates to a classification of VUS.",
      "unMetCodes": [
        "PM2",
        "PS1",
        "PS2",
        "PS3",
        "PM1",
        "PP1",
        "PP3",
        "PP4",
        "BS2",
        "BS1",
        "BS4",
        "BS3",
        "PM5",
        "BP2",
        "BA1"
      ],
      "unMetCodesSearch": "pm2 ps1 ps2 ps3 pm1 pp1 pp3 pp4 bs2 bs1 bs4 bs3 pm5 bp2 ba1",
      "uuid": "a64b2236-86cb-4b45-840e-349d93b1faeb",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    }
  ],
  "metadata": {
    "rendered": {
      "by": "https://erepo.genome.network/evrepo/api/summary/srvc",
      "when": "2026-11-19T11:22:53.651Z"
    }
  },
  "status": {
    "code": 200,
    "name": "OK"
  }
}